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ABSTRACT 
Metabolic Engineering of the Flow of Reducing Equivalents for the 
Production of Biochemicals in Escherichia coli 
by 
Irene Martinez Basterrechea 
In the present thesis, metabolic engineering principles have been applied to 
strategically design E. coli strains with improved characteristics for the production of 
biochemicals. The metabolic engineering discipline combines molecular biology 
techniques, such as gene inactivation or gene overexpression, with an engineering 
perspective to design and construct more efficient biological systems to increase product 
yield and productivity. 
Microorganisms naturally produce a wide variety of compounds of industrial 
interest, e.g. antioxidants, polymers, amino acids, hydroxyacids and chiral alcohols, 
among others. However, in many cases the production processes are not economically 
feasible due to low product yield, low productivity, and/or difficulties on cultivating the 
native producer. Product yield and productivity are affected by a variety of factors. For 
instance, the generation of side-products limits the amount of carbon, other nutrients and 
energy directed to the synthesis of the compound of interest; and the requirement of 
reducing equivalents, NAD(P)H, in stoichoimetric quantities for many enzymatic 
reactions. These compounds are expensive, although, they can be regenerated in vivo, but 
the regeneration rate may be the limiting factor in the process. Also, the metabolic 
pathway used by the cells for product synthesis is critical, different pathways leading to 
the same product could require different precursors, and have different reducing 
equivalents and energy requirements. 
Specifically, this thesis includes the design, construction and testing of strains for 
the production of NADH-dependent C4 compounds that are naturally produced in low 
quantities in E. coli such as succinate and malate, and for the production of NADPH-
dependent biochemicals naturally produced by other organisms, such as the antioxidant 
lycopene and s-caprolactone, where the genes encoding the enzymes in the corresponding 
pathway were heterogously expressed in E. coli. The strategic design included the 
inactivation of genes involved in the synthesis of side-products, the overexpression of 
heterologous genes for the production of non-native compounds, the replacement of a 
gene involved in E. coli central metabolic pathway to increase the availability of reducing 
equivalents required in the synthesis of the compound of interest, and the construction of 
multiple engineered strains to be used to study the fundamentals of redox balance in the 
cell. 
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1 Introduction 
1.1 Metabolic Engineering Overview 
Metabolic engineering (ME) is the rational genetic modification of metabolic 
pathways in an organism to improve cellular activities and generate a specific 
characteristic or phenotype (Stephanopoulos 1999). Tools such as recombinant DNA 
technology and other molecular biology techniques are applied for the achievement of the 
desired behavior. Genes can be deleted to eliminate competing pathways, overexpressed 
to increase enzyme pool or introduced from a different organism into a suitable host for 
industrial purposes. The current availability of genomic information for many organisms 
has allowed the rapid increase in ME research. Some examples of ME applications are 
the increase in productivity in organisms that naturally produce the compound of interest, 
e.g. isoleucine production by Corynebacterium (Colon et al. 1995), ethanol production 
by Saccharomyces cerevisiae (Nissen et al. 2000); production of compounds that are 
naturally produced by a different organism in an heterologous host with productivity and 
cost advantages, e.g. plant terpenoids synthesized by E. coli (Chang et al. 2007), 
production of polyhydroxybutyrate (PHB) in E. coli (Sanchez et al. 2006a); the 
generation of a product from a less expensive or renewable carbon source, e.g. production 
of ethanol from glucose and xylose using S. cerevisiae (Ho et al. 1999; Jeffries and Jin 
2004; Kuyper et al. 2005), the development of novel compounds with potential use in 
pharmaceutical and other chemical industries (Chartrain et al. 2000), e.g. production of 
new polymers in plants (Poirier 1999), to name a few. Metabolic engineering can also be 
2 
used for a more fundamental objective, to understand cell behavior under different 
environmental or genetic conditions. 
An important tool used in ME is the metabolic flux analysis (MFA); this 
technique studies the effect of genetic changes in the distribution of metabolites within 
the cell, and the alterations produced in reaction and pathway fluxes. Metabolic fluxes are 
calculated using metabolite concentrations together with a stoichoimetric model that 
includes all the important reactions in the network. Information obtained from MFA can 
serve to identify potential "bottleneck" (rate-limiting) reactions and to understand the 
effect of the genetic alterations in cell metabolism. Further genetic modifications 
designed based on the MFA results have demonstrated to contribute to whole-cell 
biocatalysis improvement (Alper et al. 2005; Wang et al. 2006a). 
1.2 Whole cell biocatalysis for the production of biochemicals 
Microorganisms naturally produce a wide variety of compounds of industrial 
interest. In many cases, the production processes are not economically feasible due to low 
product yields and productivities, or difficulties on cultivating the native producer. The 
application of metabolic engineering has contributed to the development of modified 
organisms with enhanced performances (Stephanopoulos 1999). New molecular biology 
tools and analytical methods have also contributed to the development of strains or cell 
lines with increased product yield and productivity. 
Oxidoreductases, comprising oxidases, reductases and dehydrogenases, are an 
attractive family of enzymes for industrial applications and usually require reducing 
equivalents (cofactors) in the form of nicotinamide adenine dinucleotide (NAD(H)) or 
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nicotinamide adenine dinucleotide phosphate (NADP(H)) (Ernst et al. 2005). The use of 
theses enzymes has been investigated for a wide range of applications such as the 
synthesis of antioxidants, e.g. lycopene (Alper et al. 2005); chiral alcohols (Kataoka et al. 
2003); biopolymers, e.g. polyhydroxybutyrate (PHB) (Sanchez et al. 2006a); amino acids 
(Ravnikar and Somerville 1987); succinate (Sanchez et al. 2005a); and construction of 
biosensors, among others (Hummel 1999; Liu and Wang 2007). 
The reducing equivalents NADH and NADPH are expensive; hence they may 
limit the applicability of these enzymes at an industrial scale. Recently, an important 
amount of research has been dedicated to develop cofactor regeneration systems 
(Boonstra et al. 2000; Kragl et al. 1996; Liu and Wang 2007). For instance, the 
replacement of the native cofactor-independent formate dehydrogenase (FDH) with a 
NAD -dependent FDH from Candida boidinii in recombinant E. coli has shown to 
increase NADH availability increasing the production of reduced compounds (Berrios-
Rivera et al. 2002a); and the overexpression of glucose dehydrogenase (GDH) has been 
used for cofactor regeneration in NADPH-dependent indigo production in a recombinant 
E. coli strain (Lu and Mei 2007). In addition, alcohol dehydrogenase (ADH) has been 
used for product synthesis and cofactor regeneration at the same time (Liu and Wang 
2007). 
The production and purification of enzymes to be used as biocatalysts can be 
difficult, expensive and time consuming. The production of compounds that require 
multi-step enzymatic reactions and/or cofactors can be especially expensive. Thus, the 
use of whole-cell biocatalysts is particularly attractive in these cases by providing the 
necessary enzymes for cofactor regeneration, not require of protein purification, 
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potentially increase protein stability, and their ability to catalyze complicated multi-step 
reactions (Wichmann and Vasic-Racki 2005). Despite the ability of E. coli to regenerate 
reducing equivalent cofactors through the many cell metabolic reactions, cofactor 
availability has shown to be a limiting factor in several cases (Ernst et al. 2005; Kataoka 
et al. 2003). As mentioned above, these cofactors are expensive and are required in 
stoichoimetric quantities. In some studies, the external addition of NADH or NADPH to 
the culture medium was required to overcome cofactor limitation in whole-cell 
biocatalysis (Weckbecker and Hummel 2004) 
A natural cofactor regeneration system is the use of whole-cell biocatalysts, 
where the cells produce all the enzymes required for the synthesis of the compound of 
interest and for cofactor regeneration. These systems have been also preferred when 
multi-enzymatic steps are required. Despite the ability of whole-cells to regenerate 
reducing equivalents, the regeneration rate has been found limiting in many processes 
(Ernst et al. 2005). A better understanding about how cells maintain redox balance and 
alternative and more efficient ways to regenerate the cofactor of interest are necessary for 
more processes to be economically feasible. 
This thesis is a contribution to the field of whole-cell biocatalysis, especially to 
processes that require reducing equivalents as cofactors. The research has been divided in 
two parts 
The Research section has been divided into two parts, both related to the synthesis 
of biochemicals that require reducing equivalents in the form of NAD(P)H. Part I 
describes the study of the production of natural NADH-dependent C4-compounds in E. 
coli. Specifically, the evaluation of different operation conditions on succinate production 
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by a previously engineered high succinate producing strain; and the study of the effect of 
different gene deletions, such as fumarate redutase (frdA) and fumarases (fumA, B and Q 
on C4-compounds synthesis. Part II describes the research performed towards the 
production of NADPH-dependent products; including the strategic modification on a an 
important step of glycolysis to increase NADPH availability and the rational design and 
construction of strains for the study of the importance of transhydrogenases in redox 
balance in the cell and their potential role on reducing equivalent dependent synthesis of 
heterologous compounds in E. coli. 
1.3 Thesis outline 
Materials and method used in the development of this thesis are described in 
Chapter 2. The research chapters are divided in two parts, Part I (Chapters 3 to 5) 
describes the research performed towards the production of NADH-dependent C4-
compounds. Chapter 3 describes the study of the effect of different aeration conditions 
for biomass accumulation on anaerobic succinate production by the metabolic engineered 
strain SBS550MG (pHL413), previously constructed in Dr. San lab (Sanchez et al. 
2005b). Chapter 4 describes the evaluation of different operation conditions in anaerobic 
succinate production in SBS550MG (pHL413) including cell and glucose concentration 
in shake flasks; and gas composition, pH and temperature in batch bioreactor 
experiments. The last two factors were evaluated using a full factorial design of 
experiments. Chapter 5 describes the application of metabolic engineering to assess the 
effect of different strategically defined gene deletions on fermentation product profiles in 
E. coli. The gene deletions included the elimination of by-product routes and the 
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channeling of reducing equivalents to C4 compounds synthesis. This research involved 
strains design and construction; and characterization of the strains in shake flasks 
experiments. 
Part II includes Chapters 6 and 7. These Chapters discuss the design and 
construction of different metabolic engineered strains with strategic modifications in 
genes involved in the generation or consumption of reducing equivalents. Specifically, 
Chapter 6 describes the design of an E. coli strain where the endogenous NADH-
dependent glyceraldehyde-3-phosphate dehydrogenase (GAPDH), enzyme involved in E. 
coli central metabolism, was inactivated and replaced by a GAPDH from C. 
acetobutylicum. This strain was evaluated as a platform for the production of NADPH-
dependent compounds not naturally produced in E. coli, such as lycopene and e-
caprolactone, and it showed a significant increase in product yield. 
Chapter 7 describes a strategy to assess the role and importance of the two 
different nicotinamide adenine nucleotide transhydrogenases presents in E, coli, UdhA 
and PntAB, on the synthesis of NADPH-dependent compounds. Transhydrogenases 
interchange reducing equivalents between NAD+ and NADP+ and vice versa. Redox 
balance inside the cell is crucial for cell survival and the transhydrogenases are thought to 
have a very important role in the maintenance of this balance. A set of transhydrogenase 
mutant strains, including single and double mutations, as well as overexpression plasmids 
were rationally designed and constructed. Different combinations of mutant strains and 
overexpressing plasmids were assayed for the role of theses transhydrogenase in the 
production of reducing equivalents dependent pathways, e.g. interchangeability or if they 
catalyze the reaction in one direction preferably. The evaluation of this set of strain will 
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increase the knowledge about these enzymes and may give us a sign about which strain 
would be a good platform for the synthesis of NADH or NADPH-dependent products. 
Chapter 8 presents the recommendations for the continuation of this important 
research in the future. 
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2 Materials and Methods 
In this section, general methods used during the development of this work are 
described. More specific methods and materials are described in the corresponding 
chapters. 
2.1 Bacterial Strains and Plasmids 
Escherichia coli strains and plasmids used in this work are described in each 
corresponding chapter. The E. coli mutant strains were constructed by the PI phage 
transduction method and/or the single-step inactivation method described later (Datsenko 
and Wanner 2000). 
2.2 Culture Medium 
2.2.1 LB Medium 
The Luria-Bertani broth (LB) contained 10 g/L tryptone, 5 g/L yeast extract and 
10 g/L of NaCl. The solution pH was adjusted to 7.5 using 3M NaOH. The LB medium 
was autoclaved at 121°C for 20-35 min. When required, after autoclaving, different 
carbon sources (e.g. glucose), antibiotics or other particular compounds were added 
aseptically in the amount specified for each experiment. 
For anaerobic shake flasks experiments, the LB medium used was supplemented 
with 1 g/L NaHC03. 
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2.2.2 2YT 
Culture medium 2YT contained 16 g/L of tryptone, 5 g/L yeast extract and 5 g/L 
of NaCl. The solution pH was adjusted to 7.5 with 3M NaOH, and autoclaved at 121°C 
for 20 min. 
2.2.3 Defined medium M9 
M9 medium contains 6 g/L Na2HP04, 3 g/L KH2P04, 0.5 g/L NaCl and I g/L 
NH4C1. After autoclaving, 10 ml of 0.01 M CaCl2 solution and 2 ml of 1M MgS04 are 
added to 1 L of medium. The medium was supplemented with appropriate amount of 
antibiotics and 0.4% glucose unless otherwise noted. 
2.2.4 Agar plates: short term storage and strain selection 
Agar plates were prepared using LB or defined medium and 15 g/L of technical 
agar. The mixture was autoclaved and later cooled to about 55°C before addition of 
required amount of antibiotic, X-gal and/or isopropyl-|3-D-thiogalactoside (IPTG) in 
accordance with the specific experiment. About 20 ml of this mixture was poured in each 
plate. 
2.3 Glycerol stocks 
Cells from 5 ml overnight culture were centrifuged; the pellet was re-suspended in 
0.5 ml of LB medium and 0.5 ml of sterile glycerol stock solution (65 % glycerol 
(vol/vol), 0.1 M MgS04 and 0.025 M Tris-HCl pH 8.0). The mixture was vortexed and 
kept at room temperature for about 5 min, before storing it at -80°C. 
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2.4 Cell cultivation 
2.4.1 Shake flasks experiments 
Unless otherwise noted, cells were streaked from glycerol stock in LB agar plates 
containing the corresponding antibiotics and grown overnight at 37°C. A single colony 
was inoculated into 5 ml LB in 14 ml culture tubes and incubated overnight at 37°C and 
250 rpm. In general, 1% of the overnight culture is used to inoculate a higher volume 
flask, e.g. 20 ml medium in a 250 ml flask or 200-400 ml in a 2L flask. Antibiotics and 
inducer are added depending on the specific experiment. 
2.4.2 Batch bioreactor experiments 
The fermenter system used was a 1.0 L Bioflo 110 fermenter (New Brunswick 
Scientific) equipped with a glass pH electrode and a polarographic dissolved oxygen 
(DO) electrode Ingold InPro 6000 (Mettler Toledo) to monitor and control pH and 
dissolved oxygen conditions, respectively. The medium used for the aerobic phase 
contained 20 g/L tryptone, 10 g/L yeast extract, 0.9 g/L K2HP04 x 3 H20, 1.1 g/L 
KH2P04, 3 g/L (NH4)2S04, 0.5 g/L MgS04 x 7 H20, 0.25 g/L CaCl2 x H20, 200 mg/L 
ampicillin, 30 (J.1/L antifoam sigma #204, 1 mg/L thiamine, 1 mg/L biotin, 2 g/L glucose. 
Another 2 g/L of glucose were added when the initial glucose was depleted. No pH 
control was applied during aerobic growth. After the additional glucose was depleted and 
the pH increased to 7.4-7.5, the air flow was stopped and a 0.2 L/min C02 flow was 
established. At this time 20 g/L glucose were added to the culture. Samples were taken at 
different times and their metabolite concentrations were determined by HPLC. 
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2.4.3 Extracellular metabolites analysis 
Extracellular metabolites such as glucose, succinate, formate and pyruvate among 
others were analyzed by HPLC as describer earlier (Sanchez et al. 2005b). In brief, the 
HPLC system (Shimadzu-lOA System, Shimadzu, Columbia, MD) was equipped with a 
cation-exchange column (HPX-87H, Biorad Labs, Hercules, CA), a differential refractive 
index (RI) detector (Waters 2410, Waters, Milford, MA) and an ultraviolet (UV) detector 
(Shimadzu SPD-10A). The mobile phase used was a 2.5 mM H2SO4 solution at a 0.6 
mL/min flow rate. The column was operated at 55°C. 
2.4.4 Cell Density 
Cell density was measured in spectrophotometer at 600 nm using 2.5 mM NaCl 
solution when sample dilution was needed. 
2.5 Genetic Manipulations 
2.5.1 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) was used to amplify the genes of interest for 
uses including cloning, gene inactivation or to confirm gene insertion or deletion. PCR 
was performed in a RoboCycler Gradient 96 (Stratagene, La Jolla, CA). The MasterTaq 
Kit from Eppendorf (Hamburg, Germany), which includes PCR buffer, dNTPs, Taq DNA 
polymerase, was used according to manufacturer's directions. DNA primers were 
designed for gene amplification using standard protocol. The primers were designed and 
purchased from Integrated DNA Technologies, Inc (Coralville, IA) or Sigma-Genosys. 
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In general, the PCR program involved DNA denaturation at 95°C for 1 min, 
annealing at 50-65°C for 30-60s, elongation at 72°C for 1-3 min, this procedure was 
repeated for 30-36 cycles, and a final elongation at 72°C for 10 min. PCR product sizes 
were confirmed by agarose gel electrophoresis. 
2.5.2 Agarose Gel Electrophoresis 
1% agarose gel was used to analyze DNA size and concentration. Electrophoresis 
gels were run at 100 mM for 45 min. 
2.5.3 Plasmid Isolation and DNA Purification 
Plasmid isolation was performed using the GenElute Plasmid MiniPrep Kit from 
Sigma (St. Louis, MO) or the QIAprep Spin Miniprep Kit (QIAGEN, Valencia, CA) 
using the protocol provided by manufacturers. The protocols involved the lysis of the 
cells, selective binding of the plasmid DNA to a column, washing of the column to 
remove contaminants and a final elution of the plasmid DNA using water or appropriate 
buffer. PCR products were purified in a similar manner using QIAquick PCR Purification 
Kit (QIAGEN, Valencia, CA). When necessary, PCR products were purified from 
agarose gels using the QIAEX II Gel Extraction Kit (QIAGEN, Valencia, CA). 
2.5.4 Plasmid construction 
The genes of interest were either amplified by PCR using primers containing the 
specific recognition sites for the selected restriction enzymes, or obtained by restriction 
digestion from another plasmid vector. The PCR product and plasmids were digested 
13 
using restriction enzymes purchased from New England Biolabs (Beverly, MA), Promega 
(Madison, WI), and Fisher (Pittsburgh, PA) following protocols provided by 
manufacturers. Ligations of digested DNA fragments were performed using the DNA 
Ligation Kit from Sigma (St. Louis, MO) following manufacturer's protocol. Ligated 
DNA was introduced in a suitable host by either chemical transformation or 
electroporation as described below. 
2.5.5 Cell Transformation 
2.5.5.1 Chemical Transformation 
Cells were streaked from glycerol stocks into appropriate agar plates and left 
overnight at 37°C. A single colony from the plate was used to inoculate 5 ml LB 
(antibiotic added if needed) and let grow overnight at 37°C. A flask with 20 ml of LB 
was inoculated with 0.2 ml of the overnight culture and let grow for approximately 3-4 
hours, until OD6oonm reached about 0.6. Then the culture was centrifuged at 3000xg for 5-
10 min and resuspended in 2 ml of cold sterile TSB solution (93 ml LB, 10 g PEG, 5 ml 
DMSO, 1 ml 1.0 M MgCl2 and 1 ml 1.0 M MgS04). Aliquots of 100 ul were placed in 
1.5 ml sterile centrifuge tubes and quickly frozen using dry ice and isopropanol mixture. 
Tubes were stored at -80°C for later use. 
Alternatively, chemical competent cells were prepared using an adaptation of the 
rubidium chloride method by New England Biolabs, Inc. In brief, a single colony from a 
plate was used to incoculate 5 ml LB medium. The culture was grown overnight at 37°C 
and 250 rpm. A volume of 0.2 ml of the overnight culture was used to inoculate 20 ml LB 
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supplemented with 20 mM MgS04 and the appropriate antibiotic concentrations. When 
the cells grew to 0.4 to 0.6 ODeoo they were centrifuged at 3,000xg for 7 min at 4°C. The 
pellet was resuspended in 20 ml ice cold TFBI (30 mM potassium acetate, 100 mM RbCl, 
10 mM CaCl2, 50 mM MnCl2 and 15% glycerol, pH 5.8 adjusted with acetic acid), 
incubated on ice for 5min and centrifuged (3,000xg, 5min, 4°C). The pellet was 
resuspended in 2 ml ice cold TFBII (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl and 
15% glycerol, pH adjusted to 6.5 with KOH). Cells aliquots were prepared for storage as 
described above. For transformation, the cells were thaw on ice and incubated with the 
plasmid DNA for 15-60 min on ice. The cells were heat shocked at 37°C for 45 s, 1 ml of 
Lb was added and cells were grown at 37°C and 250 rpm for lh before plating in 
selective medium. 
2.5.5.2 Electroporation 
Electrocompetent cells were grown as described in the previous method, 
centrifuged and washed three times with ice-cold 10% glycerol before freezing them on 
dry ice and isopropanol mixture and store them at -80°C for later use. 
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Parti 
The research sections in this thesis are divided in two parts. Part I, corresponding 
to Chapters 3 to 5, describes the research conducted towards the production of NADH-
dependent C4 native compounds in Escherichia coli. And, Part II, corresponding to 
Chapters 6 and 7, describes the strategic genetic modifications implemented in E. coli 
cells for the study of NADPH-dependent synthesis of heterologous products. 
Some examples of C4 compounds are succinate, malate and fumarate. These 
compounds are naturally produced by anaerobic fermentation as intermediates or final 
products in E. coli, although in very small quantities or at undetectable levels. Reducing 
equivalents in the form of NADH are required for the formation of these compounds 
which could be a limiting factor in the system (Sanchez et al. 2005b). On the other hand, 
operation conditions are known to affect yield and productivity in bioprocesses. 
Chapters 3 and 4 focus on the evaluation of different operation conditions on 
succinate production by a high succinate producer E. coli strain previously engineered in 
our lab, SBS550MG (pHL413) (Sanchez et al. 2005b). This strain contains deletions in 
routes leading to the production of competing fermentation products, e.i. adhE, IdhA and 
ack-pta, and in the iclR gene encoding the repressor of the glyoxylate shunt pathway. To 
channel the carbon towards succinate production, through the increase in the oxaloacetate 
(OAA) pool, the gene encoding the pyruvate carboxylase, pyc, from Lactococcus lactis 
was overexpressed in the strain described above (plasmid pHL413). In this strain, 
succinate is produced through a double route, the traditional fermentation pathway where 
2 NADH molecules are required per molecule of succinate produced, and the glyoxylate 
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shunt, where only 0.5 molecules of NADH are required; although the synthesis of 
succinate through the glyoxylate shunt is carbon limiting. An adequate distribution of 
carbon between both pathways results in a theoretical maximum succinate yield from 
glucose in this strain of 1.6 mole of succinate per mole of glucose (Cox et al. 2006). The 
operational conditions are critical to achieve the maximum theoretical yield as is 
described in the following Chapters. 
The process for succinate production comprises two phases, the first is aerobic for 
biomass accumulation and the second is anaerobic for product synthesis. It is well known 
that the level of aeration affects cell growth and gene expression in E. coli. Two different 
levels of aeration during the aerobic phase were studied respect to gene expression and 
their influence on fermentation product profiles and yields during the anaerobic phase. 
The results of this research are described in Chapter 3. 
Chapter 4 focuses on the study of operation factors such as initial glucose 
concentration and cell concentration in shake flasks experiments for succinate production 
using the strain described above. In addition, the effect of gas composition, pH and 
temperature were analyzed in bioreactor experiments. 
Chapter 5 describes the strategic design of strains and implementation of 
experiments to evaluate the influence of different gene deletions on C4 product synthesis 
in E. coli. Genes involved in anaerobic fermentation such as the fumarate reductase gene 
ifrdA) and fumarase genes (fumA, fumB and fumC), among others, were deleted in a 
strain lacking ethanol and lactate producing genes, adhE and IdhA. Fermentation product 
profiles in the engineered strains are reported. 
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Chapter 3 
3 Effect of the aeration condition during the growth phase 
on anaerobic succinate production by an engineered 
Escherichia coli strain 
3.1 Abstract 
The effect of different aeration conditions during the growth phase of the high 
succinate producer Escherichia coli SBS550MG (pHL413) was investigated. Different 
oxygen levels are known to induce or repress transcription and/or synthesis of different 
enzymes. The changes in metabolites and gene expression profiles were analyzed at two 
different levels of aeration. The level of aeration during the cells growth phase 
significantly affected the cells performance during the anaerobic-production phase. The 
succinate yield was 1.55 and 1.25 mol succinate/mol glucose, and the productivity was 
1.3 and 0.9 g/(L h) for the low aeration experiment and high aeration experiment, 
respectively. The formation of fermentation side products was higher in the high aeration 
case, particularly pyruvate was accumulated. The level of aeration during the growth 
phase played an essential role for anaerobic succinate production by E. coli SBS550MG 
(pHL413), where the low aeration condition allowed the attainment of the maximum 
theoretical succinate yield for this strain. 
Keywords: succinate, aeration effect, E. coli, transition 
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3.2 Introduction 
Facultative organisms are able to grow under aerobic and anaerobic conditions by 
changing their cell physiology and metabolic pathways to adapt to the new environment. 
Changes in cell metabolism are controlled by sensing and regulatory systems that sense 
oxygen levels and transmit a signal to modify gene expression accordingly (Sawers 
1999). Escherichia coli has several sensing mechanisms, among them the FNR and Arc 
regulator systems have been studied (Becker et al. 1996; Shalel-Levanon et al. 2005a; 
Shalel-Levanon et al. 2005b; Spiro and Guest 1990). In anaerobic conditions E. coli 
metabolism generates several fermentation products such as acetate, lactate, formate, 
ethanol and succinate in various yields. Efforts to genetically modify E. coli and carefully 
control growth conditions to generate high production of a single product have been 
subjects of many investigations in applied microbiology. 
Succinate is widely used in industry as additive in food and pharmaceuticals, as 
well as a precursor of biodegradable polymers, surfactants, synthetic resins, among other 
uses (Hong and Lee 2002; Lee et al. 2004). E. coli does not naturally accumulate 
succinate; its natural production is rather low (maximum theoretical yield of 1 mol 
succinate per mol of glucose). In the past few years, several engineered E. coli strains 
have been created to produce succinate from glucose at various yields. Some approaches 
include the deletion of one or more enzymes involved in competing pathways such as 
LDH (Jantama et al. 2008b; Mat-Jan et al. 1989; Sanchez et al. 2005b), ADH (Jantama et 
al. 2008b; Sanchez et al. 2005b), PFL (Jantama et al. 2008b) and ACK-PTA (Jantama et 
al. 2008b; Sanchez et al. 2005b); the overexpression of enzymes that channel the carbon 
towards succinate through the formation of OAA, such as PEPC and PYC (Gokarn et al. 
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1998; Gokarn et al. 2000; Lin et al. 2005e; Millard et al. 1996; Vemuri et al. 2002a; 
Wang et al. 2006b), or through malate formation by the malic enzyme (Hong and Lee 
2001; Kwon et al. 2007; Stols and Donnelly 1997; Stols et al. 1997). The deletion of 
transporter related genes, such as the glucose-specific permease of the 
phosphotransferase system, PTSG (Chatterjee et al. 2001; Donnelly et al. 1998) and the 
formate transporter, FocA (Jantama et al. 2008a) have also been performed to increase 
succinate production. 
The strain used in this work was SBS550MG (pHL413), created by Sanchez and 
collaborators (Sanchez et al. 2005b), it contains deletions on adhE, IdhA, iclR and ack-pta 
and overexpresses the gene pyc encoding for pyruvate carboxylase from Lactococcus 
lactis. This strain has shown to produce succinate at high yields, 1.6 mol succinate/mol 
glucose, (Sanchez et al. 2006b) in a dual-phase system; where the first phase was aerobic 
and the cells were grown in shake flasks followed by an anaerobic phase where succinate 
was produced in shake flasks or batch bioreactor (Sanchez et al. 2005b; Sanchez et al. 
2006b). This yield value is also the theoretical maximum for this strain (Cox et al. 2006; 
Sanchez et al. 2006b). In this study we developed the entire process for succinate 
production by E. coli strain SBS550MG (pHL413) in a bioreactor. The centrifugation 
step was then eliminated saving time and resources, which is desirable for scale up 
purposes. 
The physiological state of the cells is critical in a dual-phase system where the 
enzymes produced during the first phase (aerobic-growth phase) will influence the 
performance of the cells in the anaerobic-production phase. In the present study, we 
analyzed the effect of two different aeration conditions during the growth phase on 
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succinate production by the high succinate producer E. coli strain SBS550MG (pHL413). 
We evaluated the performance of this strain growing aerobically in a bioreactor and 
switching the condition to anaerobic in the same bioreactor. The effect of two different 
aeration conditions was analyzed with respect to succinate production and side product 
formation. Metabolites and gene expression profiles were determined to better understand 
the differences in cell metabolism that originate differences in product distribution. 
3.3 Material and methods 
3.3.1 Strain and plasmid 
The E. coli strain SBS550MG (pHL413) was used for the experiments. This strain 
contains the following gene deletions: adhE IdhA iclR ackptawCm (Sanchez et al. 2005b) 
and harbors the pHL413 plasmid containing the pyruvate carboxylase gene (pyc) from 
Lactococcus Lactis in pTrc99A, ApR (Lin et al. 2004). 
3.3.2 Batch cultures 
The fermenter system used was a 1.0 L Bioflo 110 fermenter (New Brunswick 
Scientific) equipped with a glass pH electrode and a polarographic dissolved oxygen 
(DO) electrode Ingold InPro 6000 (Mettler Toledo) to monitor and control pH and 
dissolved oxygen conditions, respectively. The medium used for the aerobic phase 
contained 20 g/L tryptone, 10 g/L yeast extract, 0.9 g/L K2HP04 x 3 H20, 1.1 g/L 
KH2P04, 3 g/L (NH4)2S04, 0.5 g/L MgS04 x 7 H20, 0.25 g/L CaCl2 x H20, 200 mg/L 
ampicillin, 30 fil/L antifoam sigma #204, 1 mg/L thiamine, 1 mg/L biotin, 2 g/L glucose. 
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Another 2 g/L of glucose were added when the initial glucose was depleted. No pH 
control was applied during aerobic growth. After the additional glucose was depleted and 
the pH increased to 7.4-7.5, the air flow was stopped and a 0.2 L/min CO2 flow was 
established. At this time 20 g/L glucose were added to the culture. Samples were taken at 
different times and their metabolite concentrations were determined by HPLC. 
3.3.3 Extracellular metabolites analysis 
Extracellular metabolites such as glucose, succinate, formate and pyruvate among 
others were analyzed by HPLC as describer earlier (Sanchez et al. 2005b). In brief, the 
HPLC system (Shimadzu-lOA System, Shimadzu, Columbia, MD) was equipped with a 
cation-exchange column (HPX-87H, Biorad Labs, Hercules, CA), a differential refractive 
index (RI) detector (Waters 2410, Waters, Milford, MA) and an ultraviolet (UV) detector 
(Shimadzu SPD-10A). The mobile phase used was a 2.5 mM H2SO4 solution at a 0.6 
mL/min flow rate. The column was operated at 55°C. 
3.3.4 Metabolic fluxes analysis 
The metabolic network considered for the analysis, was adapted from the network 
described by Sanchez and collaborators (Sanchez et al. 2006b). In brief, 17 fluxes were 
considered, vi-v)7j including glycolysis, glyoxylate shunt, anaerobic fermentation 
reactions, heterologous conversion of pyruvate into OAA, catalyzed by the L. lactis 
pyruvate carboxylase (PYC), and malate, succinate and pyruvate excretion. The redox 
balance for NADH was also included assuming no NADH accumulation (Sanchez et al. 
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2006b). E. coli strain SBS550MG (pHL413) did not show growth during the anaerobic 
phase, thus the flux to biomass (V2) was assumed to be zero. In the present work, the high 
aeration experiment showed pyruvate accumulation; then pyruvate excretion was also 
included in the metabolic flux analysis. The stoichiometric matrix including the above 
fluxes and the NADH balance was based on the pseudo-steady-state hypothesis (PSSH) 
for the intracellular intermediate metabolites and the law of mass conservation 
(Stephanopoulos et al. 1998). The description of the metabolic flux determination is 
presented in appendix A. 
3.3.5 Gene expression analysis 
3.3.5.1 RNA preparation 
Total RNA was isolated using the RNeasy mini kit (Qiagen, Valencia, CA) 
according to the manufacturer's protocol. Samples that were not extracted immediately 
were treated with Protect reagent from Qiagen (Valencia, CA), frozen using liquid 
nitrogen and stored at -80°C until extraction. The isolated RNA was treated with DNasel 
(Promega, Madison, WI) and RNase Inhibitor (Promega, Madison, WI) according to 
manufacturer protocol. The reaction was incubated at room temperature for 15 min. The 
RNA was then extracted with Phenol/CIA extract solution (CIA= 24:1 Chloroform: 
isoamyl alcohol) once and then with chloroform once. The RNA was mixed with 1/10 
volume of 3 M NaCl and 2 volumes of ethanol and incubated at -80°C for 20 min. Then, 
the mixture was centrifuged and washed with 75% ethanol (Shalel-Levanon et al. 2005a). 
The precipitated RNA was resuspended in RNase-free water (Sigma, St. Louis, MO). The 
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concentration of RNA was quantified by measuring the absorbance at 260 nm and 
applying the formula, concentration (ug/mL) = A260 x 40 x dilution factor. 
3.3.5.2 cDNA synthesis and quantitative PCR amplification 
The cDNA was synthesized using the Promega Reverse Transcriptase System (Promega, 
Madison, WI) and the RNA extracted as described above. The reaction was carried out in 
a RoboCycler Gradient 96 (Stratagene, La Jolla, CA). The cDNA was synthesized in a 
total reaction mixture volume of 60 ul containing 1 ug of RNA as template. The reaction 
mixture was incubated for 10 min at room temperature for primer extension, 30 min at 
50 °C for reverse transcription, and then 5 min at 95 °C and 5 min at 6 °C for inactivation 
of the reverse transcriptase. Non amplification controls were prepared by not adding 
reverse transcriptase to the mixture. The synthesized cDNA was then diluted 10-fold with 
nuclease-free water and stored at -20 °C until further use. 
Quantitative real-time PCR (Polymerase Chain Reaction) was performed in a ABI 
Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) using the 
SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA). The increase in 
fluorescence is directly related to the formation of PCR product, the SYBR Green dye 
binds to the double-stranded DNA formed during the amplification. Forward and reverse 
primers were designed for each gene to generate a PCR product of 150 ±2 bp. The list of 
selected genes for the study and the respective primer sets for the qRT-PCR are shown in 
Table 3-1. Reactions were carried out in 96-well plate using a mixture of 3 uL diluted 
cDNA prepared above as template, 2 uL mixed primers (1.25 pmol/uL), 10 uL SYBR 
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Green PCR Master Mix, and 5 uL nuclease-free water. The reaction for each gene was 
performed in quadruplicates and a non amplification control was used. 
The reaction mixture was incubated 2 min at 50°C, 10 min at 95°C for Taq 
activation, followed by 40 cycles of 15s at 95°C (denaturation) and 1 min at 60°C 
(annealing/extension). 
The comparative CT method, according to manufacturer's protocol, was used for 
relative quantification of gene expression (ABI Prism 7700 Sequence Detection System 
User Bulletin #2, Applied Biosystems). The rrsA gene encoding 16S ribosomal RNA was 
used as a reference gene to standardize the amount of template added to a reaction. The 
difference between the CT of the gene of interest and the Cj of the reference gene (ACj) 
was calculated for all the genes in Table 3-1. The AACT was calculated by taking the 
difference between the ACT of a gene in the low aeration experiment and the ACT of the 
same gene in the high aeration condition experiment. The comparative expression level 
was calculated using the formula 2 "AACT as previously described (Shalel-Levanon et al. 
2005b). This method was used to compare the expression levels of the same gene at 
different time points and different experimental conditions, but cannot be used to 
compare the expression levels of different genes. 
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3.4 Results and Discussion 
Succinate production experiments were conducted in a dual-phase system in 
bioreactors where the first phase was aerobic for biomass accumulation followed by an 
anaerobic phase for succinate production. The behavior of the succinate producer E. coli 
SBS550MG (pHL413) strain was evaluated under two different aeration conditions for 
the aerobic phase. The pH, DO, extracellular metabolites and gene expression profiles 
were analyzed. The results and discussion are described below. 
3.4.1 DO and pH profiles 
The bioreactor experiments were operated at two different aeration conditions 
during the aerobic-growth phase. The high aeration condition comprised an agitation 
speed of 800 rpm and an air flow of 2.5 L/min, whereas the bioreactor under low aeration 
was agitated at 500 rpm and had an air flow of 1.5 L/min. When the 2 g/L glucose present 
initially were consumed, glucose was added to 2 g/L final concentration. After this batch 
of glucose was depleted and the pH increased to 7.4-7.5, the air flow was stopped and the 
system was switched to the production phase, where a CO2 flow (0.2 L/min) was 
established. At this time, 20 g/L glucose were added to the culture. The different aeration 
conditions led to different dissolved oxygen profiles (Figure 3-la). The dissolved oxygen 
(DO) decreased considerably faster in the low aeration case, leading to a microaerobic 
condition that was maintained for about 3 hours before the system was switched to 
completely anaerobic. The high aeration experiment never reached a microaerobic 
condition before switching to the anaerobic phase. This microaerobic period may have 
contributed to differences in cell metabolism, reflected as differences in metabolic 
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profiles, gene expression profiles and final product yield and productivity described 
below. 
The pH was not controlled during the aerobic phase. Instead, the pH was used as 
an indicator of glucose consumption to determine glucose feeding times (Ishizaki and 
Vonktaveesuk 1996; Lee et al. 2000). The pH profiles in both experiments were 
comparable until about 7 h into the aerobic phase (Figure 3-lb). The pH decreased as 
glucose was consumed and then rose again as the acids produced by glucose metabolism 
were utilized by the cells in the absence of glucose. Once glucose was exhausted and the 
pH reached 7.4-7.5, glucose was added to 2 g/L final concentration. Glucose was rapidly 
consumed and the pH recovered rapidly in the high aeration case, probably due to a 
higher DO and a higher cell concentration (Figure 3-lb). In the low aeration condition, 
the pH decreased to about 6.6 before the acid products were uptaken by the cells and the 
pH increased. In both experiments, after the pH reached 7.4-7.5 again, a second batch of 
glucose was added (to a final concentration of 20 g/L), the pH control was activated (pH 
7.0), the air flow was stopped, and a CO2 flow (0.2 L/min) was established to create 
anaerobic conditions. In the low aeration experiment the switching to the anaerobic phase 
was delayed for about 1 h, the time required for the pH to increase back to 7.4. 
The cell growth during the aerobic phase was comparable in the low and high 
aeration cases until about 7.5 h in the aerobic phase. After this time, the DO decreased to 
a very low level in the low aerated bioreactor, creating a microaerobic environment 
where the cells grew at a lower rate compared to the high aerated bioreactor probably due 
to oxygen limitation (Figure 3a). At the end of the growth phase, the cell concentration 
reached 18.5 and 16.5 OD600 for the high and low aeration experiments, respectively. 
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Therefore, a higher aeration resulted in a higher cell growth. No cell growth was 
observed in the anaerobic phase in both cases. This result agrees with Sanchez and 
collaborators study where no cell growth was detected during the production phase using 
the same strain (Sanchez et al. 2006b). 
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Figure 3-1. Culture parameters and sampling of bioreactor experimentas under different 
conditions of aeration of strain SBS550MG (pHL413). (a) Dissolved oxygen profile and 
(b) pH profile for high and low aeration bioreactor experiments. Samples were analyzed 
by qRT-PCR at three time points for each experiment. The arrows indicate the times 
where samples were analyzed by qRT-PCR. A and D: 5 h into the aerobic phase; B and 
E: transition time from aerobic to anaerobic phase; and C and F: 3 h into the anerobic 
phase. A, B and C samples correspond to the high aeration experiment; and D, E and F 
samples correspond to the low aeration experiment. 
3.4.2 Comparison of metabolites profiles 
The extracellular metabolite profiles during the anaerobic production phase are 
shown in Figures 2b and 2c. More glucose was consumed in the low aeration case, 79.6 
versus 67.6 mmol in the high aeration case. The final succinate titer was 166.9 mM and 
115.4 mM for the low and high aeration experiments, respectively. This resulted in a 
yield of 1.55 and 1.25 mol succinate/mol glucose, respectively, and a productivity of 1.3 
and 0.9 g/(L h), respectively (Figure 3-2b). Therefore, the level of aeration during the 
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aerobic phase significantly influences the anaerobic succinate production in E. coli 
SBS550MG(pHL413). 
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Figure 3-2. Growth and metabolic profiles of cultures of strain SBS550MG (pHL413). 
(a) Cell growth profile during aerobic phase, (b) glucose consumption and succinate 
production profiles during the anaerobic phase, and (c) acetate, pyruvate and malate 
profiles during anaerobic phase for high and low aeration conditions during the aerobic-
growth phase on bioreactor experiments. 
Succinate was the main fermentation product in both aeration cases; although, a 
small amount of malate was also produced, 3.7 and 11.2 mM in the low and high aeration 
experiment, respectively (Figure 3-2c). The acetate produced was also higher in the high 
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aeration case (Figure 3-2c). Almost no pyruvate accumulation was observed in the low 
aeration case, whereas the pyruvate accumulation in the high aeration experiment reached 
27.0 mM (Figure 3-2c). Then, the formation of fermentation side-products malate, acetate 
and pyruvate, was higher in the high aeration experiment. Pyruvate accumulation has 
been also observed in E. coli W3110 after a downshift of oxygen level from aerobic to 
anaerobic at high glucose concentrations (Soini et al. 2008). In our experiments very low 
DO concentrations (microaerobic conditions) were reached in the low aeration 
experiment 3 hours before the conditions were switched to the production phase (Figure 
3-la). When the DO level decreased close to zero in the low aeration case, glucose was 
not in high concentration, but rather low, no pyruvate was accumulated in that case, and 
when glucose was added (at the same time that CO2 flow started) the anaerobic 
enzymatic machinery was ready and no pyruvate accumulation was observed. Sanchez 
and collaborators showed that pyruvate was accumulated in SBS550MG cultures where 
no PYC was overexpressed leading to a lower succinate production (Sanchez et al. 
2005b). The level of pyc mRNA in the low aeration case at the time of transition was 
significantly higher (2.2-fold) than in the high aeration case (Figure 3-4c) which may 
have contributed to no pyruvate accumulation. Pyruvate accumulation and lower 
succinate production have also been observed in E. coli mutants lacking LDH and PFL 
(pyruvate utilization enzymes) (Lin et al. 2005e; Vemuri et al. 2002a) implying a 
limitation in the capacity of E. coli to direct all the carbon flow towards succinate 
production. Vemuri and collaborators compared succinate production using an E. coli 
strain containing deletions on pflAB and IdhA, and a mutation on ptsG, and the same 
strain overexpressing the pyc gene from Rhizobium etli (Vemuri et al. 2002b). They 
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concluded that the strain overexpressing pyc showed higher succinate yield, supporting 
the idea that PYC is an important factor in succinate yield, likely because PYC directs the 
carboxylation of pyruvate to OAA decreasing pyruvate accumulation. 
The high aerated bioreactor showed a productivity of 0.92 compared to 1.32 g L" 
h"1 for the low aeration experiment. Therefore, the higher cell concentration reached in 
the high aerated case did not have a positive effect on the volumetric productivity. In 
conclusion, the low aeration experiment showed a higher succinate yield, titer and 
productivity. 
3.4.3 Metabolic fluxes 
Metabolic fluxes were estimated as described in Materials and Methods and 
Appendix A and the results are shown in Figure 3-3. 
The metabolic fluxes obtained for the low aeration case were comparable to the 
estimated fluxes reported by Sanchez and collaborators using the same E. coli strain but 
where the cells were grown aerobically in shake flasks and then transferred to a 
bioreactor for the anaerobic production phase (Sanchez et al. 2006b), instead of 
performing both steps in the same bioreactor (this work). Therefore, to carry out the 
growth phase of SBS550MG (pHL413) in a bioreactor with low aeration resulted 
equivalent to the growth of the cells in aerobic shake flasks, both providing cells in the 
right metabolic state for efficient anaerobic succinate production. The growth of the cells 
in a bioreactor instead of shake flasks eliminates the centrifugation step, simplifying 
process scalability for industrial applications. 
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Figure 3-3. Metabolic flux distribution in succinate producing strain SBS550MG 
(pHL413). Flux distribution was determined for the anaerobic-production phase for low 
and high aeration cases during the growth-aerobic phase. The values in the box show the 
metabolic fluxes, the first and second rows correspond to the flux in the low aeration and 
the high aeration experiment, respectively. The fluxes are expressed in mmol/(gDCW*h), 
normalized by the glucose uptake rate and expressed in percentage. Abbreviations: GAP: 
glyceraldehyde 3-phosphate; DHAP: dihydroxyacetone-phosphate. PYK: pyruvate 
kinase; PFL: pyruvate formate lyase; LDH: lactate dehydrogenase; PTA: phosphate 
acetyl transferase; ACK: acetate kinase; ADH: alcohol dehydrogenase; AceA: isocitrate 
lyase; AceB: malate synthase; PYC: pyruvate carboxylase from L. lactis. 
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The low aeration case showed a slightly higher flux to OAA (v5) and a 
significantly higher flux to acetyl-CoA (v7) leading to a higher total flux to succinate 
(V14). Pyruvate was accumulated in the high aeration case lowering the carbon flux to 
succinate. 
The traditional fermentation pathway in wild type E. coli produces 2 moles of 
NADH per mole of metabolized glucose; and succinate production requires 2 moles of 
NADH per mole of succinate produced through this pathway. Then, the succinate 
maximum theoretical yield for this pathway is one mol of succinate per mol of glucose 
due to NADH availability limitation. When the glyoxylate shunt is activated, a new 
succinate production pathway is available with a lower NADH requirement, only 0.5 
mole of NADH per mole of succinate produced. However, the production of succinate 
through the glyoxylate shunt is limited by carbon availability. A compromise between 
both pathways gives a maximal theoretical succinate yield of 1.6 mole succinate/mole of 
glucose, where about 30% of the OAA is directed to the glyoxylate shunt and ca. 70% is 
fermented through malate (Cox et al. 2006; Sanchez et al. 2006b). Sanchez and 
collaborators have reported this succinate yield experimentally using E. coli strain 
SBS550MG (pHL413) cultured aerobically in shake flasks and producing succinate 
anaerobically in a bioreactor (Sanchez et al. 2006b). A theoretical study performed by 
Cox and collaborators has shown that succinate yield is highly sensitive to the OAA split 
ratio between the traditional fermentation pathway and the glyoxylate shunt (Cox et al. 
2006). In our study, the OAA split ratio was different for both growth conditions, where 
the low aeration experiment showed a succinate yield and OAA split ratio comparable to 
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that obtained by Sanchez and collaborators, as mentioned earlier (Sanchez et al. 2006b); 
and the high aeration experiment showed a lower flux of OAA directed to the glyoxylate 
shunt (ca. 18% compared to ca. 30%) which led to a significantly lower succinate yield 
(1.25 compared to 1.55 mole succinate/mole glucose). This result reaffirms the 
importance of the OAA split ratio on succinate yield. 
The PEP-PYR node flux to OAA was similar in both experiments (the difference 
was only ca. 4%). Pyruvate was accumulated in the high aeration case leading to a 
significantly lower flux to acetyl-CoA and therefore to the glyoxylate shunt, decreasing 
succinate yield. 
3.4.4 Comparison of gene expression profiles 
The difference in gene expression was considered significant if the expression of 
a particular gene under a specific condition was at least two times the activity of the same 
gene in a different condition. Samples for qRT-PCR were taken at 5 h into the aerobic 
phase (A and D in Figure 3-1), at the transition time from aerobic to anaerobic (B and E 
in Figure 3-1), and 3 h into the anaerobic phase (C and F in Figure 3-1) to compare gene 
expression profiles at different stages in the process. Figure 3-4 shows the results for the 
gene expression profiles of the genes listed on Table 3-1. The relative level of expression 
was determined using the high aeration case as the reference. 
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Figure 3-4. Effect of the level of aeration during the growth (aerobic) phase on gene 
expression profiles in E. coli SBS550MG (pHL413) in batch bioreactor. 
3.4.4.1 Glycolytic genes 
The genes pykF and pykA encode for pyruvate kinase isoenzymes; and PykF is the 
main contributor to the pyruvate kinase activity in E. coli (Garrido-Pertierra and Cooper 
1983; Ponce et al. 1995). Qualitative RT-PCR revealed thai pykF was up-regulated (2.6 
times) during the transition time in the low aeration case compared to the high aeration 
experiment (Figure 3-4a). Peng and Shimizu showed a modest increase (<2-fold) on pykF 
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expression in wild type E. coli (K12) during microaerobic condition (Peng and Shimizu 
2003). 
Pyruvate is mainly metabolized to acetyl-CoA via the NAD-dependent pyruvate 
dehydrogenase complex (PDH) under aerobic conditions and through the pyruvate-
formate-lyase (PFL) during anaerobiosis. The PDH complex contains three enzymatic 
components encoded by aceE, aceF and Ipd co-expressed from a single operon from the 
Ypdh promoter. However, Ipd could also be expressed from an independent promoter 
(?lpd) which is anaerobically repressed by ArcA (Kang et al. 2005). PDH transcription is 
repressed by PdhR (present also in the PDH operon), activated by pyruvate and has a site 
for FNR regulation (Cassey et al. 1998; Kang et al. 2005; Quail et al. 1994). In addition 
to transcriptional regulation, PDH is repressed at the enzyme level by high NADH/NAD+ 
levels and inhibited by acetyl-CoA (Cassey et al. 1998). In our experiments, the PDH 
genes aceE, aceF and Ipd were down-regulated in the aerobic phase (A and D in Figure 
3-1) in the low aeration case compared to the high aeration case, probably due to the 
relatively lower oxygen availability (Figure 3-4a). In the other hand, the genes aceE and 
Ipd were overexpressed in the anaerobic phase in the low aeration experiment compared 
to the high aeration case, 2.1 and 3.8 times, respectively (samples correspond to C and F 
in Figure 3-1). The expression of the anaerobic genes pflB and pflA, involved in the 
conversion of pyruvate to acetyl-CoA under anaerobic conditions, are discussed below. 
3.4.4.2 TCA cycle and glyoxylate shunt genes 
The genes acnA and acnB encode for aconitate hydratases (aconitases), and 
catalyze the conversion of citrate into isocitrate. This reaction showed a higher metabolic 
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flux for the low aeration case (Figure 3-3), in agreement with the higher gene expression 
observed in the anaerobic phase (Figure 3-4b). 
The glyoxylate shunt genes aceA and aceB were up-regulated during the 
transition and anaerobic phases which is consistent with a higher flux through the 
glyoxylate shunt and higher succinate yields. In the high aeration case, where pyruvate 
was accumulated, a significantly lower isocitrate lyase expression (aceA) was observed 
(Figure 3-4b); this result is in agreement with Vemuri and collaborators observation that 
pyruvate was accumulated when no isocitrate lyase activity was present (Vemuri et al. 
2002a). 
The malate dehydrogenase gene (mdh), responsible for the reversible oxidation of 
malate to OAA, was highly up-regulated during the anaerobic-production phase (6.9 fold) 
potentially contributing to the higher succinate production in the low aeration case 
(Figure 3-4b). MDH overexpression has also been shown to increase succinate 
production in apflB IdhA double mutant E. coli strain (Wang et al. 2009). 
3.4.4.3 Anaplerotic genes 
The phosphoenolpyruvate synthase gene, pps, was up-regulated during the 
transition and anaerobic phases; whereas the phosphoenolpyruvate carboxylase gene, 
ppc, showed to be up-regulated only during the transition time in the low aeration case 
(Figure 3-4c). In the past, the overexpression of ppc has been shown to increase succinate 
production (Millard et al. 1996), possibly by increasing the OAA pool. Pps converts 
pyruvate into PEP, Ppc can then carboxylate PEP to generate OAA which can be finally 
transformed into succinate. The overexpression of the malate feedback inhibition-
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resistant S. vulgare phosphoenolpyruvate carboxylase, encoded by pepc, has also be shown 
to increase succinate production (Lin et al. 2004). 
The strain used for this study, SBS550MG (pHL413), overexpresses pyruvate 
carboxylase, PYC, from L. lactis (Sanchez et al. 2005b). This enzyme catalyzes the 
carboxylation of pyruvate to generate OAA. The overexpression of this pyc gene or the 
pyc gene from Rhizobium etli (Gokarn et al. 2001) increases the OAA pool and has been 
shown to consequently increase succinate production and yield (Gokarn et al. 2001; 
Sanchez et al. 2005a). In addition to pps and ppc, the pyc gene expression was also up-
regulated during the transition time in the low aeration case; these enzymes may have 
contributed to the slightly higher carbon flux towards OAA observed in the low aeration 
case (Figures 3-3 and 3-4c). 
3.4.4.4 Anaerobic genes 
In our experiment at the transition time the low aerated bioreactor was in a 
microaerobic environment for a few hours, which could have contributed to the up-
regulation of fermentative genes and therefore to the preparation of the enzymatic 
machinery for the upcoming anaerobic environment. 
The pyruvate formate lyase genes, genes pflA and pflB were up-regulated during 
the microaerobic phase (Figure 3-4d). Their up-regulation may have led to the higher flux 
towards the acetyl-CoA pool (Figure 3-3) and to relieve the pyruvate node, eliminating 
the pyruvate accumulation observed in the high aeration experiment. Peng and Shimizu 
(2003) studied the effect of microaerobic conditions on protein expression and enzyme 
activity in wild type E. coli K12 grown in LB medium supplemented with glucose. They 
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found differences in protein synthesis levels when the DO condition was changed from 
aerobic to microaerobic. The fermentative genes such as pfl and adhE were up-regulated 
in microaerobic conditions compared to aerobic growth (Peng and Shimizu 2003). An 
increase in PFL protein expression of 11.2-fold, based on 2DE, when the condition 
changes from aerobic to microaerobic has been reported (Peng and Shimizu 2003). 
Alexeeva and collaborators reported that PFL synthesis was maximal in microaerobic 
conditions and that the ArcAB regulatory two-component system was more active under 
this condition, activating/?// gene expression (Alexeeva et al. 2000). In our experiment, at 
the transition time the low aerated bioreactor was in a microaerobic environment for a 
few hours. At this time the pfl gene expression was up-regulated in the low aeration case, 
microaerobic condition; this result is in agreement with the reports mentioned above 
(Alexeeva et al. 2000; Peng and Shimizu 2003). 
PFL activity is not only regulated by gene transcription but is also regulated by 
the presence of oxygen. PFL is highly sensitive to oxygen, is usually inactive during 
aerobic conditions and active during anaerobiosis. YfiD has been suggested to activate 
PLF during microaerobic conditions by replacing the glycyl radical domain in PFL 
(Wagner et al. 2001; Wyborn et al. 2002). Transcription studies have shown maximum 
yfiD expression in cultures under microaerobic conditions (Marshall et al. 2001) and that 
yfiD expression could also been induced by low pH (Wyborn et al. 2002). In our 
experiments, the yfiD gene was highly expressed (10.8-fold) at the transition time in the 
low aeration case, where the cells had been under microaerobic conditions for about three 
hours. This result agrees with the transcription study by Marshall and collaborators 
(Marshall et al. 2001). YfiD has been shown to contribute to PFL flux in other mutant 
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strains, e.g. an arcA mutant (Zhu et al. 2007). A higher yfiD expression during the 
transition time in our low aeration experiment may have contributed to the increase in 
PFL flux and therefore to avoid pyruvate accumulation in SBS550MG (pHL413). 
3.4.4.5 Regulators 
The Arc two-component signal transduction system is known to regulate the 
expression of numerous genes in response to the redox state of the cell (Georgellis et al. 
1997; Liu and De Wulf 2004). Alexeeva and collaborators analyzed the importance of the 
presence of the ArcAB system in E. coli redox regulation at different oxygen levels; and 
they concluded that this system is more important in microaerobic conditions to maintain 
the redox balance (Alexeeva et al. 2000; Alexeeva et al. 2003). In our work, The gene 
encoding for ArcB (arcB), the sensor kinase component of the Arc two-component signal 
transduction system, was up-regulated in the aerobic phase; and no significant difference 
in gene expression was observed in the arcA and arcB genes at the transition time where 
the bioreactor with low aeration was under a microaerobic condition. At low oxygen 
levels the transmembrane sensor kinase ArcB autophosphorylates; and subsequently 
phosphorylates the response regulator component ArcA. The system continues to be 
active during anaerobic growth (Jeon et al. 2001; Lee et al. 2001; Shalel-Levanon et al. 
2005a). Arc-P binds to the promoter region regulating transcription of numerous genes. 
Thus, the action of this system is controlled by phosphorylation induced by the cell redox 
state. 
In addition to the ArcAB regulatory system, E. coli also contains a FNR global 
regulator which is known to activate expression of genes involved in anaerobic growth 
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and repression of aerobic genes (Liu and De Wulf 2004; Shalel-Levanon et al. 2005a). In 
the present study, no significant difference in fnr gene expression was found in both 
experiments, low and high aeration during the aerobic growth phase, at the analyzed time 
points. 
3.5 Conclusion 
The low aeration experiment showed better succinate production with respect to 
yield, titer and volumetric productivity. This was most likely due to the period of 
microaerobiosis that the cells experienced before switching to a completely anaerobic 
environment. This microaerobic environment may have facilitated the cells to adjust their 
enzymatic machinery by expressing the proteins that were required in the anaerobic-
production phase, making them a better biocatalyst for succinate production. 
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Chapter 4 
4 Effect of culture conditions on succinate production by a 
high succinate producing Escherichia coli strain 
4.1 Abstract 
The effects of different culture conditions on succinate production by the high 
succinate producing E. coli strain SBS550MG (pHL413), which contains deletions in 
adhE IdhA iclR acApta ::CmR and overexpresses the pyruvate carboxylase from 
Lactococcus lactis, were analyzed. The considered factors included glucose and CO2 
concentrations, pH, and temperature. Glucose concentrations above 200 mM in shake 
flasks experiments at 20 OD cell concentration had a negative effect on succinate titer 
without significantly affecting succinate yield. In the bioreactor experiments, a CO2 
concentration of 100% in the gas stream showed the highest specific succinate 
productivity, probably by favoring pyruvate carboxylation, increasing the OAA pool that 
later is converted into succinate. A full factorial design of experiments was applied to 
analyze pH and temperature effects in batch bioreactors. The temperature did not show a 
significant effect on succinate productivity, yield or titer in the range tested (37-43°C). 
On the other hand, the pH significantly affected these responses. A pH 6.5 showed very 
low productivity, whereas pH values of 7.0 and 7.5 resulted in significantly higher 
specific productivities and higher titers. The increase on pH value from 7.0 to 7.5 did not 
show significant improvement. 
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4.2 Introduction 
Succinate, a four carbon dicarboxylic acid, is one of the top twelve chemicals 
identified by the Department of Energy that could be produced from renewable 
feedstocks (plant sugars) and serves as a precursor for the manufacture of many 
important chemical products (Potera 2005; Schilling 1995; Warnecke and Gill 2005; 
Werpy and Petersen 2004). Succinate is widely used in food, pharmaceuticals, 
biodegradable polymers, synthetic resins, surfactants, ion-chelators, detergents and other 
industrial products. This compound is also a precursor of important chemicals such as 
1,4-butanediol, tetrahydrofuran, adipic acid and gamma-butyrolactone (Millard et al. 
1996; Zeikus et al. 1999). Currently, succinate production is accomplished by chemical 
processes using petroleum derivatives as starting materials which could lead to pollution 
and develop potential shortages in the future. Thus, a fermentative method of succinate 
production from renewable feedstocks has the potential to replace petrochemical 
processing as the preferred manufacturing method (Landucci et al. 1994). 
Several bacteria such as Anaerobiospirillum succiniciproducens (Samuelov et al. 
1999; Samuelov et al. 1991), Bactericides fragilis (Rotstein et al. 1987), Actinobacillus 
succinogenes sp. nov. (Guettler et al. 1999), and Ruminococcus flavefaciens (Gokarn et 
al. 1997), are able to produce succinate. Many of them are rumen microorganisms and 
difficult to culture. In the other hand, Escherichia coli presents numerous advantages 
such as ease to culture, fast growth rate, the genome has been sequenced and techniques 
to genetically manipulate it are available. E. coli produces succinate naturally at a low 
yield and only during anaerobic fermentation. The anaerobic process in wild type E. coli 
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produces a mixture of fermentative products (succinate, lactate, formate, acetate and 
ethanol). In the past, to increase product yield, E. coli strains have been genetically 
engineered to produce and accumulate succinate aerobically and anaerobically, the 
anaerobic process being the one with higher succinate yield (Lin et al. 2005a; Lin et al. 
2005b; Lin et al. 2005d; Sanchez et al. 2005b; Sanchez et al. 2006b). Strain modifications 
for anaerobic production of succinate have included the elimination of routes leading to 
other E. coli fermentative products such as lactate, acetate and ethanol, the opening of the 
glyoxylate shunt to produce succinate to a higher yield (less NADH required through this 
route compared to the fermentative pathway) and the heterologous overexpression of 
pyruvate carboxylase to replenish the OAA pool (Sanchez et al. 2005a; Sanchez et al. 
2005b; Sanchez et al. 2006b). In particular, the E. coli strain SBS550MG (pHL413) 
carrying deletions on adhE, IdhA, iclR, and ackpta::Cm , and overexpressing the pyruvate 
carboxylase gene (pyc) from Lactococcus lactis has been shown to produce high 
succinate yields (ca. 1.6 mole succinate/mole glucose) using glucose as carbon source 
(Sanchez et al. 2005b; Sanchez et al. 2006b). For the fermentation processes to be 
economically attractive, culture conditions need to be studied and optimized to increase 
process productivity. 
The succinate production process consists of two phases, the first phase is aerobic 
and corresponds to the growth phase for biomass accumulation; and the second phase is 
anaerobic where the fermentation occurs and succinate is produced and accumulated (no 
significant cell growth in this phase for the strain used in this work). Many operational 
factors can influence the performance of the culture in terms of the final yield and 
productivity. Factors such as medium composition, pH and temperature have shown a 
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significant effect in process productivities and final titers in many production systems 
(Lee et al. 2005a; Maldonado et al. 2007). In this study we analyzed the effect of 
different culture conditions on succinate production using the recombinant E. coli 
SBS550MG (pHL413) strain. A preliminary study was performed in shake flasks where 
the glucose concentration and cell density effect where assessed, followed by the analysis 
of the effect of the gas composition in the anaerobic phase in a bioreactor setting. A full 
factorial design at three levels was used to determine the effect of pH and temperature on 
succinate yield and productivity during the anaerobic-production phase in a batch 
bioreactor. 
4.3 Materials and methods 
4.3.1 Strain and plasmid 
E. coli strain SBS550MG harboring the plasmid pHL413 was used for all the 
studies. This strain is based on E. coli MG1655 and carries the following gene deletions 
or disruptions adhE IdhA iclR ackpta::CmR (Sanchez et al. 2005b). The plasmid pHL413 
encodes the pyruvate carboxylase from Lactococcus lactis cloned into pTrc99A, Ap 
(Lin et al. 2004). 
4.3.2 Shake flask experiments 
As previously described (Sanchez et al. 2005a), a single colony from a LB plate 
supplemented with 66.7 mg/L of each ampicillin, carbenicillin and oxacillin was used to 
inoculate 5 ml of LB medium supplemented with the same antibiotic concentrations. 
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Cultures were grown overnight at 37°C and 250 rpm. From the overnight culture, 4 ml 
were centrifuged; the pellet was washed three times with fresh LB medium; and 
resupended in 4 ml of the fresh LB medium. The washed cells were used to inoculate 2 L 
shake flasks containing 400 ml of LB medium supplemented with 200 mg/L ampicillin . 
These cultures were grown at 37°C and 250 rpm for 14-17h. A determined volume of 
cells, depending on the final cell concentration defined for each experiment, were 
centrifuged and resuspended in 10 ml of the corresponding anaerobic medium (LB + 1 
g/L NaC03 + glucose). The mixture was poured into 250 ml flask and purged with 1 
L/min of CO2 for 1.5 min before rubber stoppers were put in place to seal the flasks, 
preventing air entry. Shake flasks were incubated at 37°C and 250 rpm for 24 h. 
4.3.2.1 Effect of initial glucose concentration on anaerobic succinate production 
Aerobic cultures grown as described above were concentrated to 20 OD (600 nm) 
and transferred to anaerobic medium (LB + 1 g/L NaCOs) containing various amounts of 
glucose to study the effect of the initial glucose concentration on anaerobic succinate 
production. 
4.3.2.2 Effect of cell concentration on anaerobic succinate production 
Succinate production experiments were conducted as described above using cell 
densities of 20, 60 and 80 OD for the anaerobic phase. Initial glucose addition for the 
anaerobic phase was increased accordingly. 
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4.3.3 Batch bioreactor experiments 
4.3.3.1 Inoculum preparation 
A single colony of SBS550MG (pHL413) from a LB plate supplemented with 
66.7 mg/L of each ampicillin, carbenicillin and oxacillin was used to inoculate 10 ml of 
LB medium supplemented with the same antibiotic concentrations. Cultures were grown 
overnight at 37°C and 250 rpm. 
4.3.3.2 Medium 
The medium used consisted of 20 g/L tryptone, 10 g/L yeast extract, 0.9 g/L 
K2HP04x 3H20, 1.1 g/L KH2PO4, 3 g/L (NH4)2S04, 0.5 g/L MgS04 x 7H20, 0.25 g/L 
CaCb x H20, 1 mg/L thiamine, 1 mg/L biotin, 200 mg/L ampicillin and 2 g/L glucose. 
Another 2 g/L of glucose where added when glucose was depleted from the medium 
during the aerobic-growth phase. At the beginning of the anaerobic phase, glucose from a 
stock was added to a concentration of 20 g/L. 
4.3.3.3 Bioreactor conditions 
A 1-L bioreactor (New Brunswick Scientific, Bioflo 110) was used for all 
experiments. The bioreactor was initially loaded with 0.6 L of the medium described 
above and inoculated with 1% overnight culture. The growth phase conducted at 37°C, 
500 rpm, air flow rate of 1.5 L/min and no pH control. The pH profile was used as an 
indicator of glucose consumption. For the anaerobic phase, the agitation was changed to 
250 rpm, the pH was controlled using 1M Na2C03 and 1M HNO3, the air flow was 
stopped and a gas flow of 0.2 L/min C02 or N2/C02 mixture was started and maintained 
during the entire anaerobic-production phase (14h). 
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4.3.3.4 Gas composition effect 
For the production phase (anaerobic), different CO2/N2 mixtures were used to 
study their effect on succinate production. 
4.3.3.5 pH and temperature effect. DOE experiments. 
The effect of pH and temperature during the anaerobic-production phase was 
evaluated using a full factorial design of experiments (DOE) with three repetitions for the 
pH 7.0-37°C condition. The pH was set and controlled at 6.5, 7.0 or 7.5 using 1M 
Na2CC>3 and 1M HNO3; and the temperature was controlled at 37, 40 or 43 °C, depending 
on the experiment. The cell density (OD) was measured at 600 nm. Samples were 
withdrawn at different times during the aerobic and anaerobic phases and were analyzed 
for metabolite composition by HPLC as described below. 
The DOE experiment results were analyzed using the Minitab® 15 Statistical 
Software (State College, PA, USA). 
4.3.4 Extracellular metabolites analysis 
Extracellular metabolites such as glucose, succinate, formate, pyruvate among 
others were analyzed by HPLC (Shimadzu-lOA System, Shimadzu, Columbia, MD). The 
system was equipped with a cation-exchange column (HPX-87H, Biorad Labs, Hercules, 
CA), a differential refractive index (RI) detector (Waters 2410, Waters, Milford, MA) 
and an ultraviolet (UV) detector (Shimadzu SPD-10A). The mobile phase used was a 2.5 
mM H2SO4 solution at a 0.6 ml/min flow rate. The column was operated at 55°C. 
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4.4 Results and Discussion 
4.4.1 Flask experiments 
Effect of initial glucose concentration on anaerobic succinate production 
The effect of different initial glucose concentration on succinate production is 
shown in Figure 4-1. Initial glucose concentrations above 200 mM had some detrimental 
(inhibitory) effect on the titer in 20 OD600 cultures; however the succinate yield in all 
cases was comparable with an average of 1.53 ±0.05. 
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Figure 4-1. Effect of initial glucose concentration on succinate titer in flask experiments 
sampled at 24h (cell concentration was 20 ODgoo)-
4.4.2 Effect of cell concentration on anaerobic succinate production 
As mentioned above, glucose concentrations above 200 mM showed a decrease in 
succinate production without affecting product yield in 20 OD600 cultures. Then, to 
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increase succinate production, shake flask experiments at higher cell concentrations were 
performed. The results are presented in Figure 4-2. The increase in cell concentration 
resulted in higher succinate production, overcoming the glucose inhibitory effect (Figure 
2a). The overall productivity was increased from ca. 6 to 17 mM h"1 (0.7 to 2.0 g L"1 h"1) 
with no major differences in succinate yield (Figure 4-2b and 4-2c). However, higher 
cell concentrations (60-80 OD) showed a decrease in specific productivity, probably due 
to mass transfer limitations at high cell densities (Figure 4-2d). Under the conditions 
tested, the highest succinate titer was achieved with 80-90 ODeoo, where ca. 50 g/L 
succinate were produced in 24h (Figure 4-2a). 
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Figure 4-2. Effect of cell concentration and initial glucose concentration on anaerobic 
succinate production in shake flasks, (a) succinate concentration, (b) succinate yield, (c) 
succinate productivity, (d) succinate specific productivity. Initial glucose concentration, 
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in mM, is indicated for each experiment above the corresponding column in the figure. 
The results are from samples analyzed after 24h into the anaerobic phase. 
4.4.3 Bioreactor experiments 
4.4.3.1 Gas composition effect 
The effect of using different mixtures of CO2 and N2 in the anaerobic phase was 
examined in batch bioreactors. The results of this study are shown in Figure 4-3. The 
bioreactor experiment with 100% CO2 in the gas stream showed the highest specific 
succinate productivity, 104 mg/(L h OD), without a major difference in succinate yield. 
CO2 is involved in the carboxylation of pyruvate to form OAA, reaction catalyzed by the 
heterologously expressed pyruvate carboxylase. The increase in specific productivity 
could be the result of a higher availability of carbonate in the medium generated by a 
higher CO2 partial pressure. The condition chosen for the design of experiments was 
100% CO2 gas flow due to the higher specific productivity, important for industrial 
applications. The CO2 concentration in the gas phase has also been shown to affect 
succinate production by an E. coli strain carrying mutations in the pyruvate formate lyase 
(pfl), lactate dehydrogenase (IdhA) and the glucose phosphotransferase system enzyme II 
(ptsG) (Lu et al. 2009); where an increase on CO2 concentration from 0% to 50% 
showed an increase in specific productivity and yield, from 1.9 to 225 mg/g h and 0.04 
and 0.75 g/g, respectively; however no further improvement resulted from increasing the 
CO2 concentration above 50% (Lu et al. 2009). The authors performed C13 labeling 
experiment to determine metabolic fluxes and proposed a model to describe the 
dependence of succinate production on CO2 concentrations for their strain, where they 
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calculated that at least 30 to 40% C02 is required to prevent limitation by CO2 and that at 
higher CO2 concentrations the system is limited by phosphoenolpyruvate carboxylase 
(PPC) activity (Lu et al. 2009). In our system pyruvate carboxylase (PYC) is 
overproduced, catalyzing the conversion of pyruvate into OAA which may relieve the 
PPC limitation. 
i 
25 50 100 
% co2 % co2 
Figure 4-3. Effect of gas composition (CO2/N2) on (a) succinate specific productivity and 
(b) molar yield in batch bioreactor. The asterisk above the column represents a significant 
difference respect to the other column values. 
4.4.3.2 pH and temperature effect. DOE experiments. 
A full factorial design of experiments with two factors, three levels (3 ) and three 
repetitions for the pH 7.0 and 37°C condition was used to evaluate the pH and 
temperature effect on succinate production. A total of 11 experiments were performed; 
the results and conditions are shown in Table 4-1. The effect of the parameters on yield, 
productivity, specific productivity and titer were analyzed using the Minitab 15 
statistical software. Main effects plots are shown in Figure 4a-d. The effects were 
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considered statistically significant where the p-value < 0.05. The yield was not 
significantly affected by the values of temperature or pH considered, and the temperature 
did not have a significant effect on any of the responses, i.e. yield, productivity, specific 
productivity and final titer (Table 4-2). On the other hand, the results showed that the pH 
had a significant effect on productivity, specific productivity and titer (Table 4-2). pH 
values of 7.0 and 7.5 resulted in significantly higher values for these responses when 
compared to pH 6.5; however the increase of pH from 7.0 to 7.5 did not show a 
significant improvement (t-test). When the pH was controlled at 6.5, the succinate 
productivity was low as well as the titer. The pH strongly influences CO2 solubility; 
larger amounts of CO2 can be dissolved and be converted to CC^/HCCV/FkCC^ at a 
lower pH. At this pH a relatively larger amount of CO2 could be present in the form of 
H2CO3 (undissociated form) which could diffuse inside the cells potentially affecting 
internal pH and/or cell metabolism (Foster 2004). 
Succinate production during the anaerobic phase results in a decrease on pH 
which is compensated by the addition of base (Na2CC>3) to maintain the pH constant. The 
lower the operational pH the lower the cost associated with the addition of base and the 
dilution that it causes to the culture broth. Therefore, a pH of 7.0 is preferred over 7.5. 
The responses dependence on pH were analyzed by regression using a second-
order polynomial equation; results are shown on Figure 4-4e to 4-4g. The quadratic 
curves fit the experimental results adequately with a R2 (adj) in the range of 90.9 to 
95.6%. 
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Table 4-1. Effect of temperature and pH on molar yield, productivity, specific 
productivity and final titer. Results of the design of experiments (DOE). 
Run 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Factor 
Temp. 
(°Q 
37 
37 
37 
40 
40 
40 
43 
43 
43 
37 
37 
pH 
6.5 
7.0 
7.5 
6.5 
7.0 
7.5 
6.5 
7.0 
7.5 
7 
7 
Response3 
Molar yield 
(mole succinate/ 
mole glucose) 
1.84 
1.68 
1.58 
1.24 
1.61 
1.63 
1.54 
1.62 
1.55 
1.56 
1.57 
Productivity 
(g/L/h) 
0.412 
1.323 
1.591 
0.203 
1.814 
1.775 
0.111 
1.879 
1.784 
1.62 
1.45 
Specific 
productivity 
(g/L/h/OD) 
0.036 
0.116 
0.16 
0.017 
0.174 
0.164 
0.010 
0.174 
0.180 
0.14 
0.14 
Titer 
(g/L) 
5.641 
17.200 
16.834 
2.628 
19.782 
18.295 
1.465 
20.709 
17.486 
22.74 
19.12 
aOverall (14h reaction, final glucose >8mM) 
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Table 4-2. Analysis of variance results for molar yield, productivity, specific productivity 
and titer. (DF: degrees of freedom; Seq SS: sequential sum of squares; Adj SS: adjusted 
sum of squares; F: Fisher value; P: p-value). 
Analysis of Variance for Molar yield (mole succinate/mole glucose) 
Source DF Seq SS Adj SS Adj MS 
Temp. (C) 2 0.044468 0.056678 0.028339 
pH 2 0.003857 0.008626 0.004313 
Temp. (C)*pH 4 0.143863 0.143863 0.035966 
Error 2 0.008867 0.008867 0.004433 
Total 10 0.201055 
F P 
6.39 0.135 
0.97 0.507 
8.11 0.113 
Analysis of Variance for Productivity (g/L h) 
Temp. (C) 2 0.00108 0.02572 
pH 2 4.44173 4.54918 
Temp. (C)*pH 4 0.17984 0.17984 
Error 2 0.04561 0.04561 
0.01286 
2.27459 
0.04496 
0.02280 
0.56 
99.74 
1.97 
0.639 
0.010 
0.364 
Total 10 4.66826 
Analysis of Variance for Specific productivity (g/L h OD) 
Temp. (C) 2 0.0000271 0.0002947 0.0001474 
pH 2 0.0410054 0.0423500 0.0211750 
Temp. (C)*pH 4 0.0020265 0.0020265 0.0005066 
Error 2 0.0003247 0.0003247 0.0001623 
0.91 0.524 
130.44 0.008 
3.12 0.257 
Total 10 0.0433836 
Table 4-2. Continuation. 
59 
Analysis of Variance for Titer (g/L) 
Temp. (C) 2 9.520 
pH 2 492.630 
Temp. (C)*pH 4 16.640 
Error 2 1.194 
Total 10 519.985 
0.193 0.097 0.16 0.861 
499.927 249.963 418.69 0.002 
16.640 4.160 6.97 0.129 
1.194 0.597 
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Figure 4-4. Design of experiments (DOE) results analyzed using Minitab® 15 statistical 
software. Experimental data: effect of temperature and pH on (a) molar yield, (b) 
succinate productivity, (c) succinate specific productivity, and (d) succinate titer. 
Temperature effect was not statistically significant. Temperature and pH did not have a 
significant effect on succinate yield. However, pH significantly affected succinate 
productivity, specific productivity and titer. Statistically significant pH effect results were 
fit using a second-order polynomial regression. Second-order curve fitting for (e) 
succinate productivity, (f) succinate specific productivity and (g) titer are shown. 
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4.5 Conclusions 
Glucose concentrations above 200 mM, in shake flasks experiments at 20 OD cell 
concentration, had a negative effect on succinate production. Higher succinate titers were 
achieved by increasing cell concentration together with an increase in glucose. However, 
specific productivity showed a slight decrease at higher cell concentrations probably 
caused by mass transfer limitations. 
In the bioreactor experiments, succinate yield was not significantly affected by the 
values of pH and temperature analyzed. In addition, the temperature effect on succinate 
productivity, specific productivity and titer was not significant. However, the pH showed 
a significant effect on these responses, where pH values of 7.0-7.5 resulted in the highest 
succinate specific productivity. 
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Chapter 5 
5 Metabolic engineering of Escherichia coli towards the 
production of NADH-dependent C4 compounds 
Four-carbon (C4) dicarboxylic compounds such as succinate, malate and fumarate 
are currently produced from petrochemicals. These compounds can be used as building 
blocks for the synthesis of many different products as well as food additives, for the 
formulation of pharmaceuticals, synthesis of resins, biodegradable polymers and 
surfactants (Zeikus et al. 1999), and cosmetics (Fiume 2001), among others. The 
petroleum crisis, where oil prices have raised and availability has turned unpredictable in 
the future, together with environmental concerns, have led to an increase in the interest 
for alternative sources for these compounds. 
The production of succinate by a high producer as well as the evaluation of 
operational conditions that influence succinate production have been discussed 
extensively in previous sections; therefore in this thesis section the focus is on the 
metabolic engineering of E. coli to potentially produce other C4 compounds such as 
malate and fumarate. 
Malate is naturally produced by a number of organisms such as Aspergillus 
flavus, Schizophylum commune, Monascus araneosus, and Saccharomyces cerevisiae, to 
name a few (Zelle et al. 2008). However, E. coli has also the potential of producing 
malate or fumarate. These compounds are intermediates in the tricarboxylic acid (TCA) 
cycle as well as intermediates of the mixed anaerobic fermentation in E. coli. The 
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production of malate or fumarate, through the fermentative pathway of E. coli, is redox 
balanced, e.i., the maximum malate theoretical yield is two mole of malate per mole of 
glucose consumed. One mole of glucose can generate two moles of NADH and two 
moles of pyruvate. One mole of pyruvate is required to combine with one mole CO2 to 
generate one mole of malate (the same applies to fumarate). Therefore, no carbon or 
reducing equivalents is limiting or in excess in this pathway. However, E. coli does not 
accumulate malate or fumarate under usual circumstances. Thus, the present study aims 
to strategically engineered E. coli strains to evaluate its potential for malate as well as 
fumarate production. 
An E. coli malate producing strain has been developed in the past by Jantama and 
collaborators (2008) by a combination of metabolic engineering and metabolic evolution. 
The metabolic evolution in this study involved the multiple subculturing of the cells and 
selection for the ones that grew faster and presented promising product profiles together 
with the addition of gene inactivations at different stages of the evolution. The final 
evolved E. coli mutant strain KJ071 with deletions in IdhA, adhE, ackA, foe A, pflB and 
mgsA showed high malate production (Jantama et al. 2008a). This approach led the 
authors to a high malate producing strain as well as to a high succinate producing, 
although it has the limitation to result in non-genetically defined strains due to unknown 
mutations that resulted in the final strain phenotype. 
In the present thesis section a series of strategically selected genes were 
inactivated in an E. coli strain carrying lactate dehydrogenase (IdhA) and alcohol 
dehydrogenase (adhE) gene deletions, to decrease fermentation by-product formations, 
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and overexpressing the pyruvate carboxylase from L. lactis to increase flux towards C4 
compounds synthesis. 
The present research has been divided into two sections. The first section focuses 
on the effect of inactivating the fumarate reductase gene, frdA, and other routes leading to 
succinate synthesis, on E. coli fermentation product profiles, and the second section 
describes the design and implementation of a set of strains where one or more fumarase 
isoforms have been inactivated to assess the relative importance of these enzymes in C4 
product synthesis. 
5.1 Effect of fumarate reductase deletion on C4 compounds synthesis 
5.1.1 Abstract 
For the production of C4 compounds other than succinate, the inactivation of 
fumarate reductase, responsible for succinate synthesis from fumarate in anaerobic 
conditions, was evaluated together with the deletion of the glyoxylate shunt isocitrate 
lyase gene (aceA) and the acetate production genes ackA and pta. The study was 
conducted using SBS110MG (pHL413) as control strain. This strain carries deletions in 
IdhA and adhE to eliminate competing pathways, and overexpresses pyruvate 
carboxylase from L. lactis to increase OAA pool, precursor for malate, fumarate and 
succinate synthesis. The deletion offrdA resulted in a decrease in glucose consumption, a 
decrease in succinate production and an increase in malate synthesis, compared to the 
control strain. However, succinate continued to be the main fermentation product in this 
strain. Anaerobic and microaerobic conditions were tested for the production phase. The 
microaerobic condition showed the highest malate production and detectable amounts of 
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fumarate. Succinate dehydrogenase (SDH) was found to partially replace FRD for 
succinate production in this mutant, as the inactivation of sdhAB resulted in an almost 
complete elimination of succinate production and then an increase in malate yield. 
However, a significant reduction in cell growth was also observed. 
The highest malate concentration values obtained were 18-21 mM. These values 
were reached by several of the engineered strains tested under microaerobic conditions, 
although these strains showed very different glucose consumption varying from about 30 
to 70%, and molar yields ranging from about 0.25 to 0.6 mole of malate per mole of 
glucose. The highest yield was achieved with the strain MBS505KC (pHL413) 
containing deletions in IdhA, adhE, frdA, sdhAB, and ackA-pta. However the glucose 
consumption in this strain was only 30% 
5.1.2 Introduction 
In Escherichia coli, two structurally and catalytically similar enzymes, fumarate 
reductase and succinate dehydrogenase, are responsible for the interconversion between 
fumarate and succinate (Spencer and Guest 1973). Fumarate reductase (FRD) catalyzes 
the reduction of fumarate to succinate under anaerobic conditions where fumarate 
functions as the final electron acceptor in the anaerobic electron transport chain 
generating energy for cell growth (Guest 1981; Kroger 1978). The expression of the 
fumarate reductase operon, frdABCD, is activated in anaerobic conditions by the Fnr 
anaerobic global regulator (Tseng et al. 1996) and enhanced in the presence of fumarate 
(Jones and Gunsalus 1987); and it is repressed during aerobic growth or in the presence 
of nitrate through the Nar two-component regulatory system (Guest 1981; Jones and 
Gunsalus 1985; Jones and Gunsalus 1987). Succinate dehydrogenase (SDH), encoded by 
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the sdhCDAB operon, mainly oxidizes succinate to fumarate under aerobic conditions as 
part of the tricarboxylic acid cycle (TCA); and reduces ubiquinone, forming part of the 
aerobic respiratory chain (complex II). This enzyme is repressed during anaerobiosis by 
the global regulator Fnr and the two-component system ArcAB (Guest 1981; Park et al. 
1995). 
Both enzymatic complexes FRD and SDH have similar structures and function. 
They are composed of four different subunits; two membrane-bound subunits C and D, 
that allow the electron transfer between the enzyme and menaquinone (FDH) or 
ubiquinone (SDH), respectively; and serve as anchor to the two catalytic subunits A and 
B (Cecchini et al. 1986; Lemire et al. 1982; Maklashina and Cecchini 1999). The FrdA 
and SdhA subunits are flavoproteins with covalent attached flavin adenine dinucleotide 
(FAD) cofactor and the site for substrate binding; while FrdB and SdhB subunits contain 
iron-sulfur clusters (Iverson et al. 1999). The catalytic subunits show a conserved amino 
acid sequence, whereas the membrane associated subunits do not show significant 
sequence similarity (Wood et al. 1984). 
The expression of sdh under aerobic and anaerobic conditions has been assessed 
through the P-galactosidase assay using sdhC-lacZ fusion constructs (Maklashina et al. 
1998). In wild type E. coli (MC4100), sdh has been found to be expressed anaerobically 
at a very low level, approximately 3% of the sdh aerobic expression (Shen and Gunsalus 
1997). This low expression level is not enough to sustain respiration and cell growth in 
anaerobic conditions (Maklashina et al. 1998). Although, due to the similarity between 
SDH and FDH enzymatic complexes; in vitro studies have been conducted in the past to 
determine if these enzymes have the potential to be interchangeable. Experimental results 
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from isolated enzymes have shown that both enzymes are able to catalyze fumarate 
reduction and succinate oxidation at very different rates (Maklashina et al. 1998). 
Maklashina and collaborators (1998) determined the turnover of these enzymes when 
overexpressed from their native promoters and grown in the conditions of maximum 
expression which are aerobic condition for SDH and anaerobic growth for FDH. SDH 
was found to almost exclusively catalyze succinate oxidation to fumarate and FDH to 
catalyzed mainly fumarate reduction. Although, a sligh activity in the opposite direction 
was reported for both enzymes (Maklashina et al. 1998). Then, the overexpression of 
sdhCDAB from its native promoter (PSDH) was assessed in afrd-sdh double mutant strain, 
resulting in partial restoration of anaerobic cell growth in a glycerol-fumarate medium. 
However, the cells grew significantly slower, with a doubling time of more than 8h 
compared to 1.6-1.8h for the wild type strain (Maklashina et al. 1998). On the other hand, 
the overexpression of shdCDAB from the frd promoter, PFRD, restored anaerobic cell 
growth to a higher extent with a doubling time of about 3h (Maklashina et al. 1998). 
Similarly, the presence of fumarate reductase can partially replace SDH activity in 
a sdh mutant when frdA is overexpressed from a multicopy plasmid vector (Guest 1981) 
Then, both enzymes have the potential to complement each other if expressed 
properly. In addition, when either FRD or SDH are overexpressed, an increase on 
membrane surface has been noted. The extra membrane forms tubular structures to 
support the anchorage of the highly expressed enzymatic complex (Elmes et al. 1986; 
Maklashina et al. 1998; Weiner et al. 1984). 
In this work, the effect of fumarate reductase inactivation, as well as the effect of 
inactivating succinate dehydrogenase (sdhAB), isocitrate lyase (aceA) and/or acetate 
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forming enzymes (ackA and ptd) in the frdA mutant background have been analyzed 
respect to their fermentation product profiles. The present study aims to minimize or 
eliminate succinate production and assess the potential increase in other C4 compounds. 
The mutations mentioned above were introduced into a lactate dehydrogenase (IdhA) and 
alcohol dehydrogenase (adhE) double mutant strain overexpressing the pyruvate 
carboxylase from Lactococcus lactis, SBS110MG (pHL413) (Sanchez et al. 2005a). 
SBS100MG (pHL413) produces succinate as the main anaerobic fermentation product. A 
scheme of the anaerobic central metabolism of the background mutant strain, E. coli 
SBS11OMG (pHL413) is shown in Figure 5-1. 
5.1.3 Material and methods 
5.1.3.1 Bacterial strains and plasmids 
Strains and plasmids used for this study are described in Table 4-1. Mutant strains 
were created based on E. coli SBS 11 OMG strain carrying the IdhA and adhE deletions 
(Sanchez et al. 2005a). All mutations were created by PI phage transduction. The 
fumarate reductase mutant strain (frdA) and the isocitrate lyase mutant strain (aceA), 
were constructed using the Keio Collection single mutants JWk4115 and JWK3975 
respectively, as donor strains (Baba et al. 2006). The succinate dehydrogenase mutant 
(sdhAB) was constructed using the strain HL2K as the donor strain (Lin et al. 2005c). All 
the donor mutant strains with the exception of the ackA-pta mutant were constructed by 
the one-step inactivation method (Datsenko and Wanner 2000). The ackA-pta mutation 
was obtained from the E. coli strain YBS121 (Yang et al. 1999a), used as the donor 
strain for PI phage transduction. All the mutations were confirmed by PCR. 
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Table 5-1. List of E. coli strains and plasmids used in this study. 
Relevant genotype Reference or source 
Strain 
MG165 5 Wild type E. coli {¥ X) 
SBS11OMG MG1655 IdhA adhE 
LBSF1 SQSUOMG frdA::Km 
LBSF1S SBSllOMG/raW, Kms 
MBS501K LBSFlSace^.-.-^/w 
MBS502K LBSF IS sdhAB:: Km 
MBS503K LBSF\S sdhAB aceA::Km 
MBS504KC 
MBS505KC 
MBS506KC 
Plasmids 
pHL413 
LBSF1S aceAr.Km ackA-pta::Cm 
LBSF IS sdhAB::Km ackA-pta::Cm 
LBSF1S sdhAB aceAr.Km ackA-pta::Cm 
ATCC 47076 
(Sanchez et al. 2005a) 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
Pyruvate carboxylase from Lactococcus lactis (Lin et al. 2004) 
cloned in pTrc99A, ApR 
pTrc99A Cloning vector, Ap Pharmacia 
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Figure 5-1. Central metabolic pathway of E. coli SBS110MG (pHL413) strain. Adapted 
from (Sanchez et al. 2005a). 
5.1.3.2 Shake flask experiments 
Shake flask experiments were adapted from previous work (Sanchez et al. 2005a). 
The process involved an aerobic-growth phase for biomass accumulation, and an 
anaerobic or microaerobic production phase. Each strain was streaked in Luria Bertani 
(LB) agar plates containing 66.7 mg/L of each ampicillin, carbenicillin and oxacillin. A 
single colony from these plates was used to inoculate 5 ml LB medium containing the 
mixture of antibiotics. The cultures were grown at 37°C and 250 rpm overnight in 14 ml 
tubes. A volume of 4 ml of the overnight culture were centrifuged and washed three times 
with LB before used to inoculate 400 ml LB medium containing 200 mg/L ampicillin 
(Ap) in 2 L flasks. These cultures were grown for 14-17h at 37°C and 250 rpm. Later, a 
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determined volume of culture was centrifuged and resuspended in 10 ml of anaerobic 
medium (LB + 1 g/L NaHCC>3 + 20 g/L glucose + 100 mg/L Ap) to a cell concentration 
of 20 OD6oo- This suspension was poured into 250 ml flasks containing 0.5 g MgCC>3, 
purged for 1 min with 1 L/min CO2 or a mixture of 2.5% O2 in CO2 for the anaerobic and 
microaerobic experiments respectively; and finally capped with a rubber stopper to 
prevent air entry. The cultures were incubated at 37°C and 250 rpm for 24h. 
5.1.4 Extracellular metabolite analysis 
Culture samples were centrifuged in a microcentrifuge at 13,000xg for 1 min and 
filtrated through a 0.2 urn filter and stored at -20°C until analysis. 
Substrate (glucose) and fermentation products malate, formate, lactate, fumarate, 
acetate and pyruvate were analyzed by HPLC based on a method described previously 
(Sanchez et al. 2005a; Sanchez et al. 2005b). In brief, the HPLC system used (Shimadzu-
10A System, Shimadzu, Columbia, MD) equipped with a cation-exchange column (HPX-
87H, Biorad Labs, Hercules, CA), a differential refractive index (RI) detector (Waters 
2410, Waters, Milford, MA) and an ultraviolet (UV) detector (Shimadzu SPD-10A). The 
mobile phase was 2.5 mM H2SO4 solution at a 0.5 mL/min flow rate. The column was 
operated at 55°C. 
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5.1.5 Results and Discussion 
The results for the shake flask experiments performed with the frdA mutant strain 
set are presented in Figure 5-2. The strain SBS110MG (pHL413) carrying mutations on 
IdhA and adhE was used as the control strain. 
5.1.5.1 Anaerobic shake flask experiments 
The frdA mutation showed a significant decrease in glucose consumption, from 
almost 100% in the control strain to 41.3% in the, frdA mutant (LBSF1S), and a decrease 
in succinate and acetate production of 73% and 60%, respectively (Figure 5-2A). 
Succinate yield decreased about 30% (Figure 5-2C) and the concentration of succinate 
decreased from 110.3 to 29.5 mM. On the other hand, malate yield increased nine-fold 
with an increase in malate concentration from 3.3 to 12.5 mM (Figure 5-2A, C). The 
decrease in succinate production in the frdA mutant was expected as FRD is the main 
responsible for the reduction of fumarate to succinate in anaerobic condition. The non-
negligible amount of succinate produced in this mutant was presumably due to either 
SDH activity or the glyoxylate pathway. Then, sdhAB and aceA mutations were 
introduced individually and together into the frdA mutant to address this question. 
The deletion of aceA in the frdA mutant did not show any significant effect 
compared to the frdA mutant alone (Figure 5-2A). On the other hand, the deletion of 
sdhAB in the frdA mutant strain resulted in a significant decrease in glucose consumption; 
only 13%o was consumed in 24 h. The production of malate was similar but the malate 
yield from glucose increased significantly from about 0.28 to 0.44. Succinate production 
was eliminated and the production of other anaerobic products was minimal. The 
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introduction of the aceA deletion to the frdA sdhAB strain did not show significant 
difference in anaerobic product profile and glucose consumption compared to the frdA 
sdhAB mutant strain. 
Therefore, the enzyme responsible for succinate production in the frdA mutant 
was mainly SDH, which has been reported to have some modest activity in anaerobic 
conditions (Maklashina et al. 1998). Our experiments were conducted in two phases, 
where the first one was aerobic for biomass accumulation and the second phase was 
anaerobic for product synthesis. sdhAB is known to be highly expressed in aerobic 
conditions (Maklashina et al. 1998); then, some of the SDH produced during the aerobic 
phase may have remained active during the anaerobic phase contributing to the reduction 
of fumarate to succinate. SDH in the present circumstances was not a complete 
replacement for FRD. SDH has been reported to be able to replace FDH when 
overexpressed in anaerobic conditions from the FDH promoter (Maklashina et al. 1998). 
E. coli frd mutant is known to have flagella deficiency, and other metabolic 
problems not yet discovered may be possible (Montrone et al. 1998). In our experiments, 
the frdA mutant showed slightly lower cell growth that the control, 15% lower 
approximately (data not shown), but when the sdhAB mutation was introduced, the cell 
growth decreased to about 35% of the control after overnight aerobic growth at 37°C 
(data not shown). 
The frdA mutant strain was the highest producer of malate in the anaerobic 
experiments (12.5 mM) (Figure 5-2A). The theoretical maximum for malate production 
from glucose is 2 moles of malate per mole of glucose, due to the requirement of NADH, 
e. i. one molecule of NADH per molecule of malate produced). The malate yield 
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increased as succinate production and yield decreased, although the yield was 
significantly lower than the theoretical maximum (Figure 5-2C) which indicates that 
there is an opportunity for improvement in the future. 
5.1.5.2 Microaerobic experiments 
The frdA mutant strains did not consume all the glucose, the presence of an 
external electron acceptor could potentially alleviate a possible energy or NAD+ shortage 
and increase anaerobic product synthesis. To evaluate the effect of the presence of an 
external electron acceptor in the product profile of a set of frdA mutant strains, shake 
flask experiments were performed in microaerobic conditions, as described in Materials 
and Methods section of this Chapter where a mixture of 2.5% 02-97.5% CO2 (Zhu et al. 
2007), instead of 100% CO2 was used to purge the flasks. 
The presence of oxygen increased glucose consumption in all the mutant strains. 
Nevertheless, glucose consumption was still significantly lower than in the control strain 
(Figure 5-2A). An increase in anaerobic products succinate, malate, formate and acetate, 
was also observed (Figure 5-2A), similar results were obtained when nitrate was used as 
electron acceptor (data not shown). No major amounts of fumarate were produced, 
although detectable levels of fumarate were obtained in all the frdA mutants tested in 
microaerobic conditions. The fumarate concentrations observed are shown in Figure 5-3. 
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The highest malate production (21 mM) was observed with the frdA mutant 
LBSF1S and microaerobic conditions, which suggests that an external electron acceptor 
is required in the system for higher glucose conversion into fermentation products in 
these strains. Glucose utilization may have stopped after all the oxygen in the flask was 
consumed. The study of these strains under controlled conditions, a bioreactor setting is 
recommended, where oxygen can be delivered to the cells in a continuous and controlled 
manner, which may result in higher glucose conversion into malate and potentially 
fumarate. Different oxygen concentration in the gas stream could be investigated, and 
other electron acceptor could also be analyzed in the future. 
The incomplete glucose utilization may also be caused by a limitation on NAD+ 
regeneration in these strains where all the other fermentation routes are eliminated 
(Jantama et al. 2008a). The addition of external NAD+ could also be evaluated in the 
future. 
Due to the high acetate production in most of the frdA strains, especially when 
microaerobic conditions were used, the ackA-pta double gene inactivation was introduced 
to the frdA mutant strain set to evaluate if a decrease in acetate production would increase 
the synthesis of other fermentation products (Figure 5-2 B and D). The results show a 
significant decrease in acetate production, as expected, but no major improvement in 
malate or fumarate production was observed, and pyruvate was accumulated. In addition, 
the introduction of ackA-pta mutations decreased glucose consumption even further and 
reduced cell growth. 
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Figure 5-3. Production of fumarate by frdA mutant strains under anaerobic and 
microaerobic conditions. All the strains carried pHL413, plasmid encoding the pyruvate 
carboxylase from L. lactis. SBS110MG: MG1655 IdhA adhE; LBSF1S: SBS110MG 
frdA; MBS501K: LBSF1S aceAr.Km; MBS502K: LBSF1S sdhAr.Km; MBS503K: 
LBSF1S sdhAB aceAr.Km; MBS504KC: LBSF1S aceAr.Km ackA-ptarCm; 
MBS505KC: LBSF1S sdhABrKm ackA-ptar.Cm; MBS506KC: LBSF1S sdhAB 
aceAr.Km ackA-ptar.Cm. 
5.1.6 Conclusions 
The inactivation of the fumarate redutase (frdA) in a IdhA adhE mutant strain 
overexpressing pyruvate carboxylase from L. lactis, originally constructed for succinate 
production, showed a significant increase in malate production and a decreased but not 
elimination of succinate production, moreover succinate continued to be the major C4-
compound produced. 
The incorporation of the sdhAB inactivation resulted in almost complete 
elimination of succinate production, showing that SDH could partially replace FDH in 
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the conditions tested, and in an increase in malate yield from 0.28 to 0.44 mole of malate 
per mole of glucose. 
The presence of an external electron acceptor in the system increased glucose 
consumption and anaerobic product synthesis, relieving potential need for energy or 
NAD+ availability. 
5.2 Effect of inactivating fumarase genes on C4 compounds production 
5.2.1 Abstract 
E. coli contains three fumarases (A, B and C) responsible for the reversible 
conversion of malte into fumarate during the tricarboxylic (TCA) acid cycle and 
anaerobic fermentation. In this study the inactivation of one, two or all of them was 
investigated respect to the anaerobic product profile for the potential production of 
NADH-dependent C4 compounds. 
The presence of either fumarase was sufficient to allow the conversion of malate 
into fumarate, giving succinate as the main C4 product. However, the elimination of 
FumA and FumC together resulted in an almost complete elimation of succinate 
production and an increase in malate product yield. Although, aerobic cell growth was 
drastically affected and only 20-25% of the glucose was consumed in 24h of the 
anaerobic phase. 
Then, despite FumB being expressed mainly in anaerobic conditions, it was not 
sufficient for substaining fumarate production for succinate synthesis; and FumA and 
FumC together appear to be the major fumarases under the condition tested. 
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5.2.2 Introduction 
E. coli contains three fumarases denominated fumarase A, B and C (Guest et al. 
1985; Miles and Guest 1984; Woods et al. 1988). These enzymes catalyze the reversible 
conversion of (L)-malate into fumarate, participating in the tricarboxylic acid (TCA) 
cycle and in anaerobic fermentation. Fumarase A and fumarase B show high sequence 
similarity (90% identity) (Flint et al. 1992), form dimers and are part of the Class I (iron-
dependent) fumarases; whereas fumarase C does not show sequence similarity to the 
other two, is iron-independent, forms tetramers and is part of the Class II fumarases 
(Woods etal. 1988). 
Woods and collaborators (1988) studied the fumarate activity of a series of 
plasmids encoding the different fumarases (A, B and C) separately under different culture 
conditions. Fumarases A and B have been found to be thermolabile, whereas fumarase C 
was stable with 70% of the activity retained after 80 min at 50°C (Woods et al. 1988). 
FumA and FumC showed to have higher affinity for fumarate than for malate in vitro 
experiments, the opposite was found for FumB, suggesting than FumA and FumC 
participate mainly in the TCA cycle, and FumB may act primarily in anaerobic 
fermentation, converting malate into fumarate (Woods et al. 1988). 
In this research section the impact of single, double and triple fumarase deletions 
in anaerobic product profile in shake flask experiments has been investigated as part of 
the studies performed towards a better understanding of the enzymes involved in 
anaerobic fermentation in E. coli, and the evaluation of rational genetic manipulations to 
potentially improve NADH-dependent C4 compounds production. 
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5.2.3 Materials and Methods 
The list of E. coli strains and plasmids used in this study are described in Table 5-
2. 
Table 5-2. List of E. coli strains and plasmids used in this study. 
Relevant genotype Reference or source 
Strain 
MG1655 
SBS110MG 
MBS410 
MBS420 
MBS412 
MBS432 
MBS406 
MBS426 
Plasmids 
Wild type E. coli (F" X') 
MG1655 IdhAadhE 
SBS\\0MGfumA::Km 
SBS\\0MGfumB::Km 
SBS11 OMGfumAfumB::Km 
SBS\\OMGfumCfumB::Km 
SBSWOMG fumAC.Km 
SBS 11 OMGfumBfumAC::Km 
ATCC 47076 
(Sanchez et al. 2005a) 
This study 
This study 
This study 
This study 
This study 
This study 
pHL413 Pyruvate carboxylase from Lactococcus lactis (Lin et al. 2004) 
cloned in pTrc99A, ApR 
pTrc99A Cloning vector, ApR Pharmacia 
Fumarase single mutant strains were constructed by PI phage transduction using 
the Keio Collection donor strains JW1604, JW4083 and JW1603 for fumA, fumB and 
fumC gene inactivation, respectively (Baba et al. 2006). The fumAC double mutant strain 
was constructed using the single-step inactivation method developed by Datsenko and 
Wanner (Datsenko and Wanner 2000), and the following primers: Forward: 
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5 'GTGGTGGTTCGGCAAACAAGACGTATCTCTATCAGGAAACGTGTAGGCTGG 
AGCTGCTTC-3'; reverse: 5'-AAACGGTGCACAGGTAATGACTGCCAGTTCATCT 
GCTACGCATATGAATATCCTCCTTAG-3'. The underlined sequences are 
homologous to the fumAC sequence. 
5.2.3.1 Shake flask experiments 
Shake flask experiments were performed as described previously (Sanchez et al. 
2005a). In brief, the cells were cultured in a two-step process, where the first step was 
aerobic for biomass accumulation, and the second was anaerobic fermentation product 
synthesis. The strains were initially streaked on Luria Bertani (LB) agar plates containing 
66.7 mg/L of each ampicillin, carbenicillin and oxacillin. A 5 ml LB medium culture 
containing the mixture of antibiotics was inoculated using a single colony from the plate 
mentioned above. The cultures were grown at 37°C and 250 rpm overnight. Cultures 
were then centrifuged and washed with fresh LB medium three-times and finally 
resuspended in the same medium to the same initial volume. A volume of 400 ml of LB 
medium containing 200 mg/L ampicillin (Ap) in 2L flasks were inoculated to a 1% in 
volume using the cells prepared above. These cultures were grown overnight at 37°C and 
250 rpm. A calculated volume of this grown culture was centrifuged and resuspended in 
10 ml of anaerobic medium (LB + 1 g/L NaHC03 + 20 g/L glucose + 100 mg/L Ap) to a 
cell concentration of 20 OD6oo- This suspension was poured into 250 ml flasks containing 
0.5 g MgCC»3, purged for 1 min with 1 L/min CO2; and sealed with rubber stoppers. 
These cultures were incubated at 37°C and 250 rpm for 24h. 
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5.2.3.2 Extracellular metabolite analysis 
The anaerobic flask cultures were sampled at 24h. A volume of 2 ml of sample 
from each flask was centrifuged in a microcentrifuge at 13,000xg for 1 min, filtrated 
through a 0.2 um filter and stored at -20°C until analysis. 
Glucose and extracellular metabolites, e.g. succinate, malate, acetate, among 
other, were analyzed by HPLC as previously described (Sanchez et al. 2005a; Sanchez et 
al. 2005b). In brief, the HPLC system (Shimadzu-lOA System, Shimadzu, Columbia, 
MD) equipped with a cation-exchange column (HPX-87H, Biorad Labs, Hercules, CA), a 
differential refractive index (RI) detector (Waters 2410, Waters, Milford, MA) and an 
ultraviolet (UV) detector (Shimadzu SPD-10A). The mobile phase was 2.5 mM H2S04 
solution at a 0.5 mL/min flow rate. The column was operated at 55°C. 
5.2.4 Results and Discussion 
The results of the shake flask anaerobic fermentations of the different single, 
double and triple fumarase mutants are presented in Figure 5-4. 
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Figure 5-4. Anaerobic product profiles and yields of fumarase mutants. All the strains 
carried pHL413, plasmid encoding the pyruvate carboxylase from L. lactis. SBS110MG: 
MG1655 IdhA adhE; MBS410: SBS110MG fumA::Km; MBS420: SBS110MG 
fumB:: Km; MBS430: SBS110MG fumCr.Km; MBS412: SBSUOMG fumA fumB::Km; 
MBS432: SBSUOMG fumC fumB::Km; MBS406: SBSUOMG fumAC:Km, MBS426: 
SBSUOMG fumB fumAC: Km. 
All the fumarase mutant strains consume practically 100% of the glucose in the 
medium with the exception of the fumAC mutant and the triple fumB AC mutant strains. 
These two strains also showed a significantly lower cell growth after aerobic overnight 
culture in LB medium with values of 1.6 and 1.2 OD600, respectively, compared to 3.2 -
4.7 OD600 for the other fumarase mutants and control strain SBSUOMG (pHL413) (data 
not shown). 
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Succinate showed to be the major anaerobic product together with acetate and 
formate in the strains without fumAC inactivation; with concentrations of succinate 
ranging from 101 to 113 mM, and a yield of 0.93-1.05 mole of succinate per mole of 
glucose. Acetate concentrations were high, of about 140-150 mM for all the strains 
except the fumAC mutants. 
Malate was produced in all the mutant strains, with the highest values (13.5-16.6 
mM) found in the fumB mutant (MBS420), the fumAC mutant (MBS406) and the triple 
fumarase mutant (MBS426). An important difference among these strains was the malate 
yield achieved, MBS420 showed a yield of only 0.13 mole of malate per mole of glucose 
consumed, whereas the fumAC mutants (MBS406 and MBS426) showed an increase in 
malate yield up to 0.60-0.67 mole malate per mole of glucose. Although, the fumAC 
mutants, as mentioned earlier, grow slower and did not consume all the glucose in 24 h. 
A similar strategy to the one presented in the previous section for the frdA mutants, e.i. 
addition of an external electron acceptor, may improve malate production in these strains 
and is recommended for further studies. 
Fumarases A and C have been reported to be expressed to a higher level during 
aerobic growth and FumB is expressed the highest during anaerobic conditions (Park and 
Gunsalus 1995; Tseng 1997). Although, FumA is the fumarase responsible for most of 
the fumarase activity in anaerobic growth (Tseng et al. 2001). Fum C activity has been 
shown to increase several fold in growth experiments at high O2, potentially because the 
cells favor the synthesis of a non-iron dependent enzyme over a iron protein (FumA) in 
highly oxidative conditions (Tseng et al. 2001). In the present study the cells were first 
grown aerobically for biomass accumulation and then switched to an anaerobic 
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environment for the production phase. Then the enzymes produced during the aerobic 
period may still be present during the anaerobic phase contributing to the fumarase 
activity observed. 
In this work, the presence of either one of the three fumarases was sufficient to 
allow the conversion of malate into fumarate for succinate production and only when 
FumA and C, or all three, were inactivated an inhibition of succinate production was 
observed. The prevention of succinate synthesis under these circumstances led to a 
significant increase in malate yield, and some increase in final malate concentration, but 
glucose consumption decreased to only 20-25%. 
5.2.5 Conclusions 
The presence of either fumarase A, B or C showed not to be essential for 
succinate production. On the other hand, the combined inactivation of FumA and FumC 
resulted in an almost complete elimination of succinate production, and a significant 
decrease in aerobic cell growth and glucose consumption. However, the maximum malate 
yield, 0.60-0.67 mole malate/mole glucose, was obtained when FumA and FumC were 
inactivated. 
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Part II 
Part II describes the application of metabolic engineering principles to 
strategically modify pathway steps requiring or producing reducing equivalents. 
Specifically, Chapter 6 describes the design and characterization of an engineered strain 
where the endogenous glycolytic gene encoding the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was inactivated and replaced by the gene encoding GAPDH 
from Clostridium acetobutylicum. This strain was evaluated for the heterologous 
synthesis of compounds requiring NADPH as cofactor and showed a significant increase 
in yield and productivity in the synthesis of lycopene and s-caprolactone, which were 
used as NADPH-dependent model systems. 
Chapter 7 includes a discussion about the pyridine nucleotide transhydrogenases 
presents in E. coli and their potential role on redox balance inside the cell. A set of 
mutant strains and overexpression plasmids has been strategically designed and 
constructed to study the influence of these enzymes in NAD(P)H-dependent compound 
synthesis. 
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Chapter 6 
6 Metabolic Engineering of Escherichia coli to Improve 
Product Yield in NADPH-dependent pathways 
*This chapter has been published in Metabolic engineering (Martinez et al. 2008). 
6.1 Abstract 
Reactions requiring reducing equivalents, NAD(P)H, are of enormous importance 
for the synthesis of industrially valuable compounds such as carotenoids, polymers, 
antibiotics and chiral alcohols among others. The use of whole-cell biocatalysis can 
reduce process cost by acting as catalyst and cofactor regenerator at the same time; 
however product yields might be limited by cofactor availability within the cell. Thus, 
our study focused on the genetic manipulation of a whole-cell system by modifying 
metabolic pathways and enzymes to improve the overall production process. In the 
present work we genetically engineered an Escherichia coli strain to increase NADPH 
availability to improve the productivity of products that require NADPH in its 
biosynthesis. The approach involved an alteration of the glycolysis step where 
glyceraldehyde-3-phosphate (GAP) is oxidized to 1,3 bisphophoglycerate (1,3-BPG). 
This reaction is catalyzed by NAD-dependent endogenous glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) encoded by the gapA gene. We constructed a recombinant E. 
coli strain by replacing the native NAD-dependent gapA gene with the GAPDH from 
Clostridium acetobutylicum, encoded by the gene gapC. The beauty of this approach is 
that the recombinant E. coli strain produces two moles of NADPH, instead of NADH, per 
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mole of glucose consumed. Metabolic flux analysis showed that the flux through the 
pentose phosphate pathway, one of the main pathways that produce NADPH, was 
reduced significantly in the recombinant strain when compared to that of the parent 
strain. The effectiveness of the NADPH enhancing system was tested using the 
production of lycopene and e-caprolactone as model systems using two different 
background strains. The recombinant strains, with increased NADPH availability, 
consistently showed significant higher productivity than the parent strains. 
6.2 Introduction 
Many redox enzymes catalyze synthesis reactions that lead to the formation of 
industrially important compounds. These reactions commonly require precursors and 
cofactors that could be provided by cells primary metabolism. Reducing equivalents, 
such as NADPH or NADH are usually required in large quantities. Whole-cell systems 
are able to supply and regenerate reducing equivalents, although the generation rate 
might be a limiting factor for reaching high yields and high productivities (Gunnarsson et 
al. 2004; San et al. 2002). The main source of NADPH in the cells is the pentose-
phosphate pathway where two molecules of the reduced cofactor are regenerated per 
glucose directed through that pathway. The TCA cycle also regenerates NADPH but in to 
a lower extent (Gunnarsson et al. 2004). To increase product yields, NADH levels have 
been manipulated in the past by overexpressing formate dehydrogenase in E. coli 
(Berrios-Rivera et al. 2002a; Berrios-Rivera et al. 2002b; Berrios-Rivera et al. 2002c; 
Berrios-Rivera et al. 2004; Ernst et al. 2005; Hummel 1997). On the other hand, NADPH 
levels have been manipulated in Saccharomyces cerevisiae by overexpressing the malic 
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enzyme (Moreira dos Santos et al. 2004; Sanchez et al. 2006a) or the NADP+-dependent 
D-glyceraldehyde-3-phosphate dehydrogenase (NADP-GAPDH) from Kluyveromyces 
lactis (Verho et al. 2003; Verho et al. 2002); and in E. coli by forcing the carbon flow 
through the pentose phosphate pathway by knocking out the phosphoglucoisomerase 
gene (pgi) (Kabir and Shimizu 2003a), although this approach resulted in growth 
deficiency. Another approach to increase NADPH availability in E. coli has been the 
overexpression of the endogenous pyridine nucleotide transhydrogenase (UdhA) 
(Sanchez et al. 2006a), which catalyzes a reversible reaction where the reducing power 
can be interchanged between NADH and NADPH 
(NADH+NADP+ <U d h A)NAD++NADPH), therefore if NADPH is consumed, the 
enzyme has the potential to replenish it. 
In the present work, E. coli primary metabolism, specifically one glycolysis step, 
has been modified to increase product yields in NADPH-dependent synthesis systems. 
The endogenous gap A gene, encoding for a NAD-dependent glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), was knocked out and the gapC gene from Clostridium 
acetobutylicum, encoding a NADP-dependent GAPDH, was overexpressed to generate 
NADPH instead of NADH in the oxidation of glyceraldehyde-3-phosphate (GAP) during 
glycolysis. This modification increases the amount of NADPH produced through the 
glycolysis pathway maintaining such primary pathway functioning producing 
metabolites, precursors and energy. The modified strain was characterized by metabolic 
flux analysis (MFA) and the effect of the alterations in product yield and productivity 
were assessed using the synthesis of lycopene and s-caprolactone as model systems. The 
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genes required for the synthesis of these compounds were heterologously expressed in the 
recombinant E. coli. 
Lycopene is a red-colored carotenoid naturally found in vegetables (tomato) and 
fruits. This compound is a commercially important product widely used as antioxidant, 
colorant and precursor of other carotenoids. Recent studies have suggested that the 
ingestion of lycopene could reduce the risk of certain cancers (including prostate, lung 
and breast cancers) (Agarwal and Rao 2000), prevent atherosclerosis and cardiovascular 
heart diseases (Rao and Agarwal 2000) as well as enhance immune system response 
(Agarwal and Rao 2000; Bose and Agrawal 2007; Minorsky 2002; Rao and Agarwal 
2000; Stacewicz-Sapuntzakis and Bowen 2005). Lycopene has been produced in E. coli 
by means of the non-mevalonate pathway expressing the lycopene synthetic operon 
crtEBI from Erwinia herbicola (Alper et al. 2005; Cunningham et al. 1994; Vadali et al. 
2005). The biosynthesis requires glyceraldehyde-3-phosphate (GAP), pyruvate and a high 
amount of NADPH (16 molecules of NADPH per molecule of lycopene) (Alper et al. 
2005) (Figure 8-1). 
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Figure 6-1. Lycopene synthesis pathway in recombinant Escherichia coli. GAP: 
glyceraldehyde-3-phosphate, DHAP: dihydroxyacetone-3-phosphate, DXP: 
deoxyxylulose 5-phosphate, DMPP: dimethylallyl pyrophosphate, IPP: isopentenyl 
phosphate, PPP: pentose phosphate pathway. 
Baeyer-Villager (BV) reactions are very important in chemical and 
pharmaceutical industries. They involve the oxidation of aliphatic and cyclic ketones to 
produce esters and lactones, respectively. The traditional BV chemical process involves 
the use of peroxyacids or hydrogen peroxide and a transition metal catalyst. This process 
has low stereoselectivity, possible high recovery costs and it is detrimental to the 
environment. In the other hand, many oxidoreductases have been studied for their ability 
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to catalyze environmentally friendly enantio-, chemo- or region- selective reactions to 
produce a variety of compounds with high optical purity, extremely important for 
chemical and pharmaceutical applications. In particular, monooxygenases have been 
found to be highly stereoselective (Schulz et al. 2005). These enzymes use molecular 
oxygen and require NAD(P)H. Baeyer-Villager monooxygenases (BVMOs) are found in 
a wide variety of organisms such as Acinetobacter sp. (Donoghue et al. 1976), 
Arthrobacter (Kyte et al. 2004), Comamonas, Rhodococcus, Xanthobacter (Van Beilen et 
al. 2003), Nocardia (Donoghue et al. 1976), Brevibacterium (Mihovilovic et al. 2003), 
and Pseudomonas fluorescens (Kirschner et al. 2007), among others. These enzymes 
have been used in isolated form or as whole-cell biocatalysts. Whole-cells of their native 
organism or recombinant forms of E. coli or S. cerevisiae have also been studied 
(Baldwin and Woodley 2006; Lee et al. 2005b; Walton and Stewart 2002; Walton and 
Stewart 2004). BVMOs are able to accept a wide range of substrates with variable 
stereoselectivity. In particular, cyclohexanone monooxygenase (CHMO) from 
Acinetobacter sp. NCIB 9871 has been shown to oxidize thioethers and cyclohexanones 
into sulfoxides and 5- and s-caprolactones with high enantioselectivity (>95%) (Chen et 
al. 1999; Lee et al. 2005b; Stewart et al. 1996; Walton and Stewart 2002). 8-caprolactone 
is an important intermediate in the manufacture of polyurethane adhesives, 
thermoplastics (Lee et al. 2005b), resins for surface coatings and synthetic leather and 
fabrics. BVMO reactions require stoichiometric amounts of reducing equivalents that 
must be regenerated, which adds complexity and cost to the system. In this work we used 
cyclohexanone monooxygenase (CHMO) from Acinetobacter sp to study the effect our 
recombinant E. coli in s-caprolactone yield and productivity (Figure 2-2). The 
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recombinant E. coli in this case acts exclusively as a regenerator of NADPH using 
glucose as energy source. This reaction gives a more direct measure of the NADPH 
availability in our system. One mole of NADPH is consumed per mole of e-caprolactone 
produced. 
O 
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Figure 6-2. Synthesis of s-caprolactone in recombinant Escherichia coli expressing 
cyclohexanone monooxygenase (CHMO) from Acinetobacter sp. 
6.3 Materials and Methods 
6.3.1 GAPDH assay 
E. coli glyceraldehyde-3-phospate dehydrogenase (GAPDH) catalyzes the 
conversion of glyceraldehyde-3-P to 1,3-bisphosphoglycerate (1,3BPG) using NAD+ or 
NADP+ as a cofactor, depending on the enzyme origin. GAPDH activity was measured 
using method adapted from Iddar (Iddar et al. 2002). To 200 ul of crude extract, 250 ul of 
200 mM tricine buffer (pH 8.5), 300 ul of mercaptoethanol, 100 ul of 10 mM NAD(P)+ 
and 50 ul DI water were added, and finally 100 ul of 10 mM GAP were added just prior 
to measurement. Enzyme activity was followed by monitoring change in absorbance at 
340 nm. The extinction coefficient used was 6.22 mM' cm"1. 
94 
6.3.2 Bacterial strains and plasmids 
Strains and plasmids used in this work are listed in Table 6-1. The W3CG strain 
was generously donated by the E. coli Genetic Stock Center. Two gapA mutant strains 
with different E. coli genetic backgrounds (MG1655 and BL21(DE3)) were constructed 
by PI-Phage transduction using E. coli W3CG (E. coli W3110 gapA::Tc) as the donor 
strain (Ganter and Pluckthun 1990). The MG1655 gap A strain harboring the plasmid 
pK19-Lyco encoding the crtE, crtl and crtB genes from E. herbicola was used for the 
lycopene production experiments. The BL21(DE3) E. coli strain contains the gene 
encoding the T7 RNA polymerase, used for expression of genes under the T7 promoter. 
The plasmid pMM4, used for s-caprolactone synthesis, encodes the CHMO gene from 
Acinetobacter sp. NCIB 9871 under the T7 promoter, then, this host strain expressing the 
T7 RNA polymerase was constructed for CHMO expression and thus s-caprolactone 
biosynthesis. The plasmid pMM4 was kindly provided by Dr. Stewart (University of 
Florida). 
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Table 6-1. List of E. coli of strains and plasmids used in this work. 
Relevant genotype Reference 
E. coli strains 
MG1655 Wild type E. coli 
BL21 (DE3) For T7-promoter expresion 
W3CG W3110 gap A 
MBS100M MG1655 gapA 
MBS 100B BL21 (DE3) gapA 
ATCC 47076 
Invitrogen 
(Ganter and Pluckthun 1990) 
This study 
This study 
Plasmids 
pDHC29 Cloning vector, CmK 
pHL621 gapC from C. acetobutylicum in 
pDHC29, CmR 
pAC-LYC crtE, crtl, crtB genes from E. 
herbicola in pACYC184, CmR 
pK19 Cloning vector, KmR 
pK19-Lyco crtE, crtl, crtB genes from E. 
herbicola in pK19, KmR 
pMM4 CHMO gene from Acinetobacter sp. 
NCIB 9871 in pET22b(+), ApR 
(Phillips et al. 2000) 
This study 
(Cunningham et al. 1994) 
(Pridmore 1987) 
This study 
(Chenetal. 1999) 
The E. coli gapA mutant strains were selected on LB agar plates containing 15 
mg/L tetracycline and the mutation was confirmed by GAPDH assay and strain inability 
to grow on minimal medium containing glucose as the sole carbon source (6 g/L 
Na2HP04, 3 g/L KH2P04, 0.5 g/L NaCl, 1 g/L NH4C1, 0.1 mM CaCl2, 1 mM MgS04, 15 
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g/L agar, 20 mM glucose). The E. coli gapA mutants showed negligible GAPDH activity 
(data not shown). 
The gapC gene, encoding for the glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), was amplified by PCR from Clostridium acetobutylicum chromosomal DNA. 
The primers 5' -GCTCTAGAGCATGAGGTAGTTAGAATGGC-3' and 5'-
CGGGATCCCGCAAATTAATTAATGAGCGC-3' were used in the PCR reaction. The 
PCR product (about 1 kb) was digested with Xbal and BamHI (restriction sites are 
underlined in the primer sequences) and cloned into plasmid pDHC29 (CmR). One 
plasmid which showed a high level of GAPDH activity (data not shown) was selected 
and was designated as plasmid pHL621. 
The crtEBI operon encoding for lycopene synthesis enzymes together with the 
native promoter were cloned from pAC-Lyc plasmid, Cm , (Cunningham et al. 1994) 
into the kanamycin resistant pK19 vector (Pridmore 1987) using Hindlll and EcoRI 
restriction sites. The new plasmid, pK19-lyco, is compatible with pHL621 (CmR). The 
pAC-Lyc plasmid was kindly donated by Dr. Francis Cunningham, Jr. (Botany 
Department, University of Maryland, College Park, MD). 
6.3.3 Metabolic Flux Analysis 
6.3.3.1 Continuous culture 
Glucose-limited chemostat cultures were made at a dilution rate of 0.35 ± 0.01 h" 
using 20 mM of glucose as a sole carbon source. The medium used was a minimal media 
containing (per liter) 7 g Na2HP04, 3 g KH2P04, 0.5 g NaCl, 1 g NH4Cl, 6 mg thiamine, 
1 mM MgSC*4, 0.1 mM CaCl2 and 35 ug/ml chloramphenicol. A 1-L bioreactor (BioFlo 
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110, New Brunswick Scientific Edison, NJ) was used for the cultures and the working 
volume was maintained at 600 ml. The pH value was maintained at 7.0±0.04 by titrating 
with 3 M NaOH and 1.5M of HNO3. The temperature was maintained at 37 °C. The 
aerobic culture condition was controlled by purging the culture broth in the bioreactor 
with air and maintaining the agitation speed at 285 rpm. The gas flow rate was controlled 
at 2 L/min. 
6.3.3.2 Analytical procedures 
Cell dry weight was determined from cell pellets of 100-ml culture aliquots that 
were centrifuged for 10 min at 4°C and 5,000 xg, washed twice with 0.15 M NaCl, and 
then dried at 50°C until the weight was constant. Culture broth samples were centrifuged 
for 3 min at 13,000xg in an AccuSpin™ micro centrifuge. The supernatant was filtered 
through a 0.2 um syringe filter and stored chilled for HPLC analysis. The extracellular 
metabolites and glucose were quantified using an HPLC system (Shimadzu Scientific 
Instruments, Columbia, MD) equipped with a cation-exchange column (HPX-87 H, 
BioRad Labs, Hercules, CA), a differential refractive index detector (Waters, Milford, 
MA) and a UV-VIS detector (SPD-10A, Shimadzu Scientific Instruments, Columbia, 
MD). A mobile phase of 2.5 mM H2SO4 solution at a 0.6 ml/min flow rate was used and 
the column was operated at 55 °C (Sanchez et al. 2005b; Yang et al. 1999b). 
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6.3.3.3 Labeling experiments and metabolic flux analysis 
We assumed that the steady state was reached after 7 volume changes when the 
optical density at 600 nm remained constant for at least three residence times. Labeling 
experiments were started after the cultures reached the steady state. The unlabeled 
feeding media was replaced by an identical medium containing 16 mM unlabeled 
glucose, 2 mM [U-13C] glucose, and 2 mM [1-13C] glucose. Biomass samples were taken 
at the end of the chemostat cultures for GC/MS detection. Cells in 50 ml of culture were 
harvested by centrifugation for 10 min at 4°C and 5,000 xg. The cell pellets were washed 
three times with 20 mM Tris-HCl (pH 7.6) and resuspended in ca. 6 ml of 6 M HC1. The 
mixture was hydrolyzed for 12 h at 105°C and the hydrolysate was filtered through a 0.2 
um pore-size filter and evaporated to dryness. There were 16 proteinogenic amino acids 
in the resulting hydrolysate, since cysteine and tryptophan were oxidized and asparagine 
and glutamine were deaminated during the HC1 hydrolysis (Szyperski 1995). The dried 
hydrolysates were derivatized and measured using GC-MS as previously described (Zhu 
et al. 2006). 
To quantitatively estimate the metabolic flux analysis in the main metabolic 
pathways, a metabolic network was constructed (Figure 6-3) including glycolysis, 
pentose phosphate (PP) pathway, tricarboxylic acid (TCA) cycle and fermentative 
pathways. Some metabolic pools like pentose phosphates, succinyl-CoA and succinate 
(SUC), isocitrate (ICT) and citrate, were combined to simplify the network. The reactions 
through phosphoenolpyruvate carboxylase (Pepc) and phosphoenolpyruvate 
carboxykinase (Pck) were combined into a bi-directional reaction, and the reaction 
toward oxaloacetate (OAA) production was used as the positive direction. Since glucose 
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was used as a sole carbon source, we did not consider the glyoxylate shunt and Entner-
Doudoroff pathway for the flux estimation (Stephanopoulos et al. 1998). The cell 
composition was assumed to be the same in the experimental strains and it was derived 
from (Neidhardt et al. 1990). 
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Figure 6-3. Metabolic flux distribution in E. coli MG1655 pDHC29 (control) and E. coli 
NADH-GAPDH mutant strain overexpressing a NADPH-GAPDH from C. 
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acetobutylicum (MBS100M pHL621) are shown in the top and bottom rows, 
respectively. The values in brackets (< >) represent the exchange coefficients of the 
fluxes. The orange arrows represent the precursors for biomass formation. Abbreviations: 
PG, 3-phosphoglycerate; AcCoA, acetyl-CoA; AKG, a-ketoglutarate; E4P, erythrose 4-
phosphate; F6P, fructose-6-phosphate; FDP, fructose 1,6-diphosphate; FUM, fumarate; 
GAP, glyceraldehyde 3-phosphate; G6P, glucose-6-phosphate; ICT, isocitrate; Mai, 
malate; NADH, Nicotinamide Adenine Dinucleotide; NADPH, Nicotinamide Adenine 
Dinucleotide Phosphate; OAA, oxaloacetate; P5P, pentose 5-phosphate; PEP, 
phosphoenolpyruvate; PYR, pyruvate; S7P, Sedo-heptulose 7-phosphate; Sue, succinate. 
The metabolic flux distributions in the steady states were estimated using a newly 
developed computer program written in MATLAB (Version 7.0, The Mathworks Inc.) 
based on GC-MS measurements (Zhu et al. 2006). The flux estimation was made using a 
similar idea as was previously described (Schmidt et al. 1997; Wiechert et al. 1997; Zhao 
and Shimizu 2003). Briefly, by giving some arbitrary values for the free fluxes, different 
sets of metabolic flux distributions can be determined based on stoichiometric constrains. 
Then the GC-MS data can be simulated based on the estimated flux distribution and the 
labeling pattern of the feeding glucose. The best fit set of flux distribution can be elected 
by comparing the simulated GC-MS data and the experimental GC-MS data. The 
reversible reaction fluxes were converted into net fluxes and exchange coefficients 
(within the range of [0, 1]) as previously described (Wiechert and de Graaf 1997). 
Isotopomer mapping matrices were developed based on atom mapping matrices (Schmidt 
et al. 1997; Zupke and Stephanopoulos 1994) to trace the isotopomer changes in the 
reactions, and they were used for isotopomer balances based on different sets of 
metabolic flux distribution. The isotopomer distributions in the amino acids were 
deduced from the isotopomer distributions of their precursor metabolites. Then the GC-
MS signals were simulated using the isotopomer distributions of amino acids. The flux 
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solutions were evaluated by comparing the simulated data with the experimental data. 
The GC-MS data was corrected for the presence of naturally labeled H, C, N, O, Si, P, 
and S elements in the amino acids and derivatization reagent before they were used for 
flux analysis (Lee et al. 1992; van Winden et al. 2002). The best-fit sets of flux 
distributions were found using the genetic and direct search toolbox in MATLAB. The 
statistical analysis was made using a Monte Carlo approach (Schmidt et al. 1999; Zhao 
and Shimizu 2003). 
6.3.4 Experimental description 
6.3.4.1 Lycopene experiments 
Shake flask experiments were performed using 250 mL shake flasks containing 
50 mL LB (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) or 2YT (16 g/L tryptone, 
10 g/L yeast extract, 5 g/L NaCl) medium supplemented with 20 g/L of glucose and 100 
mM phosphate buffer (pH 7.0). Chloramphenicol (34 mg/L) and ampicillin (100 mg/L) 
were added to maintain plasmid stability. The cultures were inoculated with 1% (vol/vol) 
of overnight culture and grown at 30°C and 250 rpm. After 24 h, 10 mL samples were 
centrifuged at 13,000xg for 5 min and the pellets were washed once with DI water. The 
cells were resuspended in 5 mL of acetone and incubated at 55°C for 15 min in the dark 
with intermittent vortexing, to extract the lycopene accumulated in the cells. The samples 
were centrifuged at 13,000xg for 10 min and the supernatant absorbance was read at 475 
nm. To determine lycopene concentration, a calibration curve was constructed using 
lycopene standard (Sigma, St. Louis, MO). The extinction coefficient (s) obtained 
was 2.59 mg"1 cm"1 L. 
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6.3.4.2 CHMO experiments 
Cultures of MBS100B (pHL621 + pMM4) and BL21(DE3) (pDHC29 + pMM4) 
were streaked on LB plates containing 34 mg/L chloramphenicol and 100 mg/L 
ampicillin and grown at 37°C. Single colonies from these plates were used to inoculate 5 
ml of liquid LB medium containing 34 mg/L chloramphenicol and 100 mg/L ampicillin. 
After shaking overnight at 250 rpm and 37°C, 4 ml were used to inoculate 400 ml of LB 
medium supplemented with 34 mg/L chloramphenicol and 100 mg/L ampicillin. The 
cells were grown at 250 rpm and 37°C until OD600 reached 0.6-1.0; at this time 0.1 mM 
IPTG (final concentration) was added. The culture was continuously incubated until it 
reached late exponential/stationary phase. The cells were centrifuged at 12,000xg and 
4°C for 5 min. The pellet was re-suspended to an OD600 of 2.0 in 20 ml of non-growing 
medium (12.8 g/L Na2HP04, 3.0 g/L KH2P04, 0.5 g/L NaCl, 2 mM MgS04 0.1 mM 
CaCb, 0.4% glucose, 30 mM cyclohexanone, and appropriate amount of antibiotics). The 
flasks were incubated at 250 rpm and 32°C. Samples (3 ml each) were centrifuged, 
filtrated and then analyzed by HPLC. Cyclohexanone and s-caprolactone were analyzed 
using a HPLC column Luna 5um CI8(2) 100A, 250x4.6 mm (Phenomenex, Torrance, 
CA), 30-70% acetonitrile-water mobile phase at a flow rate of 1 ml/min. Column, RI and 
UV detectors temperature was 40°C. The retention times for cyclohexanone and s-
caprolactone were 8.0 and 5.28 min, respectively. Glucose concentration was analyzed as 
described previously (Sanchez et al. 2005b; Yang et al. 1999b). 
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6.4 Results 
6.4.1 Metabolic flux analysis 
6.4.1.1 Growth parameters 
The maximum specific growth rate ({imwi) of the cultures was determined in shake 
flasks experiments. The (imax for the control strain (MG1655 pDHC29) and the NAD+-
GAPDH E. coli mutant strain overexpressing the NADP+-GAPDH from C. 
acetobutylycum (MBS100M pHL413) were 0.48 and 0.38 h"1, respectively. Then, the 
glucose-limited aerobic chemostat cultures were carried out at a dilution rate of 0.35 h" . 
The biomass yields and specific glucose uptake rates of the two strains are summarized in 
Table 6-2. It can be seen that the biomass yields and the specific glucose utilization rates 
were similar in the two experimental strains, while the gapA mutant strain showed a 
significantly higher specific acetate excretion rate compared to that of the control strain 
(P < 0.05). The carbon recoveries were calculated from the biomass and fermentative 
metabolite production determined by experimental measurements, and the CO2 
production was derived from the flux distributions (Figure 6-3) of the experimental 
strains. The carbon recovery values showed in Table 6-2 confirmed our network 
assumptions. 
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Table 6-2. Growth parameters determined for the chemostat cultures of a NADH-
GAPDH E. coli mutant strain overexpressing a NADPH-GAPDH from C. 
acetobutylicum. 
Strain 
MG1655pDHC29 
(control) 
MBS100M pHL621 
(MG1655 gapA' gapC+) 
Errors were calculatec 
Biomass 
yield 
(g/g 
glucose) 
0.27 ±0.01 
0.29 ±0.02 
Specific rates 
(mmol/g DCW/h) 
Glucose 
consumption 
6.15 ±0.14 
6.18 ±0.44 
Acetate 
production 
3.64 ±0.08 
4.98 ±0.39 
based on at least three measurements. 
C balance 
(%) 
103 ±5 
96 ±3 
6.4.1.2 Metabolic flux analysis results 
The metabolic flux distributions in the cultures of the two experimental strains 
were estimated based on C-13 labeling experiments. As shown in Figure 6-3, the flux 
partitioning at glucose 6-phosphate (G6P) node was significantly affected by the genetic 
manipulation which replaced the native NAD-dependent gapA gene with an exogenous 
NADP-dependent gapC. The flux through glycolytic pathway was increased about 35 % 
in the mutant strain compared to that in the control strain. Correspondingly, the flux 
through the oxidative pentose phosphate pathway, one of the main pathways used to 
produce NADPH in E. coli, was reduced to less than 20 % of that in the control strain. 
The activities of the non-oxidative pentose phosphate pathway reactions were also 
reduced in the metabolic engineered strain (Figure 6-3). 
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The flux through GAPDH was slightly higher in the mutant strain than that in the 
control strain. However, the flux difference in this reaction is much smaller than that at 
the G6P node. Considering the lower value of the transaldolase net flux and the negative 
value of the transketolase net flux in the mutant strain, the relatively higher GAPDH flux 
was mainly caused by the flux distribution at the G6P node. 
Another important branch point is the Acetyl Coenzyme A (AcCoA) node. The 
mutant strain converted ca. 25.6% of AcCoA into the Tricarboxylic Acid (TCA) cycle, 
relatively lower than the 39.2% in the control strain (Figure 6-3). Therefore, less NADPH 
was produced from the reaction through isocitrate dehydrogenase in the mutant strain 
than the control. As a result of lower TCA cycle flux, the mutant strain excreted more 
acetate than the control strain. 
The flux through phosphoenolpyruvate carboxylase (Pepc) was used to 
supplement the oxaloacetate (OAA) pool to sustain the TCA cycle and provide precursor 
for biomass synthesis. The relatively higher (P <0.05) PPC flux was consistent with 
higher flux toward biomass in the mutant strain than that in the control. 
6.4.2 Lycopene production experiments results 
The cell growth of the mutant E. coli strain was comparable and actually slightly 
higher (« 6%) than the control, showing that no growth impairment was detected. The use 
of 2YT medium resulted in ca. 19% increase in cell concentration for both strains (Figure 
6-4). A significant difference was found in lycopene production between the two strains. 
The mutant strain produced lycopene equivalent to 2.5-fold that of the control in 
concentration (Figure 6-5) and 2.4-fold when expressed as specific lycopene production 
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(Figure 6-6). The specific lycopene production was higher with the LB medium than with 
he 2YT, although that difference was less significant for the final lycopene 
concentrations. These results showed that the modified E. coli strain was able to increase 
lycopene yield. 
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Figure 6-4. Cell growth of control (MG1655 pDHC29 pK19-Lyco) and modified E. coli 
(MBS100M pHL621 pK19-Lyco: E. coli NADH-GAPDH mutant strain overexpressing a 
NADPH-GAPDH from C. acetobutylicum) strains after shake flask culture under aerobic 
conditions using LB or 2YT medium supplemented with 20 g/L of glucose for 24h at 
30°C and 250 rpm. The data shown is the average of three replicate experiments where 
the error bars represent the standard deviation. Both strains express the pK19-Lyco 
plasmid containing the genes for lycopene biosynthesis (See Table 6-1). 
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Figure 6-5. Lycopene concentration, based on culture volume, of control (MG1655 
pDHC29 pK19-Lyco) and modified E. coli (MBS100M pHL621 pK19-Lyco: E. coli 
NADH-GAPDH mutant strain overexpressing a NADPH-GAPDH from C. 
acetobutylicum) strains after shake flask culture under aerobic conditions in LB or 2YT 
medium supplemented with 20 g/L of glucose for 24h at 30°C and 250 rpm. The data 
shown are the average of three replicate experiments where the error bars represent the 
standard deviation. Both strains express the pK19-Lyco plasmid containing the genes for 
lycopene biosynthesis (see Table 6-1). 
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Figure 6-6. Specific lycopene production, based on dry cell weight (DCW), of control 
(MG1655 pDHC29 pK19-Lyco) and modified E. coli (MBS100M pHL621 pK19-Lyco: 
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E. coli NADH-GAPDH mutant strain overexpressing a NADPH-GAPDH from C. 
acetobutylicurri) strains after shake flask culture under aerobic conditions in LB or 2YT 
medium supplemented with 20 g/L of glucose for 24h at 30°C and 250 rpm. The data 
shown are the average of three replicate experiments where the error bars represent the 
standard deviation. Both strains express the pK19-Lyco plasmid containing the genes for 
lycopene biosynthesis (see Table 6-1). DCW: dry cell weight. 
6.4.3 E-caprolactone production experiments 
The mutant strain MBS100B (pHL621 + pMM4) showed higher s-caprolactone 
yield that the control, 2.97 compared to 1.72 mole s-caprolactone/mole glucose (Table 6-
-3). One mole of NADPH is consumed per mole of s-caprolactone produced (Figure 6-2); 
therefore the mutant strain produced 72.7% more NADPH than the control strain. Also, 
the product formation rate was almost doubled. 
The results of the two model systems showed that the gapA mutant E. coli strain 
expressing the NADPH-dependent gapC from Clostridium acetobutylicum has a higher 
NADPH availability that can be used to increase the yield and productivity of NADPH-
dependent products. 
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Table 6-3. Production of s-caprolactone in shake flasks by non-growing NADH-GAPDH 
E. coli mutant strain overexpressing a NADPH-GAPDH from C. acetobutylicum using 
glucose as energy source. 
Strain 
BL21(DE3) pDHC29 pMM4 
(control) 
MBS100B pHL621 pMM4 
gapAgapC+ 
s-caprolactone volumetric 
productivity3 
(mmol L"1 h"1) 
2.49 ±0.18 
4.86 ±0.16 
Yieldb 
(mole NADPH/mole 
glucose) 
1.72 ±0.19 
2.97 ±0.05 
a
 The volumetric productivity was calculated using the total culture volume. 
b
 The yield was calculated considering the NAPDH produced that was used for s-
caprolactone biosynthesis. In this experiment the cells are used as reaction catalysts under 
non-growing conditions. The production of each s-caprolactone molecule requires one 
molecule of NADPH. 
6.5 Discussion 
Many studies have shown that E. coli adapts its metabolism by 
activating/inactivating alternative pathways to reach reducing power balance and 
efficiently utilize the available nutrients. The inactivation of the NAD-dependent 
GAPDH gene (gapA) and the overexpression of the GAPDH gene encoded by gapC from 
C. acetobutylicum produced a change in the metabolic flux distribution within the cell. 
The mutant strain showed a higher flux through glycolysis and a reduced flux through the 
PP pathway compared to the control. This is a combined effect of the overexpression of 
the gapC gene and the generation of NADPH during glycolysis, alleviating the 
requirement NADPH provided by the PP pathway. The mutant E. coli strain did not show 
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growth deficiency, but on the contrary it grew faster under many of the conditions tested. 
Kabir and Shimizu (Kabir and Shimizu 2003a; Kabir and Shimizu 2003b) studied an E. 
coli strain where the phosphoglucose isomerase gene (pgi) was knocked out to direct the 
carbon flow through the PP pathway, the main source of NADPH in the cell. But in this 
case the mutant strain showed growth deficiency. This deficiency was later partially 
recovered when the PHB synthetic pathway was introduced into the cells. This approach 
was later complemented by overexpressing the SthA gene from E. coli encoding for 
pyridine nucleotide transhydrogenase, an enzyme responsible for the interchange of 
reducing power between NADH and NADPH, that showed an increase of 25 % in cell 
growth by partially re-establishing the redox equilibrium (Kabir and Shimizu 2003a). 
The overexpression of the gopC-GAPDH from C. acetobutylicum together with 
the knockout of the native NADH-dependent GAPDH showed improvement in lycopene 
and s-caprolactone synthesis confirming that cofactor availability is a limiting factor for 
the system. In a similar manner, Verho and collaborators showed an increase in the rate 
and yield of ethanol production from D-xylose by increasing the NADPH availability by 
the overexpression of a NADP+-GAPDH in S. cerevisiae (Verho et al. 2003). 
Farmer and collaborators, manipulated precursor availability to increase lycopene 
production, they showed the GAP pool could be a limiting factor in their system (Farmer 
and Liao 2001). Although, that was not the case in our system, the overexpression of 
GAPDH lead to a higher flux though glycolysis and to a higher conversion of GAP into 
3PG virtually making less GAP available for lycopene synthesis but the modification in 
the glycolysis pathway resulted in an increase of lycopene synthesis likely due to a higher 
NADPH availability. 
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As the lycopene and s-caprolactone production experiments indicated, replacing 
the NAD+-dependent GAPDH encoded by gapA with the GAPDH encoded by gapC may 
result in reduced NADH production while producing more NADPH. However, since the 
chemostat cultures were conducted under aerobic conditions, it's very difficult to explore 
the impact of reduced NADH production due to variant respiratory chain regulations and 
P/O ratios. The overproduction of NADPH should also affect the NADP+ availability in 
the reaction through isocitrate dehydrogenase, which is mainly NADP+-dependent (Dean 
et al. 1996; Hurley et al., 1991). The slightly higher biomass concentration in the 
bioreactor will result in a lower oxygen level in the gap A' gapC+ strain culture than that 
of the wild type strain. Both factors will result in relatively lower TCA cycle fluxes in the 
gap A' gapC+ strain culture than that of the wild type strain. The higher acetate production 
in the gap A' gapC+ strain compared to the control strain could be a consequence of lower 
TCA cycle fluxes. 
The single step reaction for the formation of s-caprolactone from cyclohexanone 
catalyzed by resting E. coli showed that the mutant strain was able to produce 73% more 
NADPH than the control. 
Each production system involved the construction of a gap A' gapC+ strain based 
on a different E. coli host. Different genetic backgrounds in E. coli could lead to different 
culture behaviors (enzyme expression) and therefore different products profiles. In this 
study we showed that two E. coli gapA mutant strains with different backgrounds 
(MG1655 and BL21(DE3)) exhibited an increase in NADPH-dependent product 
synthesis when the endogenous NAD+-GAPDH was replaced by the NADP+-GAPDH 
from C. acetobutylicum showing the flexibility of the approach. 
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The synthesis of lycopene and 8-caprolactone was increased in the mutant strain 
to different extents due to differences in synthetic pathways and precursor metabolites. A 
combination of different strategies where an optimal balance between precursors and 
cofactors is achieved would lead to higher improvement in product yields. 
6.6 Conclusion 
The overexpression of the gapC-GAPDH from C. acetobutylicum together with 
the knockout of the native NADH-dependent GAPDH successfully increased NADPH 
availability in two different E. coli whole cell systems, showed by the increase in 
lycopene and s-caprolactone productions. 
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7 Role of Pyridine Nucleotide Transhydrogenases in 
reducing equivalent-dependent product synthesis in 
Escherichia coli 
7.1 Abstract 
Escherichia coli contains two pyridine nucleotide transhydrogenases, a soluble 
energy-independent UdhA and a proton-translocating membrane bound PntAB. These 
enzymes are responsible for the transfer of reducing equivalents between NAD and 
NADP+. 
A set of single and double transhydrogenase mutants were strategically 
constructed together with overexpression plasmids to be used to determine the potential 
of manipulating pyridine nucleotide transhydrogenases expression level as a way to 
increase NAD(P)H availability for NAD(P)H-dependent synthesis of compounds of 
industrial interest. Preliminary experiments using the production of e-caprolactone 
catalyzed by the NADPH-dependent cyclohexanone monooxygenase (CHMO) from 
Acinetobacter sp., as model system, suggest that the overexpresion of PntAB has 
detrimental effect in s-caprolactone yield and that in the contrary the overexpression of 
UdhA seems to increase s-caprolactone yield. Although, variability in the results of 
different experiements suggest that the use of CHMO may not be an appropriate model 
system due to protein solubility and stability problems. Therefore, the use of a different 
model system is recommended for future studies. 
114 
Transhydrogenase gene deletions and overexpression plasmids were also 
introduced in a glyceraldehyde-3 -phosphate dehydrogenase (GAPDH) mutant, 
constructed previously (Martinez et al. 2008), to assess the role of transhydrogenases in 
maintaining the redox balance in this mutant and study how they affect NADPH-
dependent product synthesis in this strain. 
The set of strains constructed during the development of this thesis could be used 
as a platform to study issues related to redox balance inside the cell other that reducing 
equivalents-dependent product synthesis. 
7.2 Introduction 
The application of biocatalysis at the industrial level has been increasing in the 
past few years. Biocatalysis has the advantage over chemical catalysis of being highly 
enantio- and regio- selective and requiring mild reaction conditions. In addition, the 
production processes are potentially more efficient and environmentally friendly. 
Oxidoreductases are especially attractive for industrial purposes; they are able to catalyze 
many regio-, stereo- and enantio- selective reactions leading to a variety of compounds, 
including chiral compounds at high purity. However, these enzymes often require 
reducing equivalent cofactors in the form of nicotinamide adenine dinucleotide 
(NAD(H)) or nicotinamide adenine dinucleotide phosphate (NADP(H)). These cofactors 
are expensive and need to be recycled to make the process economically feasible. Several 
in vitro cofactor regeneration systems have been developed in the past. The substrate-
coupling regeneration system, where the same enzyme is able to use the reduced and 
oxidized forms of a cofactor and two different substrates leading to the formation of the 
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product of interest and the cofactor regeneration (e.g. alcohol dehydrogenase, ADH); the 
enzyme-coupling system, where two different enzymes catalyze the reaction of interest 
and the cofactor regeneration reaction, e.g. formate dehydrogenase (FDH) and glucose 
dehydrogenase (GDH) have been used for cofactor regeneration; and the electrochemical 
cofactor regeneration system, where a mediator molecule, or the cofactor, directly 
undergo a redox reaction (Liu and Wang 2007). 
However, biocatalysis using isolated enzymes is in many cases not economically 
feasible, e.g. when multiple enzymatic steps are required or when process costs are high 
due to the protein purification steps, the need of external cofactor addition, or the 
implementation of a cofactor regeneration system which often requires the addition of a 
co-substrate and a cofactor regeneration enzyme as well as downstream processing to 
separate or eliminate byproduct(s). This could be avoided by using a whole-cell system 
where all the required enzymes are produced by the same organism, either naturally or by 
heterologous expression, the cofactor regenerating machinery is present in situ, and no 
protein purification is necessary (Schmid et al. 2001). On the other hand, whole-cells can 
act as biocatalyst and cofactor regeneration system at the same time; however, the 
intracellular cofactor regeneration rate may sometimes limit product yield and 
productivity. 
Despite the high chemical similarity between NADH and NADPH, in biological 
systems the former primarily transfers electrons to oxygen, driving oxidative 
phosphorylation of ADP to ATP and act as a cofactor in catabolic reactions, and the latter 
is mainly involved in anabolic pathways (Canonaco et al. 2001; Russell and Cook 1995; 
Sauer et al. 2004). Cofactor requiring enzymes can be specific for NADH or NADPH, or 
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in some cases more flexible and able to use both reducing equivalents with different 
affinities. Besides the regeneration of the oxidized and reduced forms of these cofactors 
by different catabolic and anabolic reaction steps, many organisms contain nicotinamide 
nucleotide transhydrogenases which catalyze the reversible transfer of reducing 
equivalents between NAD and NADP, as shown in the following equation (7.1): 
OH;,,) + NADH + NADP+ «• («H£) + NAD+ + NADPH (7.1) 
There are two types of pyridine nucleotide transhydrogenases, energy linked and 
energy independent. The former has been found in mitochondria and certain bacteria and 
the latter is present in some bacteria (Voordouw et al. 1983). Microorganisms usually 
have only one isoform or none, with the exception of the Enterobacteriaceae family 
which contains both types, in particular E. coli contains a soluble and energy independent 
transhydrogenase, UdhA (also called SthA), and a proton-translocating membrane-bound 
transhydrogenase, PntAB (Boonstra et al. 1999; Clarke and Bragg 1986; Clarke et al. 
1986; Sauer et al. 2004). These enzymes are thought to play an important role on redox 
balance and flexibility to accommodate reducing equivalent pools inside the cell 
depending on the cell requirements at a specific time. 
There is a limited information about the pyridine nucleotide transhydrogenases in 
E. coli, and there is some controversy concerning the role and degree of specificity 
respect to the direction of the reaction they catalyze (Canonaco et al. 2001; Chin et al. 
2009; Hansen and Schonheit 2005; Hanson and Rose 1980; Sanchez et al. 2006a; Sauer 
et al. 2004). It has been traditionally thought that NADPH is mainly generated through 
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the oxidative steps of the pentose phosphate (PP) pathway and the isocitrate 
dehydrogenase step in the tricarboxylic acid (TCA) cycle (Sauer et al. 2004). However, 
there is evidence that transhydrogenases play an important role in the availability of these 
reducing equivalents inside the cell. Hanson and Rose (1980) have constructed a pnt 
mutant and have reported that PntAB is not required for the generation of NADPH or 
ATP in E. coli since no significant differences in cell growth were found in a pnt mutant 
compared to wild-type when cells were grown using glucose, succinate, glycerol and 
fructose as carbon sources (Hanson and Rose 1980). They also constructed pnt mutants in 
a glucose-6-phosphate-l -dehydrogenase, zwf and in a phosphoglucose isomerase, pgi, 
mutant backgrounds. Zwf is the first enzyme in the PP pathway, and as mentioned earlier, 
this pathway generates NADPH, and Pgi participate in glycolysis. The zwf single mutant 
showed similar growth rate, and the pgi single mutant showed lower growth rate 
compared to the wild-type strain. The pnt mutation lowered the growth rate significantly 
in the zwf mutant, but did not affect the pgi mutant or wild-type growth, suggesting that 
PntAB is mainly involved in the production of NADPH (Hanson and Rose 1980). Sauer 
et al (2004) study also supports the idea of PntAB being the main responsible for the 
generation of NADPH in E. coli during aerobic growth on glucose (Hanson and Rose 
1980; Sauer et al. 2004). The unaffected growth rate when pnt is deleted in the pgi mutant 
suggests that PntAB does not significantly reduce NAD+ to NADH using the NADPH 
formed in the PP pathway. 
On the other hand, the soluble transhydrogenase UdhA has been found to be 
critical for growth in conditions where NADPH is in excess, e.g. growth on acetate 
(Sauer et al. 2004), and in apgi mutant grown on glucose (Canonaco et al. 2001). In the 
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pgi mutant, glucose is degraded through the PP pathway, producing an excess of NADPH 
and a decrease in the NADH pool (Canonaco et al. 2001; Csonka and Fraenkel 1977). 
When UdhA is overexpressed in this mutant, the growth rate is partially restored 
supporting the hypothesis that UdhA mainly reduces NAD+ to NADH using NADPH as 
electron donor, and that the growth is not recovered completely because the PP pathway 
is not as efficient as the glycolysis-TCA cycle route for cell growth (Canonaco et al. 
2001). In addition, a pgi udhA double mutant has been reported to be unable to grow on 
glucose as the only carbon and energy source (Hansen and Schonheit 2005), also 
supporting the hypothesis that UdhA mainly reduces NAD+ using NADPH as a donor 
(Canonaco et al. 2001) and the inability of pgi udhA double mutant to produce the NADH 
required for cell growth (Hansen and Schonheit 2005). 
Only a few articles have reported the study of the role of pyridine nucleotide 
transhydrogenases on cofactor-dependent synthesis of products. Chin and collaborators 
(2009) reported the deletion of udhA and/or pntA had not effect on NADPH-dependent 
xylitol production yield and that the expression of a xylose reductase with relaxed 
cofactor specificity showed an increase in xylitol yield in E. coli. In addition, they 
overexpressed each UdhA and PntAB together with xylose reductase from Candida 
boidinii. The overexpression of UdhA had not effect on xylitol yield; and unexpected by 
the authors, the overexpression of PntAB actually lowered xylitol yield (Chin et al. 
2009). On the other hand, Sanchez and collaborators have reported a significant increase 
on NADPH-dependent polyhydroxybutyrate (PHB) production when UdhA was 
overexpressed; as well as some increase in ethanol production, although the later is a 
minor product in the system (ethanol synthesis requires NADH) (Sanchez et al. 2006a). 
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Weckbecker and Hummel (2004) reported the NADPH- dependent production of 
the chiral alcohol (R)-phenylethanol from prochiral acetophenone in E. coli cells. They 
overexpressed NADP+-dependent alcohol dehydrogenase (ADH) from Lactobacillus 
kefir, for acetophenone reduction, and a NAD+-dependent formate dehydrogenase (FDH) 
from Candida boidinii for regeneration of NADH pool. L. kefir ADH is mainly NADP+-
dependent but has some NAD+-activity and therefore some conversion of acetophenone 
into (7?J-phenylefhanol occurs under these circumstances. Authors compared (R)-
phenylethanol production in the strain described above (ADH + FDH) with the same 
strain overexpressing PntAB for NAD+ and NADPH regeneration (Figure 7.1); NAD+ 
and NADP+ were also externally supplemented in both cases as they were found to be a 
limiting factor in the system. (7?)-phenylethanol production increased from 19% to 66% 
when PntAB was overexpressed, showing that PntAB increased the NADPH pool and 
that NADPH formation was the limiting factor in this system (Weckbecker and Hummel 
2004). 
Acetophenone —==. =— • (7?)-phenylethanol 
NADPH NADP+ 
PntAB 
NADH 
Formate • ^— • CO, 
FDH 
Figure 7-1. Scheme of a (7?)-phenylethanol production system where the alcohol 
dehydrogenase (ADH) from Lactobacillus kefir was overexpressed together with the 
formate dehydrogenase (FDH) from Candida boidinii and the endogeneous 
transhydrogenase PntAB for reducing equivalents regeneration. Adapted from 
(Weckbecker and Hummel 2004). 
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Then, the role of the two transhydrogenases isoforms present in E. coli is still not 
completely understood. As mentioned above from growth experiments, the literature 
suggests that UdhA favors the reduction of NAD+ using NADPH as reducing power 
donor and that PntAB favors the opposite direction of the reaction. Although, the 
evidence does not discard that both enzymes may be able to catalyze the opposite 
reaction depending on the culture conditions and strain genotype, or that the 
overexpression of one of them could relieve the limitation on one of the cofactors and 
therefore lead to an increase in product yields in NAD(P)H-dependent synthesis. Hence, 
more research needs to be conducted to achieve a better understanding about the role of 
the transhydrogenases on reducing equivalent availability to improve NAD(P)H-
dependent product synthesis. 
To increase the pyridine nucleotide transhydrogenases knowledge and potentially 
increase reducing equivalent availability for cofactor dependent biosynthesis, single and 
double transhydrogenase mutants and PntAB overexpression plasmid have been 
constructed during the course of this research. The UdhA overexpression plasmid 
pUDHAK previously constructed in our laboratory was also used for the study (Sanchez 
et al. 2006a). The set of strains with combinations of mutations and plasmids constructed 
during this thesis research are described in Table 7.1. A similar set was constructed using 
the gapA mutant strain described in Chapter 6 as background to evaluate the role of 
transhydrogenases in this mutant strain. 
The combination of transhydrogenase mutants and overexpression plasmids will 
give some insights on whether or not these enzymes are fully exchangeable or if they 
intrinsically have a substrate preference; and if the control of their expression will favor 
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NAD(P)H dependent product synthesis. To the extent of my knowledge, the 
overexpression of one transhydrogenase in the absence of the other has not been reported 
at this time. Therefore, the present study considers the study of the effect of 
overexpressing UdhA in a pnt mutant and vice versa, as well as the other possible 
combinations described in Table 7.1, on the production of NADPH-dependent 
compounds. 
The single step NADPH-dependent conversion of cyclohexanone into s-
caprolactone was used as model system (Equation 7.1). e-caprolactone is an important 
intermediate in the manufacture of adhesives, thermoplastics (Lee et al. 2005b), resins for 
surface coatings and synthetic leather and fabrics. The enzyme cyclohexanone 
monooxygenase (CHMO) from Acinetobacter sp. is able to catalyze the reduction of 
cyclohexanone, as well as substituted cyclohexanones, into optically pure lactones, 
generating important building blocks for chemical industries (Lee et al. 2005b; 
Mihovilovic et al. 2001; Walton and Stewart 2004). Therefore this enzyme was used for 
the experiments. 
O 
(7.1) 
+ 02 + NADPH + H+ C H M O , / \ + H20 + NADP+ 
cyclohexanone e-caprolactone 
122 
7.3 Material and Methods 
7.3.1 Bacterial strains and plasmids 
Strains and plasmids used in this study are described in Table 7.1. Single udhA 
and pntB mutants and a double transhydrogenase mutant have been constructed in wild-
type E. coli MG1655. The same mutations were also introduced into a gapA E. coli 
mutant strain. Mutations were confirmed by PCR and enzyme activity assay. 
Table 7-1. List of E. coli strain and plasmids used in the study. 
Relevant Genotype Reference or source 
Strains 
MG1655 
MBS601 
MBS602 
MBS603K 
MBS100M 
MBS701 
MBS702 
MBS703K 
JW1594 
Wild-type 
MG1655 AudhA 
MG\655ApntB 
MG1655 AudhA pntB::Km 
MG1655 gapA::Tc 
MG1655 gapA::Tc AudhA 
MG1655 gapAr.Tc ApntB 
MG1655 gapAr.Tc AudhA pntB:: Km 
BW25U3 pntB: :Km 
ATCC 47076 
This study 
This study 
This study 
(Martinez et al. 
2008) 
This study 
This study 
This study 
(Baba et al. 2006) 
Plasmids 
pUDHAK Soluble pyridine nucleotide transhydrogenase (Sanchez et al. 
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gene, udhA, from E. coli in pDHK29, Km 
Table 7-1. Continuation. 
Plasmid Relevant Genotype 
2006a) 
Reference or source 
This study pPNTAB Proton-translocating pyridine nucleotide 
transhydrogenase genes, pntAB, from E. coli 
in pDHC29, CmR 
pMM4 Cyclohexanone monooxygenase gene, chnB, (Chen et al. 1999) 
from Acinetobacter sp. in pET22b(+), Ap 
pDHC29 Cloning vector, CmR 
pDHK29 Cloning vector, KmR 
pTrc99- Cyclohexanone monooxygenase gene, chnB, 
CHMO from Acinetobacter sp. in pTrc99A, ApR 
(Phillips et al. 2000) 
(Phillips et al. 2000) 
This study 
The udhA mutant was constructed by the one-step inactivation method reported 
by Datsenko and Wanner (2000). The primers used for the introduction of the kanamycin 
cassette in the udhA gene were the following: Forward: ATGCCACATTCC-
TACGATTACGATGCCATAGTAATAGGGTGTAGGCTGGAGC-TGCTTC: reverse: 
GTTTCTAGCCCAATGTTCTGTAACGCCAGCGAATCGCATATGAATATCCTCCT 
TAG. The underlined part of the sequence is homologous to udhA and the non-underlined 
portion is homologous to the kanamycin region sequence of pKD4. 
The pntB mutant was constructed by PI-phage transduction using the strain 
JW1594 from the Keio Collection as the donor strain (Baba et al. 2006). 
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The gapA mutant strain used in this study was previously constructed in our lab 
(Martinez et al. 2008) by PI-phage transduction using E. coli W3CG (E. coli W3110 
gapA::Tc) as the donor strain (Ganter and Pluckthun 1990). 
The UdhA overexpression plasmid pUDHAK (KmR) constructed by Sanchez and 
collaborators was used in this work (Sanchez et al. 2006a). For the construction of the PntAB 
overexpression plasmid, pntA and pntB genes were amplified together from E. coli MG1655 
chromosomal DNA with 300 bp before and 20 bp after the sequence to include the native 
promoter in the construct. The following primers were used: PntAB-F: TTATCTGCAGAAGT 
AGTGA-TTCGTGC; PntAB-R: ATTATATCGATCTCAGCAGAGGCCGTC. primers 
included a PstI and a Clal restriction site (underlined), respectively. The PCR product 
was digested with PstI and Clal and cloned into pDHC29 (CmR). 
The synthesis of NADPH-dependent s-caprolactone (Martinez et al. 2008; Walton 
and Stewart 2004) was used as model system to assess the effect of one or both 
transhydrogenases deletions and their overexpression in different strain backgrounds. The 
production plasmid, compatible with transhydrogenase overexpression plasmids, 
encoding the cyclohexanone monooxygenase (CHMO), chnB, was constructed by 
amplifying chnB by PCR from pMM4 (Chen et al. 1999) and cloning into pTrC99A 
using the following primers: chnB-F-Ncol: CCGCCATGGGAATGTCACAAAAAATG 
GATTTTGATGCTATCGTG and chnB-R-Xbal: CGCTCTAGATTAGGCATTGGCAG 
GTTGCTTGATATCTGA. Restriction sites are underlined. The 1.6 Kb chnB PCR 
product was digested with Ncol and Xbal and ligated into pTrc99A. This construct was 
denominated pTrc-CHMO and was constructed by Dr. Yipeng Wang (Dr. Bennett's Lab, 
Rice University). 
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7.3.2 Experimental approach 
This work involves two major phases. The first one is the design and construction 
of strains and plasmids (Table 7-1). And the second phase is the characterization of the 
different strains respect to the synthesis of a NADPH-dependent product. The first phase 
has been completed and for the second phase some preliminary results are discussed in 
this thesis. 
The performance of the different engineered E. coli strains described in Table 7-1 
was assessed using the NADPH-dependent synthesis of s-caprolactone catalyzed by the 
heterologous expression of cyclohexanone monooxygenase (CHMO) from Acinetobacter 
sp. NCIB 9871 (Martinez et al. 2008; Walton and Stewart 2004). It is a single step 
reaction where the substrate (cyclohexanone) is added to the culture medium and one 
molecule of NADPH is consumed to reduce one molecule of the substrate into the 
product (s-caprolactone), as described in Equation 7.1. Then, the NADPH consumed due 
to product formation can be calculated and a product yield can be determined. NADPH is 
produced by glucose metabolism; therefore glucose is added to the medium together with 
the substrate of interest. To minimize glucose consumption for cell growth the reaction is 
performed with resting cells in a medium lacking nitrogen source as described below 
(Walton and Stewart 2004). 
Different combinations of strain backgrounds and overexpression plasmids were 
strategically design to obtain the maximum information about the role of the 
transhydrogenases and their effect on reducing equivalents-dependent synthesis of 
products. The different strain sets and the potential information that may be obtained 
from them are described in the following sections. 
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7.3.2.1 Determination of the relative importance of each E. coli pyridine nucleotide 
transhydrogenase for NADPH-dependent conversions 
E. coli mutant strains lacking one or both pyridine nucleotide transhydrogenases 
were constructed (MBS601, MBS602 and MBS603K). Their capacity to generate 
NADPH was explored by introducing the heterologous expression of the CHMO enzyme 
for s-caprolactone synthesis as described above (Equation 7.1). 
7.3.2.2 Effect of overexpressing the proton-translocating membrane bound 
transhydrogenase PntAB in the absence of the soluble transhydrogenase 
UdhA in NADPH-product synthesis. 
From growth experiments, UdhA is suggested to be mainly responsible for the 
reduction of NAD+ using NADPH as electron donor, and PntAB is reported to 
preferentially catalyze the opposite reaction, the reduction of NADP+ using NADH as 
electron donor (Canonaco et al. 2001; Hanson and Rose 1980; Sauer et al. 2004). Then, 
for biosynthesis of NADPH-dependent products, the overexpression of PntAB may 
contribute to an increase in the NADPH pool and therefore an increase in product yield. 
Weckbecker and Hummel (Weckbecker and Hummel 2004) reported a significant 
increase in the production of the chiral alcohol (7?)-phenylefhanol from acetophenone 
when PntAB was overexpressed. On the other hand, the presence of UdhA could 
potentially decrease NADPH availability by oxidizing NADPH back to NADP+. The 
udhA mutation may help avoid NADPH re-oxidation and therefore potentially increase 
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NADPH availability inside the cell even further. However, the reported results from 
NADPH-dependent product synthesis differ, some authors report no effect on product 
yield when either one or both transhydrogenases are inactivated or when UdhA was 
overexpressed (Chin et al. 2009); and a deleterious effect on product yield when PntAB 
was overexpressed, contrary to the predicted effect by the authors (Chin et al. 2009). In 
addition, UdhA overexpression has been reported to enhance production of NADPH-
dependent PHB (Sanchez et al. 2006a). To the extent of my knowledge, the effect of 
overexpressing PntAB in an udhA mutant E. coli strain on NADPH-dependent product 
synthesis has not been reported to date. Also, from the few existing reports, it is possible 
that the effect of the presence, absence or overexpression of these enzymes is product 
dependent as well as dependent on the plasmid system used in the case of the 
overexpression. Therefore, more research needs to be conducted to elucidate the role of 
these enzymes in the production of NADPH-dependent compounds. 
The present study will contribute to the knowledge of the E. coli pyridine 
nucleotide transhydrogenases and potentially provide directions on how can we 
strategically manipulate them to increase product yield. 
Table 7-2. List of strains to determine the effect of deleting sthA and/or everexpressing 
pntAB on NADPH-dependent product synthesis. 
Strain Relevant genotype 
MG1655 pDHC29 pTrc99-CHMO Control strain 
MBS601 pDHC29 pTrc99-CHMO udhA 
MG1655 pDHC-pntAB pTrc99-CHMO pntAB++ 
MBS601 pDHC-pntAB pTrc99-CHMO udhA pntAB++ 
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7.3.2.3 Effect of overexpressing the soluble transhydrogenase UdhA in the absence 
of the proton-translocating membrane bound transhydrogenase PntAB in 
NADPH-product synthesis. 
UdhA is thought to be responsible mainly for the reduction of NAD+ to NADH 
using NADPH as electron donor and that PntAB mainly catalyzes the opposite reaction. 
Therefore, a strain lacking PntAB and overexpressing UdhA was constructed to study the 
effect of these modifications on NADPH-dependent product synthesis. The strains used 
for this study are described in Table 7-3. 
Table 7-3. List of strains to determine the effect of deleting pntB and/or everexpressing 
udhA on NADPH-dependent product synthesis. 
Strain Relevant genotype* 
MG1655 pDHK29 pTrc99-CHMO Control strain 
MG1655 pUDHAK pTrc99-CHMO udhA++ 
MBS602 pDHK29 pTrc99-CHMO pntB 
MBS602 pUDHAK pTrc99-CHMO pntB udhA++ 
*A11 the strains are overexpressing cyclohexanone monooxygenase 
(CHMO) from Acinetobacter sp. 
++overexpression 
7.3.2.4 Importance (role) of pyridine nucleotide transhydrogenases in an E. coli 
strain lacking glyceraldehyde-3-phosphate dehydrogenase. 
E. coli glyceraldehyde 3-phosphate dehydrogenase (GAPDH), encoded by gapA, 
is an important glycolytic enzyme that catalyzes the oxidation of glyceraldehyde-3-
phosphate (GAP) to 1,3 bisphophoglycerate (1,3-BPG) with the generation of one 
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molecule of NADH. This glycolytic step is one of the important sources of NADH in the 
cell. When gapA is inactivated the carbon flux is channeled through the PP pathway and 
an excess of NADPH and a decrease on NADH pools is possible. Single and double 
transhydrogenase mutations were introduced into an E. coli gapA mutant strain to 
evaluate the effect of the presence of transhydrogenases on the redox balance inside the 
cell, specifically assess the effect on NADPH-dependent product synthesis when GAPDH 
is absent. Also, the importance of the presence of GAPDH in NADPH-dependent product 
synthesis can be elucidated independently of the effect of the transhydrogenases by using 
a double transhydrogenase mutant with and without gapA expression. The list of strains 
to be used for this study is shown in Table 7-4. 
Table 7-4. List of strains to study the effect of transhydrogenases presence in a gapA 
mutant on a NADPH-dependent product synthesis. 
Strain Relevant genotype* 
MG1655pTrc99-CHMO Control strain 
MBS701 pTrc99-CHMO gapAr.Tc udhA 
MBS702 pTrc99-CHMO gapA::TcpntB 
MBS703K pTrc99-CHMO gapA udhA pntB::Km 
*A11 the strains are overexpressing cyclohexanone 
monooxygenase (CHMO) from Acinetobacter sp. 
7.3.3 Crude extract preparation and protein determination 
Cell crude extracts were prepared from cells grown at 37°C in LB for 10-14h. 
Cells were harvested by centrifugation at 3000 xg and 4°C in an Eppendorf Centrifuge 
581 OR and the pellets stored at -80°C. Pellets were washed once with 50 mM potassium 
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phosphate buffer (pH 7.0) and resuspended in the same buffer. Cells were sonicated in a 
Misonix Ultrasonic Liquid Processors for 4 min at 50%. The lysate was centrifuged at 
10,000 xg for 20 min. The supernatant was used as crude cell extract for enzyme assay 
and protein concentration analysis, unless otherwise stated. 
Protein concentration was determined using Bradford Method (Sigma Bradford 
Solution) and bovine serum albumin (Sigma) as protein standard as instructed by 
manufacturer. 
7.3.4 Transhydrogenase enzymatic activity assay 
Transhydrogenase activity determination was adapted from a previously described 
method (Kabus et al. 2007). In brief, the reaction mixture was prepared in 1 ml final 
volume containing 50 mM potassium phosphate buffer (pH 7.0), 100 mM NaCl, 0.1 mM 
NADPH, 0.1 mM 3-acetylpyridine-NAD, 10 mM mercaptoethanol final concentrations, 
and 100 ul crude extract prepared as described above (Kabus et al. 2007). Increase in 
absorbance was followed at 375 nm and 30°C in a Beckman Coulter DU800 
Spectrophotometer. An extinction coefficient 6.1 mM"1 cm"1 was used for acetylpyridine-
NADH (Venning and Jackson 1999). One unit (U) is defined as the amount of enzyme 
that catalyzes the reduction of 1 umol of 3-acetylpyridine-NAD per min. Specific 
activities were expressed in U/(mg protein), where the protein concentration was 
determined as described above. 
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7.3.5 CHMO experiment 
Cyclohexanone monooxygenase experiments were performed as described in the 
previous section with some minor modifications (Martinez et al. 2008). In brief, strains 
were streaked in fresh LB plates supplemented with the corresponding antibiotics and 
grown overnight at 37°C. A single colony was used to inoculate 5 ml of liquid LB 
medium supplemented with antibiotics. This pre-culture was grown overnight at 250 rpm 
and 37°C. In the morning, 4 ml of this overnight culture were used to inoculate 400 ml of 
LB medium and corresponding antibiotics in 2L shake flasks. Cells were grown at 250 
rpm and 27°C. When the culture reached 0.4 OD6oo, the CHMO synthesis was induced 
with 1 mM IPTG. The cells were harvested 5h after induction, centrifuged at 12,000xg 
and 4°C for 10 min and washed with nitrogen free-M9 medium. The cells were finally 
resuspended to an ODgoo of 4 in 20 ml of non-growing medium (12.8 g/L Na2HPO<4, 3.0 
g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgS04 0.1 mM CaCl2, 0.4% glucose, 30 mM 
cyclohexanone, and appropriate amount of antibiotics). The flasks were incubated at 250 
rpm and 27°C. Samples (2 ml each) were centrifuged, filtered and then analyzed by 
HPLC. Cyclohexanone and s-caprolactone were analyzed using a HPLC column Luna 
5um CI8(2) 100A, 250x4.6 mm (Phenomenex, Torrance, CA), 30-70% acetonitrile-
water mobile phase at a flow rate of 1 ml/min. Column, RI and UV detectors temperature 
was 40°C. Glucose concentration was analyzed by HPLC as previously described 
(Sanchez et al. 2005b; Yang et al. 1999b). 
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7.4 Preliminary Results and Discussion 
Preliminary results for the transhydrogenase study are presented below. 
7.4.1 Strain and plasmid construction 
All the strains described in Table 7-1 have been constructed and confirmed by 
PCR. All the plasmids described in Table 7-1 have also been constructed. 
7.4.2 Transhydrogenase activity in pntAB overexpressing plasmid 
Transhydrogenase activity was determined in the pDHC-pntAB construct. The 
PntAB overexpressing strain showed an activity of 0.965 U/(mg protein) compared to 
0.005 U/(mg protein) of the wild type, e.i. about a 20-fold increase. 
7.4.3 Effect of udhA deletion and pntAB overexpression on e-caprolactone 
production 
Preliminary results for the yield and productivity of s-caprolactone produced by 
the strains described in Table 7-2 are shown in Figure 7-2. The udhA deletion did not 
significantly affect product yield and productivity. However, the yield showed a drastic 
decrease when pntAB was overexpressed in either wild type E. coli or in the udhA 
mutant; although the effect on the udhA mutant was less detrimental. 
The overexpression of PntAB appeared to have a detrimental effect on s-
caprolactone (this study) and xylitol production (Chin et al. 2009). This enzyme is 
membrane bound and involved in proton translocation, and its overexpression may have 
affected the membrane properties and proton translocation process and equilibrium. In 
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this study pntAB was overexpressed from a high copy plasmid under a lac promoter, 
without laclq, which leads to constitutive expression. The use of a different plasmid 
system and/or the use of a plasmid system with tighter expression control are 
recommended. There may be a level of pntAB overexpression that would increase 
NADPH-dependent product synthesis. 
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Figure 7-2. Effect of udhA deletion and pntAB overexpression on s-caprolactone yield 
and productivity. 
7.4.4 Effect of pntB deletion and udhA overexpression on s-caprolactone 
production 
The strains listed in Table 7-3 were used to study the effect of inactivating the 
membrane bound transhydrogenase (PntAB) and overexpressing the soluble 
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transhydrogenase UdhA. Preliminary results are shown in Figure 7-3. This experiment 
was repeated a few times, the majority of the experiments show an increase in e-
caprolactone yield when udhA was overexpressed, but the results need to be confirmed 
using a more appropriate model system due to a some significant variability in the results. 
This variability is attibuited to the instability of cyclohexanone monooxygenase 
(CHMO). CHMO expression has been shown to produce inclusion bodies in other strains 
(Lee et al. 2005b). Temperatures between 25°C and 30°C have been found to produce 
some soluble protein for catalysis (Lee et al. 2005b); then 27°C was chosen for this study. 
Nevertheless, the formation of inclusion bodies is an unpredictable process, variation in 
cells genetic background, expression vectors and growth rate may also affect this 
phenomena. Therefore, the study of a different model system using the set of strains 
prepared during this research is recommended, an enzymatic production system where 
the enzyme is highly soluble and stable. In addition, the evaluation of different NADH-
and NADPH- dependent reaction systems would contribute to a better understanding of 
the role of the transhydrogenases in production processes requiring reducing equivalents. 
One of the potential systems to be considered in future experiments with the 
transhydrogenase strain is the NADPH-dependent human carbonyl reductase 1 (CBR1) 
which has been produced in E. colt in active form in the past (El-Hawari et al. 2009; 
Persson et al. 2009). Several substrates for this enzymes have been described, such as 
2,3-butanedione or ethyl acetoacetate among others (Carlquist et al. 2008; Johanson et al. 
2008). The screening of a number of substrates is recommended, the activity assays 
performed by Carlquist and collaborator was conducted using isolated enzymes, no 
whole-cell biocatalysis. Therefore, a screening to determine if the candidate substrates 
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are uptaken by the cells and a toxicity test to determine substrate working concentrations 
that do not affect cell metabolism, are recommended. 
7.5 Conclusion 
E. coli contains two pyridine nucleotide transhydrogenases with potentially 
different substrate specificities. In this work, single and double transhydrogenase mutants 
were designed and constructed, as well as overexpression plasmids. Combination of 
mutations and overepression plasmids were prepared and a heterologous pathway 
requiring NADPH was introduced. This set of strains was tested for the effect of 
transhydrogenase manipulations on NADPH dependent product synthesis, specifically 
the production of s-caprolactone by the cyclohexanone monooxygenase from 
Acinetobacter sp. Preliminary results showed a detrimental effect of overexpression of 
pntAB and a potentially positive effect on product yield from overexpressing udhA. 
Although, the use of a different model system in addition to a NADH-dependent system 
is recommended to confirm these results and obtain important information about the role 
of the transhydrogenases in different systems. 
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8 Recommendations 
The development of a bioprocess for the production of biochemicals involves the 
development or selection of a suitable biocatalyst and the use of the appropiate operation 
conditions. Oxidoreduction reactions are valuable in industry for the synthesis of an 
enourmous number of important compounds. Many of these reactions can be catalyzed 
by individual enzymes or by whole-cell catalysts, leading to products with high purity. 
These proceses usually require reducing equivalents as cofactors. Cells have the ability to 
regenerate these cofactors through their metabolism and can adapt their machinery to the 
cell requirements under specific conditions in an efficient manner. 
In this thesis, the effect of different operation conditions was evaluated for the 
NADH-dependent production of succinate by a metabolic engineered E. coli strain. The 
level of aeration used for biomass accumulation, previous to the production phase, was 
shown to be crucial for achieving the maximum theoretical succinate yield. Other 
parameters such as glucose concentration and gas composition were also assessed. The 
production process could be further improved by increasing the cell concentration 
reached during the aerobic phase to increase process productivity, although as shown in 
Chapter 3, the cells have to grow under the appropriate conditions to be in the correct 
metabolic state for succinate production at high yields. Some parameters to consider in 
future studies include medium optimization, agitation and aeration. 
The effect of deleting genes involved in anaerobic fermentation in E. coli was 
evaluated with respect to fermentation product profiles. The deletion of genes involved in 
succinate synthesiser^ and sdhAB showed limited glucose uptake; and the addition of a 
limited amount of oxygen as final electron acceptor, improved glucose consumption and 
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increased malate production in shake flask experiments. Then, the study of these strains 
in bioreactor experiments is recommended to control oxygen level and provide a 
continous flow of electron acceptor to potentially increase C4-compound synthesis. In 
theses strains NAD+ availability may be limiting, the direct addition of NAD+ could be 
analyzed to address this point. 
The production of NAD(P)H-dependent heterologous compounds in E. coli have 
high potential, especially due to their ability to generate chiral compounds at high purity. 
However, the cofactor regeneration rate is sometimes limiting for achieving high yield 
and productivity. Reducing equivalents, NAD(P)H, are regenerated in several steps of E. 
coli cell metabolism, as well as by two pyridine nucleotide transhydrogenases that 
transfer reducing equivalents between NAD+ and NADP+ which are thought to play an 
important role in maintaining redox balance inside the cells. A set of mutant strains and 
overexpression palsmids have been strategically designed, constructed and combined to 
analyze their impact on NAD(P)H-dependent synthesis of products. The selection of a 
NADH and a NADPH robust model system for testing these strains in the future is 
recommended. 
In addition to pyridine nucleotide transhydrogenases, E. coli contains a NAD 
kinase responsible for the phosphorylation of NAD using inorganic phosphate or ATP as 
phosphoryl donor (Li et al. 2009). The overexpression of this enzyme has been shown to 
increase NADPH-dependent poly(3-hydroxybutyrate) synthesis in E. coli (Li et al. 2009). 
The combination of overexpression or inactivation of this enzyme together with the 
engineering of the transhydrogenases could lead to a wide rnage of biocatalyst with 
different suitable characteristics the production of a variety of biochemicals. 
138 
References 
Agarwal S, Rao AV. 2000. Tomato lycopene and its role in human health and chronic 
diseases. Can Med Assoc J 163(6):739-44. 
Alexeeva S, de Kort B, Sawers G, Hellingwerf KJ, de Mattos MJ. 2000. Effects of 
limited aeration and of the ArcAB system on intermediary pyruvate catabolism in 
Escherichia coli. J Bacteriol 182(17):4934-40. 
Alexeeva S, Hellingwerf KJ, Teixeira de Mattos MJ. 2003. Requirement of ArcA for 
redox regulation in Escherichia coli under microaerobic but not anaerobic or 
aerobic conditions. J Bacteriol 185(l):204-9. 
Alper H, Jin YS, Moxley JF, Stephanopoulos G. 2005. Identifying gene targets for the 
metabolic engineering of lycopene biosynthesis in Escherichia coli. Metab Eng 
7(3):155-64. 
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, 
Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, 
single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:2006 0008. 
Baldwin CV, Woodley JM. 2006. On oxygen limitation in a whole cell biocatalytic 
Baeyer-Villiger oxidation process. Biotechnol Bioeng 95(3):362-9. 
Becker S, Holighaus G, Gabrielczyk T, Unden G. 1996. 02 as the regulatory signal for 
FNR-dependent gene regulation in Escherichia coli. J Bacteriol 178(15):4515-21. 
Berrios-Rivera SJ, Bennett GN, San KY. 2002a. The effect of increasing NADH 
availability on the redistribution of metabolic fluxes in Escherichia coli chemostat 
cultures. Metab Eng 4(3):230-7. 
Berrios-Rivera S J, Bennett GN, San KY. 2002b. Metabolic engineering of Escherichia 
coli: increase of NADH availability by overexpressing an NAD(+)-dependent 
formate dehydrogenase. Metab Eng 4(3):217-29. 
Berrios-Rivera SJ, San KY, Bennett GN. 2002c. The effect of NAPRTase overexpression 
on the total levels of NAD, the NADH/NAD+ ratio, and the distribution of 
metabolites in Escherichia coli. Metab Eng 4(3):238-47. 
Berrios-Rivera SJ, Sanchez AM, Bennett GN, San KY. 2004. Effect of different levels of 
NADH availability on metabolite distribution in Escherichia coli fermentation in 
minimal and complex media. Appl Microbiol Biotechnol 65(4):426-32. 
139 
Boonstra B, French CE, Wainwright I, Bruce NC. 1999. The udhA gene of Escherichia 
coli encodes a soluble pyridine nucleotide transhydrogenase. J Bacteriol 
181(3): 1030-4. 
Boonstra B, Rathbone DA, French CE, Walker EH, Bruce NC. 2000. Cofactor 
regeneration by a soluble pyridine nucleotide transhydrogenase for biological 
production of hydromorphone. Appl Environ Microbiol 66(12):5161-6. 
Bose KS, Agrawal BK. 2007. Effect of lycopene from cooked tomatoes on serum 
antioxidant enzymes, lipid peroxidation rate and lipid profile in coronary heart 
disease. Singapore Med J 48(5):415-20. 
Canonaco F, Hess TA, Heri S, Wang T, Szyperski T, Sauer U. 2001. Metabolic flux 
response to phosphoglucose isomerase knock-out in Escherichia coli and impact 
of overexpression of the soluble transhydrogenase UdhA. FEMS Microbiol Lett 
204(2):247-52. 
Carlquist M, Frejd T, Gorwa-Grauslund MF. 2008. Flavonoids as inhibitors of human 
carbonyl reductase 1. Chem Biol Interact 174(2):98-108. 
Cassey B, Guest JR, Attwood MM. 1998. Environmental control of pyruvate 
dehydrogenase complex expression in Escherichia coli. FEMS Microbiol Lett 
159(2):325-9. 
Cecchini G, Thompson CR, Ackrell BA, Westenberg DJ, Dean N, Gunsalus RP. 1986. 
Oxidation of reduced menaquinone by the fumarate reductase complex in 
Escherichia coli requires the hydrophobic FrdD peptide. Proc Natl Acad Sci U S 
A 83(23):8898-902. 
Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD. 2007. Engineering Escherichia 
coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 
3(5):274-7. 
Chartrain M, Salmon PM, Robinson DK, Buckland BC. 2000. Metabolic engineering and 
directed evolution for the production of pharmaceuticals. Curr Opin Biotechnol 
11(2):209-14. 
Chatterjee R, Millard CS, Champion K, Clark DP, Donnelly MI. 2001. Mutation of the 
ptsG gene results in increased production of succinate in fermentation of glucose 
by Escherichia coli. Appl Environ Microbiol 67(1): 148-54. 
Chen G, Kayser MM, Mihovilovic MD, Mrstik ME, Martinez CA, Stewart JD. 1999. 
Asymmetric oxydations at sulfur catalyzed engineered strains that overexpress 
cyclohexanone monooxygenase. New J Chem 23:827-832. 
Chin JW, Khankal R, Monroe CA, Maranas CD, Cirino PC. 2009. Analysis of NADPH 
supply during xylitol production by engineered Escherichia coli. Biotechnol 
Bioeng 102(l):209-20. 
140 
Clarke DM, Bragg PD. 1986. Expression of the cloned subunits of Escherichia coli 
transhydrogenase from separate replicons. FEBS Lett 200(1 ):23-6. 
Clarke DM, Loo TW, Gillam S, Bragg PD. 1986. Nucleotide sequence of the pntA and 
pntB genes encoding the pyridine nucleotide transhydrogenase of Escherichia 
coli. Eur J Biochem 158(3):647-53. 
Colon GE, Nguyen TT, Jetten MS, Sinskey AJ, Stephanopoulos G. 1995. Production of 
isoleucine by overexpression of ilvA in a Corynebacterium lactofermentum 
threonine producer. Appl Microbiol Biotechnol 43(3):482-8. 
Cox SJ, Shalel Levanon S, Sanchez A, Lin H, Peercy B, Bennett GN, San KY. 2006. 
Development of a metabolic network design and optimization framework 
incorporating implementation constraints: a succinate production case study. 
MetabEng8(l):46-57. 
Csonka LN, Fraenkel DG. 1977. Pathways of NADPH formation in Escherichia coli. J 
BiolChem252(10):3382-91. 
Cunningham FX, Jr., Sun Z, Chamovitz D, Hirschberg J, Gantt E. 1994. Molecular 
structure and enzymatic function of lycopene cyclase from the cyanobacterium 
Synechococcus sp strain PCC7942. Plant Cell 6(8): 1107-21. 
Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 
97(12):6640-5. 
Donnelly MI, Millard CS, Clark DP, Chen MJ, Rathke JW. 1998. A novel fermentation 
pathway in an Escherichia coli mutant producing succinic acid, acetic acid, and 
ethanol. Appl Biochem Biotechnol 70-72:187-98. 
Donoghue NA, Norris DB, Trudgill PW. 1976. The purification and properties of 
cyclohexanone oxygenase from Nocardia gluberula CL1 and Acinetobacter 
NCIB 9871. Eur. J. Biochem 63:175-192. 
El-Hawari Y, Favia AD, Pilka ES, Kisiela M, Oppermann U, Martin HJ, Maser E. 2009. 
Analysis of the substrate-binding site of human carbonyl reductases CBR1 and 
CBR3 by site-directed mutagenesis. Chem Biol Interact 178(l-3):234-41. 
Elmes ML, Scraba DG, Weiner JH. 1986. Isolation and characterization of the tubular 
organelles induced by fumarate reductase overproduction in Escherichia coli. J 
Gen Microbiol 132(6):1429-39. 
Ernst M, Kaup B, Muller M, Bringer-Meyer S, Sahm H. 2005. Enantioselective reduction 
of carbonyl compounds by whole-cell biotransformation, combining a formate 
dehydrogenase and a (R)-specific alcohol dehydrogenase. Appl Microbiol 
Biotechnol 66(6):629-34. 
141 
Farmer WR, Liao JC. 2001. Precursor balancing for metabolic engineering of lycopene 
production in Escherichia coli. Biotechnol Prog 17(1):57-61. 
Fiume Z. 2001. Final report on the safety assessment of Malic Acid and Sodium Malate. 
Int J Toxicol 20 Suppl 1:47-55. 
Flint DH, Emptage MH, Guest JR. 1992. Fumarase a from Escherichia coli: purification 
and characterization as an iron-sulfur cluster containing enzyme. Biochemistry 
31(42): 10331-7. 
Foster JW. 2004. Escherichia coli acid resistance: tales of an amateur acidophile. Nat 
Rev Microbiol 2(11):898-907. 
Ganter C, Pluckthun A. 1990. Glycine to alanine substitutions in helices of 
glyceraldehyde-3-phosphate dehydrogenase: effects on stability. Biochemistry 
29(40):9395-402. 
Garrido-Pertierra A, Cooper RA. 1983. Evidence for two distinct pyruvate kinase genes 
in Escherichia coli K-12. FEBS Lett 162(2):420-2. 
Georgellis D, Lynch AS, Lin EC. 1997. In vitro phosphorylation study of the arc two-
component signal transduction system of Escherichia coli. J Bacteriol 
179(17):5429-35. 
Gokarn RR, Altman E, Eiteman MA. 1998. Expression of pyruvate carboxylase enhances 
succinate production in Escherichia coli without affecting glucose uptake. 
Biotechnol Lett 20:795-798. 
Gokarn RR, Eiteman MA, Altman E. 2000. Metabolic analysis of Escherichia coli in the 
presence and absence of the carboxylating enzymes phosphoenolpyruvate 
carboxylase and pyruvate carboxylase. Appl Environ Microbiol 66(5): 1844-50. 
Gokarn RR, Eiteman MA, Martin SA, Eriksson KE. 1997. Production of succinate from 
glucose, cellobiose, and various cellulosic materials by the ruminal anaerobic 
bacteria Fibrobacter succinogenes and Ruminococcus flavefaciens. Appl Biochem 
Biotechnol 68(l-2):69-80. 
Gokarn RR, Evans JD, Walker JR, Martin SA, Eiteman MA, Altman E. 2001. The 
physiological effects and metabolic alterations caused by the expression of 
Rhizobium etli pyruvate carboxylase in Escherichia coli. Appl Microbiol 
Biotechnol 56(l-2):188-95. 
Guest JR. 1981. Partial replacement of succinate dehydrogenase function by phage- and 
plasmid-specified fumarate reductase in Escherichia coli. J Gen Microbiol 
122(2):171-9. 
142 
Guest JR, Miles JS, Roberts RE, Woods SA. 1985. The fumarase genes of Escherichia 
coli: location of the fumB gene and discovery of a new gene (fumC). J Gen 
Microbiol 131(11):2971-84. 
Guettler MV, Rumler D, Jain MK. 1999. Actinobacillus succinogenes sp. nov., a novel 
succinic-acid-producing strain from the bovine rumen. Int J Syst Bacteriol 49 Pt 
1:207-16. 
Gunnarsson N, Eliasson A, Nielsen J. 2004. Control of fluxes towards antibiotics and the 
role of primary metabolism in production of antibiotics. Adv Biochem Eng 
Biotechnol 88:137-78. 
Hansen T, Schonheit P. 2005. Escherichia coli phosphoglucose isomerase can be 
substituted by members of the PGI family, the PGI/PMI family, and the cPGI 
family. FEMS Microbiol Lett 250(l):49-53. 
Hanson RL, Rose C. 1980. Effects of an insertion mutation in a locus affecting pyridine 
nucleotide transhydrogenase (pnt:Tn5) on the growth of Escherichia coli. J 
Bacteriol 141(l):401-4. 
Ho NW, Chen Z, Brainard AP, Sedlak M. 1999. Successful design and development of 
genetically engineered Saccharomyces yeasts for effective cofermentation of 
glucose and xylose from cellulosic biomass to fuel ethanol. Adv Biochem Eng 
Biotechnol 65:163-92. 
Hong SH, Lee SY. 2001. Metabolic flux analysis for succinic acid production by 
recombinant Escherichia coli with amplified malic enzyme activity. Biotechnol 
Bioeng 74(2):89-95. 
Hong SH, Lee SY. 2002. Importance of redox balance on the production of succinic acid 
by metabolically engineered Escherichia coli. Appl Microbiol Biotechnol 
58(3):286-90. 
Hummel W. 1997. New alcohol dehydrogenases for the synthesis of chiral compounds. 
Adv Biochem Eng Biotechnol 58:145-84. 
Hummel W. 1999. Large-scale applications of NAD(P)-dependent oxidoreductases: 
recent developments. Trends Biotechnol 17(12):487-92. 
Iddar A, Valverde F, Serrano A, Soukri A. 2002. Expression, purification, and 
characterization of recombinant nonphosphorylating NADP-dependent 
glyceraldehyde-3-phosphate dehydrogenase from Clostridium acetobutylicum. 
Protein Expr Purif 25(3):519-26. 
Iverson TM, Luna-Chavez C, Cecchini G, Rees DC. 1999. Structure of the Escherichia 
coli fumarate reductase respiratory complex. Science 284(5422): 1961-6. 
143 
Jantama K, Haupt MJ, Svoronos SA, Zhang X, Moore JC, Shanmugam KT, Ingram LO. 
2008a. Combining metabolic engineering and metabolic evolution to develop 
nonrecombinant strains of Escherichia coli C that produce succinate and malate. 
Biotechnol Bioeng 99(5): 1140-1153. 
Jantama K, Zhang X, Moore JC, Shanmugam KT, Svoronos SA, Ingram LO. 2008b. 
Eliminating side products and increasing succinate yields in engineered strains of 
Escherichia coli C. Biotechnol Bioeng 101(5):881-93. 
Jeffries TW, Jin YS. 2004. Metabolic engineering for improved fermentation of pentoses 
by yeasts. Appl Microbiol Biotechnol 63(5):495-509. 
Jeon Y, Lee YS, Han JS, Kim JB, Hwang DS. 2001. Multimerization of phosphorylated 
and non-phosphorylated ArcA is necessary for the response regulator function of 
the Arc two-component signal transduction system. J Biol Chem 276(44):40873-
9. 
Johanson T, Carlquist M, Olsson C, Rudolf A, Frejd T, Gorwa-Grauslund MF. 2008. 
Reaction and strain engineering for improved stereo-selective whole-cell 
reduction of a bicyclic diketone. Appl Microbiol Biotechnol 77(5): 1111-8. 
Jones HM, Gunsalus RP. 1985. Transcription of the Escherichia coli fumarate reductase 
genes (frdABCD) and their coordinate regulation by oxygen, nitrate, and 
fumarate. J Bacteriol 164(3): 1100-9. 
Jones HM, Gunsalus RP. 1987. Regulation of Escherichia coli fumarate reductase 
(frdABCD) operon expression by respiratory electron acceptors and the fnr gene 
product. J Bacteriol 169(7):3340-9. 
Kabir MM, Shimizu K. 2003 a. Fermentation characteristics and protein expression 
patterns in a recombinant Escherichia coli mutant lacking phosphoglucose 
isomerase for poly(3-hydroxybutyrate) production. Appl Microbiol Biotechnol 
62(2-3):244-55. 
Kabir MM, Shimizu K. 2003b. Gene expression patterns for metabolic pathway in pgi 
knockout Escherichia coli with and without phb genes based on RT-PCR. J 
Biotechnol 105(1-2): 11-31. 
Kabus A, Georgi T, Wendisch VF, Bott M. 2007. Expression of the Escherichia coli 
pntAB genes encoding a membrane-bound transhydrogenase in Corynebacterium 
glutamicum improves L-lysine formation. Appl Microbiol Biotechnol 75(1):47-
53. 
Kang Y, Weber KD, Qiu Y, Kiley PJ, Blattner FR. 2005. Genome-wide expression 
analysis indicates that FNR of Escherichia coli K-12 regulates a large number of 
genes of unknown function. J Bacteriol 187(3): 1135-60. 
144 
Kataoka M, Kita K, Wada M, Yasohara Y, Hasegawa J, Shimizu S. 2003. Novel 
bioreduction system for the production of chiral alcohols. Appl Microbiol 
Biotechnol 62(5-6):437-45. 
Kirschner A, Altenbuchner J, Bornscheuer UT. 2007. Cloning, expression, and 
characterization of a Baeyer-Villiger monooxygenase from Pseudomonas 
fluorescens DSM 50106 in E. coli. Appl Microbiol Biotechnol 73(5): 1065-72. 
Kragl U, Kruse W, Hummel W, Wandrey C. 1996. Enzyme engineering aspects of 
biocatalysis: Cofactor regeneration as example. Biotechnol Bioeng 52(2):309-19. 
Kroger A. 1978. Fumarate as terminal acceptor of phosphorylative electron transport. 
Biochim Biophys Acta 505(2): 129-45. 
Kuyper M, Hartog MM, Toirkens MJ, Almering MJ, Winkler AA, van Dijken JP, Pronk 
JT. 2005. Metabolic engineering of a xylose-isomerase-expressing 
Saccharomyces cerevisiae strain for rapid anaerobic xylose fermentation. FEMS 
Yeast Res 5(4-5):399-409. 
Kwon YD, Kwon OH, Lee HS, Kim P. 2007. The effect of NADP-dependent malic 
enzyme expression and anaerobic C4 metabolism in Escherichia coli compared 
with other anaplerotic enzymes. J Appl Microbiol 103(6):2340-5. 
Kyte BG, Rouviere P, Cheng Q, Stewart JD. 2004. Assessing the substrate selectivities 
and enantioselectivities of eight novel Baeyer-Villiger monooxygenases toward 
alkyl-substituted cyclohexanones. J Org Chem 69(1): 12-7. 
Landucci R, Goodman B, Wyman C. 1994. Methodology for evaluating the economics of 
biologically producing chemicals and materials from alternative feedstocks. 
Applied Biochemistry and Biotechnology 45-46:677-696. 
Lee DH, Jun WJ, Shin DH, Cho HY, Hong BS. 2005a. Effect of culture conditions on 
production of 5-aminolevulinic acid by recombinant Escherichia coli. Biosci 
Biotechnol Biochem 69(3):470-6. 
Lee SY, Hong SH, Lee SH, Park SJ. 2004. Fermentative production of chemicals that can 
be used for polymer synthesis. Macromol Biosci 4(3): 157-64. 
Lee WH, Park YC, Lee DH, Park K, Seo JH. 2005b. Simultaneous biocatalyst production 
and Baeyer-Villiger oxidation for bioconversion of cyclohexanone by 
recombinant Escherichia coli expressing cyclohexanone monooxygenase. Appl 
Biochem Biotechnol 121-124:827-36. 
Lee WN, Bergner EA, Guo ZK. 1992. Mass isotopomer pattern and precursor-product 
relationship. Biol Mass Spectrom 21(2):114-22. 
145 
Lee YS, Han JS, Jeon Y, Hwang DS. 2001. The arc two-component signal transduction 
system inhibits in vitro Escherichia coli chromosomal initiation. J Biol Chem 
276(13):9917-23. 
Lemire BD, Robinson JJ, Weiner JH. 1982. Identification of membrane anchor 
polypeptides of Escherichia coli fumarate reductase. J Bacteriol 152(3): 1126-31. 
Li ZJ, Cai L, Wu Q, Chen GQ. 2009. Overexpression of NAD kinase in recombinant 
Escherichia coli harboring the phbCAB operon improves poly(3-
hydroxybutyrate) production. Appl Microbiol Biotechnol 83(5):939-47. 
Lin H, Bennett GN, San KY. 2005a. Chemostat culture characterization of Escherichia 
coli mutant strains metabolically engineered for aerobic succinate production: a 
study of the modified metabolic network based on metabolite profile, enzyme 
activity, and gene expression profile. Metab Eng 7(5-6):337-52. 
Lin H, Bennett GN, San KY. 2005b. Fed-batch culture of a metabolically engineered 
Escherichia coli strain designed for high-level succinate production and yield 
under aerobic conditions. Biotechnol Bioeng 90(6):775-9. 
Lin H, Bennett GN, San KY. 2005c. Genetic reconstruction of the aerobic central 
metabolism in Escherichia coli for the absolute aerobic production of succinate. 
Biotechnol Bioeng 89(2): 148-56. 
Lin H, Bennett GN, San KY. 2005d. Metabolic engineering of aerobic succinate 
production systems in Escherichia coli to improve process productivity and 
achieve the maximum theoretical succinate yield. Metab Eng 7(2): 116-27. 
Lin H, San KY, Bennett GN. 2005e. Effect of Sorghum vulgare phosphoenolpyruvate 
carboxylase and Lactococcus lactis pyruvate carboxylase coexpression on 
succinate production in mutant strains of Escherichia coli. Appl Microbiol 
Biotechnol 67(4):515-23. 
Lin H, Vadali RV, Bennett GN, San KY. 2004. Increasing the acetyl-CoA pool in the 
presence of overexpressed phosphoenolpyruvate carboxylase or pyruvate 
carboxylase enhances succinate production in Escherichia coli. Biotechnol Prog 
20(5): 1599-604. 
Liu W, Wang P. 2007. Cofactor regeneration for sustainable enzymatic biosynthesis. 
Biotechnol Adv 25(4):369-84. 
Liu X, De Wulf P. 2004. Probing the ArcA-P modulon of Escherichia coli by whole 
genome transcriptional analysis and sequence recognition profiling. J Biol Chem 
279(13):12588-97. 
Lu S, Eiteman MA, Altman E. 2009. Effect of C02 on succinate production in dual-
phase Escherichia coli fermentations. J Biotechnol 143(3):213-23. 
146 
Lu Y, Mei L. 2007. Co-expression of P450 BM3 and glucose dehydrogenase by 
recombinant Escherichia coli and its application in an NADPH-dependent indigo 
production system. J Ind Microbiol Biotechnol 34(3):247-53. 
Maklashina E, Berthold DA, Cecchini G. 1998. Anaerobic expression of Escherichia coli 
succinate dehydrogenase: functional replacement of fumarate reductase in the 
respiratory chain during anaerobic growth. J Bacteriol 180(22):5989-96. 
Maklashina E, Cecchini G. 1999. Comparison of catalytic activity and inhibitors of 
quinone reactions of succinate dehydrogenase (Succinate-ubiquinone 
oxidoreductase) and fumarate reductase (Menaquinol-fumarate oxidoreductase) 
from Escherichia coli. Arch Biochem Biophys 369(2):223-32. 
Maldonado LM, Hernandez VE, Rivero EM, Barba de la Rosa AP, Flores JL, Acevedo 
LG, De Leon Rodriguez A. 2007. Optimization of culture conditions for a 
synthetic gene expression in Escherichia coli using response surface 
methodology: the case of human interferon beta. Biomol Eng 24(2):217-22. 
Marshall FA, Messenger SL, Wyborn NR, Guest JR, Wing H, Busby SJ, Green J. 2001. 
A novel promoter architecture for microaerobic activation by the anaerobic 
transcription factor FNR. Mol Microbiol 39(3):747-53. 
Martinez I, Zhu J, Lin H, Bennett GN, San KY. 2008. Replacing Escherichia coli NAD-
dependent glyceraldehyde 3-phosphate dehydrogenase (GAPDH) with a NADP-
dependent enzyme from Clostridium acetobutylicum facilitates NADPH 
dependent pathways. Metab Eng 10(6):352-9. 
Mat-Jan F, Alam KY, Clark DP. 1989. Mutants of Escherichia coli deficient in the 
fermentative lactate dehydrogenase. J Bacteriol 171(l):342-8. 
Mihovilovic MD, Chen G, Wang S, Kyte B, Rochon F, Kayser MM, Stewart JD. 2001. 
Asymmetric Baeyer-Villiger oxidations of 4-mono- and 4,4-disubstituted 
cyclohexanones by whole cells of engineered Escherichia coli. J Org Chem 
66(3):733-8. 
Mihovilovic MD, Rudroff F, Muller B, Stanetty P. 2003. First enantiodivergent Baeyer-
Villiger oxidation by recombinant whole-cells expressing two monooxygenases 
from Brevibacterium. Bioorg Med Chem Lett 13(8):1479-82. 
Miles JS, Guest JR. 1984. Complete nucleotide sequence of the fumarase gene fumA, of 
Escherichia coli. Nucleic Acids Res 12(8):3631-42. 
Millard CS, Chao YP, Liao JC, Donnelly MI. 1996. Enhanced production of succinic acid 
by overexpression of phosphoenolpyruvate carboxylase in Escherichia coli. Appl 
Environ Microbiol 62(5): 1808-10. 
Minorsky PV. 2002. Lycopene and human health. Plant Physiol 130(3): 1077-8. 
147 
Montrone M, Eisenbach M, Oesterhelt D, Marwan W. 1998. Regulation of switching 
frequency and bias of the bacterial flagellar motor by CheY and fumarate. J 
Bacterid 180(13):3375-80. 
Moreira dos Santos M, Raghevendran V, Kotter P, Olsson L, Nielsen J. 2004. 
Manipulation of malic enzyme in Saccharomyces cerevisiae for increasing 
NADPH production capacity aerobically in different cellular compartments. 
MetabEng6(4):352-63. 
Neidhardt FC, Ingraham JL, Schaechter M. 1990. Physiology of the Bacterial Cell. A 
Molecular Approach. Sinauer Associate, Sunderland Inc., Massachusetts. 
Nissen TL, Kielland-Brandt MC, Nielsen J, Villadsen J. 2000. Optimization of ethanol 
production in Saccharomyces cerevisiae by metabolic engineering of the 
ammonium assimilation. Metab Eng 2(l):69-77. 
Park SJ, Gunsalus RP. 1995. Oxygen, iron, carbon, and superoxide control of the 
fumarase fumA and fumC genes of Escherichia coli: role of the arcA, yhr, and 
soxR gene products. J Bacteriol 177(21):6255-62. 
Park SJ, Tseng CP, Gunsalus RP. 1995. Regulation of succinate dehydrogenase 
(sdhCDAB) operon expression in Escherichia coli in response to carbon supply 
and anaerobiosis: role of ArcA and Fnr. Mol Microbiol 15(3):473-82. 
Peng L, Shimizu K. 2003. Global metabolic regulation analysis for Escherichia coli K12 
based on protein expression by 2-dimensional electrophoresis and enzyme activity 
measurement. Appl Microbiol Biotechnol 61(2):163-78. 
Persson B, Kallberg Y, Bray JE, Bruford E, Dellaporta SL, Favia AD, Duarte RG, 
Jornvall H, Kavanagh KL, Kedishvili N and others. 2009. The SDR (short-chain 
dehydrogenase/reductase and related enzymes) nomenclature initiative. Chem 
Biol Interact 178(l-3):94-8. 
Phillips GJ, Park SK, Huber D. 2000. High copy number plasmids compatible with 
commonly used cloning vectors. Biotechniques 28(3):400-2, 404, 406 passim. 
Poirier Y. 1999. Production of new polymeric compounds in plants. Curr Opin 
Biotechnol 10(2): 181-5. 
Ponce E, Flores N, Martinez A, Valle F, Bolivar F. 1995. Cloning of the two pyruvate 
kinase isoenzyme structural genes from Escherichia coli: the relative roles of 
these enzymes in pyruvate biosynthesis. J Bacteriol 177(19):5719-22. 
Potera C. 2005. Making succinate more successful. Environmental Health Perspectives 
113(12):A832-A835. 
Pridmore RD. 1987. New and versatile cloning vectors with kanamycin-resistance 
marker. Gene 56(2-3):309-12. 
148 
Quail MA, Haydon DJ, Guest JR. 1994. The pdhR-aceEF-lpd operon of Escherichia coli 
expresses the pyruvate dehydrogenase complex. Mol Microbiol 12(1):95-104. 
Rao AV, Agarwal S. 2000. Role of antioxidant lycopene in cancer and heart disease. J 
AmCollNutrl9(5):563-9. 
Ravnikar PD, Somerville RL. 1987. Structural and functional analysis of a cloned 
segment of Escherichia coli DNA that specifies proteins of a C4 pathway of 
serine biosynthesis. J Bacteriol 169(10):4716-21. 
Rotstein OD, Wells CL, Pruett TL, Sorenson JJ, Simmons RL. 1987. Succinic acid 
production by Bacteroides fragilis. A potential bacterial virulence factor. Arch 
Surg 122(l):93-8. 
Russell JB, Cook GM. 1995. Energetics of bacterial growth: balance of anabolic and 
catabolic reactions. Microbiol Rev 59(l):48-62. 
Samuelov NS, Datta R, Jain MK, Zeikus JG. 1999. Whey fermentation by 
Anaerobiospirillum succiniciproducens for production of a succinate-based 
animal feed additive. Appl Environ Microbiol 65(5):2260-3. 
Samuelov NS, Lamed R, Lowe S, Zeikus JG. 1991. Influence of CO(2)-HCO(3) Levels 
and pH on Growth, Succinate Production, and Enzyme Activities of 
Anaerobiospirillum succiniciproducens. Appl Environ Microbiol 57(10):3013-
3019. 
San KY, Bennett GN, Berrios-Rivera SJ, Vadali RV, Yang YT, Horton E, Rudolph FB, 
Sariyar B, Blackwood K. 2002. Metabolic engineering through cofactor 
manipulation and its effects on metabolic flux redistribution in Escherichia coli. 
MetabEng 4(2): 182-92. 
Sanchez AM, Andrews J, Hussein I, Bennett GN, San KY. 2006a. Effect of 
overexpression of a soluble pyridine nucleotide transhydrogenase (UdhA) on the 
production of poly(3-hydroxybutyrate) in Escherichia coli. Biotechnol Prog 
22(2):420-5. 
Sanchez AM, Bennett GN, San KY. 2005a. Efficient succinic acid production from 
glucose through overexpression of pyruvate carboxylase in an Escherichia coli 
alcohol dehydrogenase and lactate dehydrogenase mutant. Biotechnol Prog 
21(2):358-65. 
Sanchez AM, Bennett GN, San KY. 2005b. Novel pathway engineering design of the 
anaerobic central metabolic pathway in Escherichia coli to increase succinate 
yield and productivity. Metab Eng 7(3):229-39. 
Sanchez AM, Bennett GN, San KY. 2006b. Batch culture characterization and metabolic 
flux analysis of succinate-producing Escherichia coli strains. Metab Eng 
8(3):209-26. 
149 
Sauer U, Canonaco F, Heri S, Perrenoud A, Fischer E. 2004. The soluble and membrane-
bound transhydrogenases UdhA and PntAB have divergent functions in NADPH 
metabolism of Escherichia coli. J Biol Chem 279(8):6613-9. 
Sawers G. 1999. The aerobic/anaerobic interface. Curr Opin Microbiol 2(2): 181-7. 
Schilling LB. 1995. Chemicals from alternative feedstocks in the United States. FEBS 
Microbiol Rev 16:101-110. 
Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, Witholt B. 2001. Industrial 
biocatalysis today and tomorrow. Nature 409(6817):258-68. 
Schmidt K, Carlsen M, Nielse J, Villadsen J. 1997. Modeling isotopomer distributions in 
biochemical networks using isotopomer mapping matrices. Biotechnol Bioeng 
55:831-840. 
Schmidt K, Norregaard LC, Pedersen B, Meissner A, Duus JO, Nielsen JO, Villadsen J. 
1999. Quantification of intracellular metabolic fluxes from fractional enrichment 
and 13C-13C coupling constraints on the isotopomer distribution in labeled 
biomass components. Metab Eng l(2):166-79. 
Schulz F, Leca F, Hollmann F, Reetz MT. 2005. Towards practical biocatalytic Baeyer-
Villiger reactions: applying a thermostable enzyme in the gram-scale synthesis of 
optically-active lactones in a two-liquid-phase system. Beilstein J Org Chem 
1(1):10. 
Shalel-Levanon S, San KY, Bennett GN. 2005a. Effect of ArcA and FNR on the 
expression of genes related to the oxygen regulation and the glycolysis pathway in 
Escherichia coli under microaerobic growth conditions. Biotechnol Bioeng 
92(2): 147-59. 
Shalel-Levanon S, San KY, Bennett GN. 2005b. Effect of oxygen, and ArcA and FNR 
regulators on the expression of genes related to the electron transfer chain and the 
TCA cycle in Escherichia coli. Metab Eng 7(5-6):364-74. 
Shen J, Gunsalus RP. 1997. Role of multiple ArcA recognition sites in anaerobic 
regulation of succinate dehydrogenase (sdhCDAB) gene expression in 
Escherichia coli. Mol Microbiol 26(2):223-36. 
Soini J, Falschlehner C, Liedert C, Bernhardt J, Vuoristo J, Neubauer P. 2008. Norvaline 
is accumulated after a down-shift of oxygen in Escherichia coli W3110. Microb 
Cell Fact 7:30. 
Spencer ME, Guest JR. 1973. Isolation and properties of fumarate reductase mutants of 
Escherichia coli. J Bacteriol 114(2): 5 63-70. 
Spiro S, Guest JR. 1990. FNR and its role in oxygen-regulated gene expression in 
Escherichia coli. FEMS Microbiol Rev 6(4):399-428. 
150 
Stacewicz-Sapuntzakis M, Bowen PE. 2005. Role of lycopene and tomato products in 
prostate health. Biochim Biophys Acta 1740(2):202-5. 
Stephanopoulos G. 1999. Metabolic fluxes and metabolic engineering. Metab Eng 1(1): 1-
11. 
Stephanopoulos GN, Aristidou AA, Nielsen J. 1998. Metabolic Engineering: Principles 
and Methodologies. Academic Press, San Diego.327pp. 
Stewart JD, Reed KW, Zhu J, Chen G, Kayser MM. 1996. A "Designer Yeast" That 
Catalyzes the Kinetic Resolutions of 2-Alkyl-Substituted Cyclohexanones by 
Enantioselective Baeyer-Villiger Oxidations. J Org Chem 61(22):7652-7653. 
Stols L, Donnelly MI. 1997. Production of succinic acid through overexpression of 
NAD(+)-dependent malic enzyme in an Escherichia coli mutant. Appl Environ 
Microbiol 63(7):2695-701. 
Stols L, Kulkarni G, Harris BG, Donnelly MI. 1997. Expression of Ascaris suum malic 
enzyme in a mutant Escherichia coli allows production of succinic acid from 
glucose. Appl Biochem Biotechnol 63-65:153-8. 
Szyperski T. 1995. Biosynthetically directed fractional DC-labeling of proteinogenic 
amino acids. An efficient analytical tool to investigate intermediary metabolism. 
Eur J Biochem 232(2):433-48. 
Tseng CP. 1997. Regulation of fumarase (fumB) gene expression in Escherichia coli in 
response to oxygen, iron and heme availability: role of the arcA, fur, and hemA 
gene products. FEMS Microbiol Lett 157(l):67-72. 
Tseng CP, Albrecht J, Gunsalus RP. 1996. Effect of microaerophilic cell growth 
conditions on expression of the aerobic (cyoABCDE and cydAB) and anaerobic 
(narGHJI, frdABCD, and dmsABC) respiratory pathway genes in Escherichia 
coli. J Bacteriol 178(4): 1094-8. 
Tseng CP, Yu CC, Lin HH, Chang CY, Kuo JT. 2001. Oxygen- and growth rate-
dependent regulation of Escherichia coli fumarase (FumA, FumB, and FumC) 
activity. J Bacteriol 183(2):461-7. 
Vadali RV, Fu Y, Bennett GN, San KY. 2005. Enhanced lycopene productivity by 
manipulation of carbon flow to isopentenyl diphosphate in Escherichia coli. 
Biotechnol Prog 21(5): 1558-61. 
Van Beilen JB, Mourlane F, Seeger MA, Kovac J, Li Z, Smits TH, Fritsche U, Witholt B. 
2003. Cloning of Baeyer-Villiger monooxygenases from Comamonas, 
Xanthobacter and Rhodococcus using polymerase chain reaction with highly 
degenerate primers. Environ Microbiol 5(3): 174-82. 
151 
van Winden WA, Wittmann C, Heinzle E, Heijnen JJ. 2002. Correcting mass isotopomer 
distributions for naturally occurring isotopes. Biotechnol Bioeng 80(4):477-9. 
Vemuri GN, Eiteman MA, Altman E. 2002a. Effects of growth mode and pyruvate 
carboxylase on succinic acid production by metabolically engineered strains of 
Escherichia coli. Appl Environ Microbiol 68(4): 1715-27. 
Vemuri GN, Eiteman MA, Altman E. 2002b. Succinate production in dual-phase 
Escherichia coli fermentations depends on the time of transition from aerobic to 
anaerobic conditions. J Ind Microbiol Biotechnol 28(6):325-32. 
Venning JD, Jackson JB. 1999. A shift in the equilibrium constant at the catalytic site of 
proton-translocating transhydrogenase: significance for a 'binding-change' 
mechanism. Biochem J 341 (Pt 2):329-37. 
Verho R, Londesborough J, Penttila M, Richard P. 2003. Engineering redox cofactor 
regeneration for improved pentose fermentation in Saccharomyces cerevisiae. 
Appl Environ Microbiol 69(10):5892-7. 
Verho R, Richard P, Jonson PH, Sundqvist L, Londesborough J, Penttila M. 2002. 
Identification of the first fungal NADP-GAPDH from Kluyveromyces lactis. 
Biochemistry 41(46): 13833-8. 
Voordouw G, van der Vies SM, Themmen AP. 1983. Why are two different types of 
pyridine nucleotide transhydrogenase found in living organisms? Eur J Biochem 
131(3):527-33. 
Wagner AF, Schultz S, Bomke J, Pils T, Lehmann WD, Knappe J. 2001. YfiD of 
Escherichia coli and Y06I of bacteriophage T4 as autonomous glycyl radical 
cofactors reconstituting the catalytic center of oxygen-fragmented pyruvate 
formate-lyase. Biochem Biophys Res Commun 285(2):456-62. 
Walton AZ, Stewart JD. 2002. An efficient enzymatic Baeyer-Villiger oxidation by 
engineered Escherichia coli cells under non-growing conditions. Biotechnol Prog 
18(2):262-8. 
Walton AZ, Stewart JD. 2004. Understanding and improving NADPH-dependent 
reactions by nongrowing Escherichia coli cells. Biotechnol Prog 20(2):403-l 1. 
Wang Q, Chen X, Yang Y, Zhao X. 2006a. Genome-scale in silico aided metabolic 
analysis and flux comparisons of Escherichia coli to improve succinate 
production. Appl Microbiol Biotechnol 73(4):887-94. 
Wang Q, Wu C, Chen T, Chen X, Zhao X. 2006b. Expression of galactose permease and 
pyruvate carboxylase in Escherichia coli ptsG mutant increases the growth rate 
and succinate yield under anaerobic conditions. Biotechnol Lett 28(2):89-93. 
152 
Wang W, Li Z, Xie J, Ye Q. 2009. Production of succinate by apflB IdhA double mutant 
of Escherichia coli overexpressing malate dehydrogenase. Bioprocess Biosyst 
Eng 32(6):737-45. 
Warnecke T, Gill RT. 2005. Organic acid toxicity, tolerance, and production in 
Escherichia coli biorefining applications. Microb Cell Fact 4:25. 
Weckbecker A, Hummel W. 2004. Improved synthesis of chiral alcohols with 
Escherichia coli cells co-expressing pyridine nucleotide transhydrogenase, 
NADP+-dependent alcohol dehydrogenase and NAD+-dependent formate 
dehydrogenase. Biotechnol Lett 26(22): 1739-44. 
Weiner JH, Lemire BD, Elmes ML, Bradley RD, Scraba DG. 1984. Overproduction of 
fumarate reductase in Escherichia coli induces a novel intracellular lipid-protein 
organelle. J Bacteriol 158(2):590-6. 
Werpy T, Petersen G. 2004. Top Value Added Chemicals from Biomass. Volume I-
Results of Screening for Potential Candidates from Sugars and Synthesis Gas. 
National Technical Information Service. Springfield, VA. 
Wichmann R, Vasic-Racki D. 2005. Cofactor regeneration at the lab scale. Adv Biochem 
Eng Biotechnol 92:225-60. 
Wiechert W, de Graaf AA. 1997. Bidirectional reaction steps in metabolic engineering 
networks: I. Modeling and simulation of carbon isotope labeling experiments. 
Biotechnol Bioeng 55:101-117. 
Wiechert W, Siefke C, de Graaf AA, Marx A. 1997. Bidirectional reaction steps in 
metabolic networks: II Flux estimation and statistical analysis. Biotechnol Bioeng 
55:118-135. 
Wood D, Darlison MG, Wilde RJ, Guest JR. 1984. Nucleotide sequence encoding the 
flavoprotein and hydrophobic subunits of the succinate dehydrogenase of 
Escherichia coli. Biochem J 222(2):519-34. 
Woods SA, Schwartzbach SD, Guest JR. 1988. Two biochemically distinct classes of 
fumarase in Escherichia coli. Biochim Biophys Acta 954(1): 14-26. 
Wyborn NR, Messenger SL, Henderson RA, Sawers G, Roberts RE, Attwood MM, 
Green J. 2002. Expression of the Escherichia coli yfiD gene responds to 
intracellular pH and reduces the accumulation of acidic metabolic end products. 
Microbiology 148(Pt 4): 1015-26. 
Yang YT, Bennett GN, San KY. 1999a. Effect of inactivation of nuo and ackA-pta on 
redistribution of metabolic fluxes in Escherichia coli. Biotechnol Bioeng 
65(3):291-7. 
153 
Yang YT, San KY, Bennett GN. 1999b. Redistribution of metabolic fluxes in Escherichia 
coli with fermentative lactate dehydrogenase overexpression and deletion. Metab 
Eng l(2):141-52. 
Zeikus JG, Jain MK, Elankovan P. 1999. Biotechnology of succinic acid production and 
markets for derived industrial products. Appl Microbiol Biotechnol 51:545-552. 
Zelle RM, de Hulster E, van Winden WA, de Waard P, Dijkema C, Winkler AA, 
Geertman JM, van Dijken JP, Pronk JT, van Maris AJ. 2008. Malic acid 
production by Saccharomyces cerevisiae: engineering of pyruvate carboxylation, 
oxaloacetate reduction, and malate export. Appl Environ Microbiol 74(9): 2766-
77. 
Zhao J, Shimizu K. 2003. Metabolic flux analysis of Escherichia coli K12 grown on 
13C-labeled acetate and glucose using GC-MS and powerful flux calculation 
method. J Biotechnol 101(2): 101-17. 
Zhu J, Shalel-Levanon S, Bennett G, San KY. 2006. Effect of the global redox 
sensing/regulation networks on Escherichia coli and metabolic flux distribution 
based on C-13 labeling experiments. Metab Eng 8(6):619-27. 
Zhu J, Shalel-Levanon S, Bennett G, San KY. 2007. The YfiD protein contributes to the 
pyruvate formate-lyase flux in an Escherichia coli arcA mutant strain. Biotechnol 
Bioeng97(l):138-43. 
Zupke C, Stephanopoulos G. 1994. Modeling of isotope distributions and intracellular 
fluxes in metabolic networks using atom mapping matrices. Biotechnol Prog 
10:489-498. 
